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ADVANCES IN MOLECULAR THERAPIES  
 
AMT1. In Vitro Evaluation of Type II Ribosome-Inactivating Proteins 
(RIPs) for Experimental Chemoablation of Muscle Cells in Strabismus and Eye-
Movement Disorders 
D. Mercatelli1, M. Bortolotti1, L. Polito1, M. Battelli1, A. Bolognesi1 
1Dipartimento Patologia Sperimentale Bologna, Bologna, Italy 
Background: Today the treatment with botulinum toxin (BTX) is the most used 
molecular surgery of strabismus and other eye-movement disorders, as alternative to 
traditional surgery. However the temporary effect of BTX treatment requires the 
research of alternative therapies. To this purpose the in vitro effects of three type II 
RIPs from plants (lanceolin, stenodactylin and ricin)and of the skeletal muscle-
specific immunotoxin saporin-mAb73 were evaluated on muscle cells. Methods: The 
RIPs and the immunotoxin were tested for their cytotoxicity in three cell lines: L6E9 
(myoblasts), TE671 and RD/18 (rhabdomyosarcoma), both undifferentiated and 
differentiated. The aspecific toxicity was evaluated on conjunctival IOBA-NHC cell 
line. Protein synthesis inhibition, viability and apoptotic changes were assayed. 
Results: All substances showed a strong cytotoxic effect on protein synthesis and 
viability, with IC50 and LC50 ranging from 0.1 nM to 0.01 pM. Lanceolin and 
stenodactylin were 1-2 logs more toxic than ricin and 2-3 logs more toxic than the 
immunotoxin. Myoblasts were particularly susceptible to stenodactylin 
(IC50<0.01pM). All RIP-treated cells showed typical morphological apoptotic 
changes and no signs of necrosis. In further experiments miming in vivo treatment, 
no toxic effects were reported on conjunctival IOBA-NHC cell line. Conclusions: 
The strong cytotoxicity observed for stenodactylin at very low dose could be 
compatible with loco-regional treatments in strabismus and eye-movement disorders. 
It could be possible to modulate the effect on muscle fibers and to obtain a complete 
ablation of myoblasts, gaining more durable effects as compared to BTX treatment. 
Moreover, the absence of necrosis should avoid flogistic side effects. 
 
AGING 
 
AGE1. The Role of Dermal Fibroblasts in the Development of Ectopic 
Calcifications 
F. Boraldi1, G. Annovi1, R. Tiozzo1, D. Quaglino1 
1University of Modena and Reggio Emilia, Modena, Italy 
Background: Ectopic calcifications (EC) represent a deleterious consequence of 
diabetes, renal disorders and aging, being a key determinant of cardiovascular 
morbidity and mortality. Although the molecular pathways leading to the undesired 
mineralization of soft connective tissues have been largely investigated in smooth 
muscle cell cultures (SMC), no effective treatments are available. Methods: To 
further investigate EC, dermal fibroblasts (DF) from healthy individuals and from 
patients affected by Pseudoxanthoma elasticum, a disease characterized by 
progressive calcification of elastic fibres, were grown up to 30 days in a standard or 
in a calcifying medium. Results: Degree of mineralization was evaluated after Von 
Kossa staining, whereas markers of calcification (ALP, ANKH, BMP2, ENPP1, MGP, 
SPP1) were assessed by RT-PCR and Western Blot. Conclusions: Data 
demonstrate that: 1) DF can be responsible for ectopic calcifications in vivo, but, as 
all other mesenchymal cells, require a specific medium to mineralize in vitro; 2) in 
contrast to SMC, cultured DF do not develop a calcifying signature resembling that of 
osteoblasts, 3) changes in osteogenic markers are mostly related to the duration of 
cell cultures, 4) development of a calcified matrix is tightly dependent on the 
characteristics of the extracellular environment and the availability of phosphate 
donor substrates, 5) increased ALP activity is necessary but not sufficient to have 
mineral deposit formation; 6) the complex balance between pro- and anti-calcifying 
factors, including circulating factors as fetuin, plays a significant role in the 
occurrence of ectopic calcifications in vivo. Work supported by FCRMO(EctoCal). 
 
AGE2. Vascular Aging Effect on Medial Aorta Degeneration: Focus on 
Blood Leukocyte Telomere Length in Hypertensive and Old Patients with 
Sporadic Thoracic Aortic Aneurysm 
C. Balistreri1, C. Pisano1, A. Martorana1, M. Bulati1, S. Buffa1, G. Candore1, G. 
Colonna-Romano1, G. Ruvolo1, D. LIo1, C. Caruso1 
1University of Palermo, Palermo, Italy 
Background: Aging is a well recognised factor in the development of cardiovascular 
diseases (i.e. sporadic thoracic aortic aneurysm). The physiological aging process 
determines various changes and a progressive deterioration in structure and function 
of heart and vascular system, i.e. thoracic aorta. As consequence of these age-
related modifications having catalyst and accelerator effect for sporadic thoracic 
aortic aneurysm (S-TAA), medial degeneration occurs. This pathological entity leads 
to weakening of aorta wall, which in turn results in aortic dilatation, aneurysm, 
increased risk for aortic dissections and ruptures. Thus, S-TAA risk increases with 
chronological as well as biological aging. One optimal marker of this might be 
peripheral blood leukocyte telomere content. It accurately reflects that of vascular 
wall and its decrease is associated with premature vascular disease. Thus, the aim 
of this study was the evaluation of mean blood leukocyte telomere length as 
predictor for S-TAA. Methods: Peripheral blood samples were collected from TAA 
patients and age- and gender matched controls. Genomic DNA was extracted from 
leukocytes and telomere length was determined using a chemioluminescence 
technique. We examined patients and controls selected randomly, but considering 
the same age and gender. Results: A significant lower mean telomere length was 
detected in TAA group, significantly correlated with age, smoking, hypertension, 
inflammatory cellular infiltrate and genetic inflammatory variants Conclusions: Thus, 
telomere assay could contribute to identify individuals at risk for S-TAA. Accordingly, 
our results should seem to suggest that vascular biological aging might have a 
strong role in the S-TAA pathogenesis.  
 
AGE3. Trafficking Profile in Naive and Memory B Cells in Young and Old 
Subjects 
M. Bulati1, S. Buffa1, A. Martorana1, C. Balistreri1, M. Pellicanò1, G. Candore1, D. 
Lio1, C. Caruso1, G. Colonna-Romano1 
1University of Palermo, Palermo, Italy 
Background: The impairment of humoral immune response in the elderly human 
population has been extensively demonstrated. We have reported the increase of a 
memory B cell (IgG+IgD-CD27-, double negative, DN) population in the elderly, in 
which there is also a typical inflammatory micro-environment. To evaluate whether 
this pro-inflammatory status could influence the trafficking phenotype of 
naive/memory B cells, we have assessed the expression of CCR7, CCR6, CXCR3, 
CXCR4, CXCR5 and CD62L on naive/memory B subpopulations in young and 
elderly subjects. Methods: We evaluated the expression of some receptors involved 
in trafficking on different naive/memory B cell subpopulations by flow cytometry 
approach, using a FACSCALIBUR Cytometer (BD, CA, US). Results: In young 
donors naive/memory B lymphocytes express different chemokine receptors 
according to the stage of peripheral maturation, whereas the DN B population 
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express only CXCR3, that leads them to site of inflammation. In the elderly donors 
this receptor is higher expressed than in young people. Moreover memory switched 
and DN B cells also express CCR6, which is also involved in the recruitment of cells 
in the site of inflammation. Conclusions: Our data demonstrate that in the elderly 
naive/memory B cell populations express differently the studied receptors from those 
observed in young people. This could be discussed in terms of “inflamm-aging.” Our 
hypothesis is that the inflammatory environment, typical of aging, in some way 
changes the trafficking ability of B cells rendering them more sensitive to the 
cytokines and chemokines that are over-produced in the elderly. 
 
AGE4. Autoantibody Production in Aging: Effect of Cytokine Gene 
Polymorphisms in Sicilian Ultra-Nonagenarians 
G. Candore1, C. Balistreri2, M. Bova2, G. Colonna-Romano2, S. Milano2, M. Palmeri2, 
L. Vaccarino2, C. Caruso2, L. Scola2, D. Lio2 
1University of Palermo, Palermo, Italy; 2Department of Pathobiology and Medical and 
Forensic Biotechnologies, Palermo, Italy 
Background: Several studies have examined changes in immune functions with 
advancing age; in particular, the increase in auto-antibodies production might be a 
marker of the aging associated with a deregulation of immune system. On the other 
hand, pro- or anti-inflammatory genotypes (particularly cytokine polymorphisms) 
might impinge upon successful or unsuccessful aging. Here are reported data on the 
analysis of the effects of cytokine gene polymorphisms on auto-antibody production 
in aging. Methods: We evaluated non-organ specific autoantibodies by an indirect 
fluorescent antibody test system in a group of ultra-nonagenarians typed for 
functionally relevant single gene polymorphisms (SNP) of pro- or anti-inflammatory 
cytokines according to our laboratory procedures. Results: Our results demonstrate 
a significantly increased frequency of anti-nuclear antibody positivity among ultra-
nonagenarians bearing the pro-inflammatory 308A TNF allele. Conversely, the 
percentage of anti-nuclear antibody positivity was significantly reduced among 
subjects bearing the anti-inflammatory 1082G IL-10 SNP. Conclusions: Several 
studies have largely demonstrated the role of an anti-inflammatory genetic 
background in the achievement of successful aging. Present results indicate that non 
organ-specific auto-antibodies production in very old subjects might be an useful 
marker for the evaluation of the effect of aging associated with reshaping of immune 
response in subjects bearing a genetically determined pro- or anti-inflammatory 
profile. 
 
AGE5. Age-related Diseases: Key Role of Insulin Resistance for the 
Association Between Type II Diabetes and Alzheimer’s Disease 
G. Accardi1, C. Caruso1, G. Colonna Romano1, D. Lio1, G. Candore1 
1University of Palermo, Palermo, Italy 
Background: Alzheimer’s disease (AD) and Type 2 diabetes mellitus (T2DM) 
present many relationships. Insulin resistance (IR) plays a key role in neuronal 
degeneration and death. Reduced energy makes neurons more sensible to oxidation 
causing mitochondrial damages. Moreover AD brain has lower insulin utilization, 
reduced expression of its receptors and of IGF 1 and 2, all necessary for neuronal 
survival and learning and memory processes. Hyperinsulinemia is correlated with 
increase of hyerphosphorilated tau-protein. SHIP2, a phosphatase, is an antagonist 
of PI3K. Since the PI3K plays a key role in the biological effects of insulin, its 
attenuation could be associated with IR in T2DM. Methods: We have conducted a 
case-control study evaluating the association of three SNPs of SHIP2 in T2DM and 
AD patients and old and young subjects. SNPs study has been developed by ARMS 
PCR that make it possible to detect a single SNP thanks to the terminal 3’-nucleotide 
of one of the primers that anneal with target mutation. Results: Significant 
differences were observed for one functional SNP between AD patients and young 
subjects, old and young subjects but not AD patients and old subjects. 
Conclusions: Our preliminary results seem to suggest a putative correlation 
between this SNP and aging thus strengthening the hypothesis of a close 
relationship among AD and diabetes. In fact, to verify this relationship we are 
collecting blood from T2DM patients. Moreover we will collect AD samples because 
to confirm these results a bigger cohort needs. 
 
AGE6. Combination Therapy in Neovascular Age-Related Macular 
Degeneration 
D. Veritti1, V. Sarao1, P. Lanzetta1 
1Dept. of Ophthalmology, University of Udine, Udine, Italy 
Background: Pathological choroidal neovascularization (CNV) due to age-related 
macular degeneration (AMD) is a leading cause of legal blindness in people older 
than 50 years in the Western world. CNV is a multifactorial condition whose 
pathogenesis involves angiogenesis, inflammation, and fibrosis. All available 
monotherapies (anti-VEGF agents, steroids, photodynamic therapy with verteporfin 
(PDT-V)) are directed specifically to only one part of the CNV process. The purpose 
of this review is to discuss the current role of combination therapy for the treatment 
of CNV due to AMD. Methods: A MedLine review via PubMed was performed. 
Evidence available from clinical studies evaluating the use of the combination of anti-
VEGFs, steroids and/or PDT-V and from a selective literature search has been 
considered for this review. Results: The results of trials focused on the actual 
options in the management of neovascular AMD are discussed. Anti-VEGF 
monotherapy results in a significant increase in visual acuity in patients with wet 
AMD. The combination of anti-VEGFs with occlusive therapies (PDT-V) potentially 
offers a reduction of re-treatment rate while maintaining long-term visual benefit. 
Steroids demonstrated an antiangiogenic effect, targeted the extravascular 
components of CNV such as inflammatory cells and fibrocytes and seems to be 
efficacious in patients non-responder to anti-VEGF monotherapy. Conclusions: 
Combination therapy has been proposed to interfere with the multiple stimuli to 
pathologic vascular proliferation. Many experiences have been conducted and 
showed encouraging results. Although there is a strong rationale for applying 
multiple combined therapy in the treatment of CNV, further study is required to 
determine correct combinations and dosage. 
 
AGE7. Mediterranean Diet and Longevity 
S. Vasto1, C. Rizzo1, C. Caruso1 
1University of Palermo, Palermo, Italy 
Background: The effect of calorie restriction on human health has been debated 
due to the lack of information and appropriate study. Furthermore, in many 
population-based studies and randomized trials there are evidences that a dietary 
pattern rich in some nutritional food groups such as fruits and vegetables plays a role 
in delaying age-related diseases. In the inner part of Western Sicily we have some 
"blue zones" where the ratio of centenarians vs. total population is higher (4.32) than 
in the Italian population (2.4). Those “blue zones” are located far from the sea in the 
area of Sicani Mountains. Methods: The people that we interviewed are female and 
male centenarians belonging to several villages that underwent many analyses: 
hematological, chemical analysis, complete anamnesis, ADL, MMSE and MNA 
nutritional assessment tests. Furthermore oxidative stress assessment, such as 
ROS and NOS, were performed. Also dietary intake, through 24 hours recall has 
been recorded and different levels of adherence to the Mediterranean diet observed. 
Results: The results taken together showed a good control of hematological and 
chemical parameters of healthy status and good adherence to Mediterranean diet, 
which seems to play a key role in diseases prevention. Conclusions: Mediterranean 
diet might play a key role in disease prevention and for management of age-related 
diseases. To reach successful aging it is advisable to follow a diet with low quantity 
of saturated fat and high amount of fruits and vegetables rich in phytochemicals. 
 
AGE8. Impact of Smoking, Alcohol Consumption and Aging on 
Antioxidant/Pro-Oxidant Balance in Age-Related Macular Degeneration 
M. Venza1, M. Visalli1, C. Saoca1, M. Cucinotta1, R. OterI1, D. Teti1, I. Venza1 
1University of Messina, Messina, Italy 
Background: Oxidative stress, inflammation, and genetics are thought to contribute 
to the development of age-related macular degeneration (ARMD), the most common 
cause of blindness in the elderly. The aim of this study was to determine whether 
smoking, alcohol consumption and aging, which constitute the main exogenous 
sources of reactive oxygen species (ROS), affect the balance between oxidant 
production and antioxidant levels in ARMD. Methods: Superoxide dismutase (SOD), 
glutathione peroxidase (GSHPx), and catalase (CAT) activities as well as 
malondialdehyde (MDA), protein carbonyl (PC), 8-hydroxy-29-deoxyguanosine (8-
OhdG) and total oxidation status (TOS) levels, were measured in patients with early 
ARMD (n=211) and late ARMD (n=205), and control persons (n=262). Results: 
When compared with healthy controls, early- and late- ARMD patients showed 
significant decreases in the activities of SOD and GSHPx, but not CAT, along with 
marked enhancements of MDA, PC, TOS and 8-OhdG (P < 0.01). No notable 
differences were observed in the early- versus the late-ARMD group for each of the 
above-mentioned dependent variables. Multiple regression analysis revealed that in 
healthy subjects chronic smoking and aging had the strongest impact on oxidative 
stress parameters, whereas in ARMD patients, the combination of smoking, drinking, 
and aging was the greatest predictor of oxidative DNA, protein and lipid damage. 
Conclusions: Cigarette smoking, alcohol consumption and aging could be 
aggravating factors contributing to serious redox imbalance and oxidative damage in 
ARMD. Identification of factors exacerbating ARMD-associated oxidative stress can 
facilitate development and adoption of effective preventative measures for this 
disease. 
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AGE9. BPIFB4 Missense Variants Associate with Exceptional Longevity 
in Independent Populations and Influence Cell Signaling 
A. Puca1, F. Villa2, A. Ferrario3, A. Malovini4 
1University of Salerno, Baronissi, Italy; 2ITB-CNR, Segrate, Italy; 3IRCCS 
Multimedica, Milano, Italy; 4University of Pavia, Pavia, Italy 
Background: Centenarians, despite being exposed to the same environmental 
conditions as members of the average population, manage to live much longer. A 
recent Genome-Wide Association Study (GWAS) for exceptional longevity in 
Southern Italian Centenarians (SICs) identified four SNPs that were either non-
synonymous or non-synonymous taggers with a P < 1x10-4. Methods: A two-stage 
genetic association study on long-living individuals and controls, followed by in vitro 
and ex vivo kinase activity detection of mutated and wild type BPIFB4. Results: We 
identified rs2070325 (BPIFB4-Ile268Val) consistently associated with human 
longevity under recessive model in Italian, German and US cohorts. Rs2070325 is in 
strong LD (r2=0.93/D’=0.98) with rs2889732 (BPIFB4-Asn320Thr) and in vitro 
studies show that BPIFB4 is detected in cytoplasmic vescicles and secreted together 
with 14-3-3. HEK293T transfections with Ile268Val/Asn320Thr BPIFB4 activate PKC 
alpha, AMPK, p65/RELA and improves BPIFB4/14-3-3 cellular secretion, 
counteracting PKC alpha, AMPK and p65/RELA inhibition observed after wild type 
BPIFB4 transfection. Conclusions: Further studies are needed to understand why 
these mutations are protective for human health. 
 
AGE10. In Situ Determination of Epigenetic Mechanisms at Work in Soft 
Elastic Tissues during Aging 
P. Sommer 
Institut de Biologie et Chimie des Protéines, Lyon, France 
Background: Epigenetic modifications, such as DNA methylation and histone 
modification, are largely responsible for the variable activation and repression of 
specific genes at specific time points during cell lifespan. Thus, epigenetic 
mechanisms have been described as crucial processes for embryonic development 
and deregulation leading to malignant transformation or senescence and aging. 
More recently, epigenetic imprinting has been associated to stem cell 
reprogramming and therefore to tissue growth and regeneration. Methods: The 
methylation of mammalian genomic DNA mainly occurs in GC rich regions termed 
CpG islands. Methylation of cytosine residues is catalyzed by DNA 
methyltransferases (DNMTs), which encompass three active isoforms: DNMT1, 
DNMT3a and DNMT3b. DNMT1 is mainly associated to the maintenance of the 
methylation pattern on the daughter stand during DNA replication, whereas DNMT3a 
and DNMT3b are powerful de novo methyltransferases. Results: In our studies, we 
have focused on the epigenetic imprinting that could affect the differentiation of 
elastic tissues, as a hallmark of well formed and healthy tissues, a status that must 
be reached to heal, to reconstruct and to regenerate soft tissues. Though epigenetic 
mechanisms have been poorly investigated for such tissues, GpC rich motifs 
allowing Sp-1/Sp-3 binding on extra cellular matrix genes have been documented. 
Conclusions: Our recent experiments confirmed the importance of such GC rich 
regions on the methylation status of promoters driving genes encoding elastic fiber-
related elements. Several technical approaches have been proposed to be as close 
as possible of the native tissue, including the determination of CpG methylation 
pattern from embedded human tissues. 
 
AGE11. Involvement of Oxysterols in the Pathogenesis of Alzheimer’s 
Disease 
G. Testa1, P. Gamba1, E. Tamagno2, M. Guglielmotto2, S. Gargiulo1, B. Sottero1, G. 
Leonarduzzi1, G. Poli1 
1Department of Clinical and Biological Sciences, University of Turin, Orbassano, 
Italy; 2Department of Experimental Medicine and Oncology, University of Turin, 
Torino, Italy 
Background: Alzheimer’s disease (AD) is a neurodegenerative disorder 
characterized by the extracellular accumulation of amyloid-beta (Aβ) in neuritic 
plaques. Altered cholesterol metabolism in the brain has been suggested to be 
implicated in pathogenesis of AD. Methods: We have investigated the potential 
interaction between the oxysterols 24-hydroxycholesterol (24-OH), 27-
hydroxycholesterol (27-OH) and 7β -hydroxycholesterol (7β -OH), present in the 
brain, and Aβ in human differentiated neuronal cell lines, SK-N-BE and NT-2. 
Expression and synthesis of CD36 and β1-integrin receptors were analyzed by real 
time RT-PCR and Western blotting. The necrotic, apoptotic and redox parameters 
were measured by microscopic and biochemical analysis. Results: Our studies 
show that all three oxysterols enhance the binding of Aβ to neuronal cells by up-
regulating expression and synthesis of CD36 and β1-integrin receptors, which both 
form, with CD47 receptor, the multireceptor complex that mediates the Aβ binding to 
the plasma membrane of neurons. However, only 24-OH markedly potentiates the 
proapoptotic and pronecrogenic effects of Aβ on cells, likely through a strong 
enhancement of reactive oxygen species’ (ROS) generation and impairment of cell 
redox equilibrium. Cell incubation with antioxidants quercetin or genistein prevents 
24-OH’s pro-oxidant effect and potentiation of Aβ -induced necrosis and apoptosis. 
Thus, the presence of 24-OH in the close vicinity of amyloid plaques appears to 
enhance the adhesion of large amounts of Aβ to the plasma membrane of neurons, 
then to amplify the neurotoxic action of Aβ by locally increasing ROS steady-state 
levels. Conclusions: These results support a primary involvement of altered brain 
cholesterol metabolism in the complex pathogenesis of AD. 
 
AGE12. Interaction Between 4-Hydroxynonenal and Amyloid-β in 
Amplifying Neuronal Damage 
P. Gamba1, G. Testa1, S. Gargiulo1, B. Sottero1, F. Di Scipio1, A. Sprio1, P. 
Salomone1, G. Berta1, G. Leonarduzzi1, G. Poli1 
1Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy 
Background: Alzheimer’s disease (AD) is characterized by intracellular 
neurofibrillary tangles made of hyperphosphorylated tau and senile plaques made of 
extracellular deposits of amyloid β (Aβ). Lipid peroxidation is considered as primarily 
involved in the pathogenesis of AD. One of its more reactive end-products, 4-
hydroxynonenal (HNE), has been proposed as a candidate biomarker of AD because 
it was found in the brain of AD patients, in both neurofibrillary tangles and in senile 
plaques, as well as in the cerebrospinal fluid. HNE production in the brain is 
stimulated by Aβ and, conversely, Aβ formation is up-regulated by HNE. Methods: 
We applied a precursor-cell-based approach, comprising primary cultures of human 
dental-pulp progenitor cells, which spontaneously differentiate to neuron-like cells in 
vitro. Membrane receptor gene expression was quantified by real time RT-PCR. 
Amyloid β internalization was observed by Congo red staining. Necrosis was 
evaluated by measuring the extracellular percentage of lactate deydrogenase. 
Results: Our findings point to the ability of HNE and Aβ to interact, with consequent 
potentiation of Aβ’s cytotoxicity. HNE was found to cause overexpression not only of 
CD36 but also of another component of the multireceptor complex that binds the Aβ 
peptide, namely β 1-integrin. The up-regulation of these components allowed the 
neurotoxic peptide to accumulate in greater amounts within the cells, and to induce 
much more extensive cell death than occurred in cells challenged with Aβ alone. Cell 
death was completely prevented by the specific receptor blockade. Conclusions: 
These results support the involvement of HNE in the pathogenesis of AD. 
 
BIOMARKERS FOR (NON-CANCER) DISEASE DETECTION 
 
BM1. HepG2 Spheroids as in Vitro Model to Study the Release of 
Gamma-glutamyltransferase Fractions 
M. Franzini1, F. Nemo2, E. Lorenzini2, A. Corti2, I. Fornaciari2, A. Paolicchi2, V. 
Fierabracci2 
1Scuola Superiore Sant'Anna, Pisa, Italy; 2Dip. Patologia Sperimentale B.M.I.E., 
Università di Pisa, Pisa, Italy 
Background: Four gamma-glutamyltransferase (GGT) fractions (b-, m-, s-, and f- 
GGT) have been described in plasma. Clinical study on healthy subjects and 
patients affected by non-alcoholic or alcoholic liver disease or chronic viral hepatitis 
showed that s-GGT fraction is a marker of hepatocellular damage, whereas b-GGT 
is an index of liver metabolic dysfunction. Methods: Aim of this study is to deepen 
the mechanism of fractional GGT release by hepatocytes. For this purpose we used 
HepG2 cells cultured as spheroids. Morphology, biochemical parameters (GGT 
activity, protein content), cellular GGT distribution (immunohistochemistry) were 
evaluated over a period of 15 days. Secreted GGT fractions were quantified by gel-
filtration chromatography associated with a GGT-specific post-column reaction. 
Results: HepG2 spheroid formation can be divided in two stages, immature (1-6 
days) and mature (>6 days). In the media of immature spheroids only b-GGT [mean 
(SD), 1.31 (0.01) U/L] and f-GGT [0.45 (0.01) U/L] were present. Between day 6 and 
9, f-GGT [3.49 (0.36) U/L, P < 0.001 vs. day 6] and s-GGT [0.25 (0.02) U/L, P < 
0.001 vs. day 6] increased significantly, whereas b-GGT activity was unchanged 
[1.04 (0.08) U/L]. Morphological and immunohistochemical analysis showed the 
presence, in mature spheroids, of structure compatible with bile-canaliculi 
surrounded by GGT protein. s-GGT fraction was non-detectable in media obtained 
from HepG2 monolayer culture. Conclusions: In conclusion, mature HepG2-
spheroid culture is a good model for the in vitro study of fractional GGT release. 
Obtained results showed that the 3D structure is necessary for the secretion of s-
GGT, which could result from an extracellular modification inside bile-canaliculi. 
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BM2. YKL-40 (Versus COMP) as a New Marker of Knee Osteoarthritis 
F. Poggioli1, T. Taverriti2, C. Crapanzano2, W. Albisetti3, G. Mineo3, B. Marelli4 
1Clinca Ortopedica Traumatologica - Università delgi Studi di Milano, Milano, Italy; 
2A.O. Istituto Ortopedico Gaetano Pini, Milano, Italy; 3Clinica Ortopedica 
Traumatologica - Università delgi Studi di Milano, Milano, Italy; 4Dipartimento 
OrtoTraumatologia Generale -A.O. Ist Ortop. Gaetano Pini, Milano, Italy 
Background: The identification and study of markers of osteoarthritis is an 
established goal of the scientific community. The purpose of this work is to point out 
the correlations between YKL-40 and COMP, two glycoproteins involved for a long 
time, as markers in the study of the osteo-cartilagineous degenerative process. The 
efficacy of YKL-40 as a serum marker of cartilage has been demonstrated in patients 
with knee osteoarthritis (OA), correlating the variations of the same group with 
viscosupplementant treatment and with COMP serum. Methods: 35 patients, divided 
into two groups, were recruited for the study. The first group was administered a 
cycle of 5 intra-articular injections of hyaluronic acid while the second group received 
a cycle of 5 injections of polynucleotide gel. Patients were evaluated by means of 
end-points including the KOOS scale and VAS. Results: In all the three groups there 
is indiscriminately a decrease in pain symptoms. In the second subgroup of patients 
(moderate osteoarthritis) the amount of YKL-40 at 3 weeks decreased significantly 
(P = 0.0473 CI 95%). After 5 weeks, in the same subgroup, a significant decrease of 
COMP (P = 0.0003 CI 95%) was noted. As for COMP, YKL-40 seems to be a valid 
biomarker in evaluating the severity of the initial osteoarthritis; it also appears to be 
effective in monitoring the clinical course of patients with moderate osteoarthritis. 
Conclusions: The two proteins appear to describe different aspects of osteoarthritis: 
YKL-40 is more sensitive in monitoring short-term variations, whereas COMP is more 
suitable to monitor the long term. 
 
BM3. Simultaneous Detection of Circulating Biomarkers of Oxidative 
Stress and Endothelial Dysfunction in Patients with Psoriatic Arthritis (PsA) 
V. De Gennaro Colonna1, P. Ferrario1, L. Tomasoni1, M. Turiel1 
1State University of Milano, Milano, Italy 
Background: Psoriatic arthritis (PsA)is a chronic inflammatory arthritis associated 
with significant disability and increased cardiovascular mortality. Enhanced oxidative 
stress and endothelial dysfunction may contribute to the increased cardiovascular 
risk in patients with PsA. To ascertain simultaneous presence of oxidative stress and 
endothelial dysfunction in PsA patients, we measured plasma levels of 
malondialdehyde (MDA, marker of lipid peroxidation), protein carbonyls (ProCa, 
marker of protein oxidation), asimmetric dimethylarginine (ADMA, marker of 
endothelial dysfunction), and L-arginine and evaluated L-arginine/ADMA ratio as a 
measurement of endothelial dysfunction. Methods: Twenty patients with PsA without 
any signs of cardiovascular disease and 20 healthy controls were recruited for our 
study. PsA patients were matched for age, sex and disease duration. Fasting venous 
blood samples were obtained and plasma was used for determination of MDA with 
high-performance liquid cromatography (HPLC), ProCa with fluorescein 
thiosemicarbazide fluorimetric assay, ADMA and L-arginine with HPLC. Results: 
Plasma MDA and ProCa levels were significantly higher in PsA patients than in 
healthy controls (1.43 +/- 0.09 micromol/L and 0.24 +/- 0.02 nmol/mg proteins vs. 
respectively 0.57 +/- 0.08 micromol/L and 0.10 +/- 0.02 nmol/mg proteins, P < 
0.001). Conclusions: In conclusion, increased oxidative stress coupled with 
endothelial dysfunction (as shown by increased plasma ADMA levels and reduced L-
arginine/ADMA ratio) is present in PsA patients. 
 
BM4. Dopaminergic Receptor Gene Polymorphisms in Children 
Affected by ADHD/ASD Overlapping 
A. Vincenti1, F. Craig1, A. Lamanna1, A. Cassano1, R. Fumarulo1, L. Margari1, M. 
Mariggio1 
1University of Bari, Bari, Italy 
Background: Several studies have shown a genetic role in the pathogenesis of 
many childhood psychiatric disorders. The most common childhood psychiatric 
disorder is the attention deficit hyperactivity disorder (ADHD) and some reports 
showed the co-occurance in ADHD children and Autism Spectrum Disorders (ASD). 
Many investigators focused their attention on polymorphisms affecting gene regions 
coding for dopamine receptors. In this study we evaluate the association of three 
single-nucleotide polymorphisms (SNPs) with clinically significant level of autistic 
symptoms among children with ADHD. Methods: We enrolled 150 children who 
were divided into four groups: children with ADHD, children with ASD, children with 
co-occurance of ADHD/ASD, and control subjects. We investigated rs265975 C/T 
(174862195C>T) for dopamine receptor D1 gene, rs1076560 C/A (113283688C>A) 
and rs1079597 G/A (113296286C>T) for dopamine receptor D2 gene utilizing 
previous DNA extraction and amplification, restriction enzymes that recognized one 
of two allelic variants. Results: Our results demonstrated that homozygosis T/T for 
rs265975 had a lower frequency in ADHD patients compared to other groups, 
whereas small differences were seen in heterozygosis C/T. Both heterozygosis C/A 
for rs1076560 and heterozygosis G/A for rs1079597 showed higher frequency in 
ASD group with respect to control children and ADHD patients, whereas in 
ADHD/ASD group a ratio 3:1 vs unaffected people was seen. The same trend, but 
with slight differences, was observed in homozygosis A/A for rs1076560 and 
rs1079597. Conclusions: These preliminary data pointing to differences between 
ADHD/ASD and other groups must be confirmed and encourage us to enlarge our 
study populations. 
 
BM5. Performance of CD64 Index and Soluble TREM-1 as Biomarkers in 
Late Onset Sepsis of Preterm Neonates 
I. Mazzucchelli1, L. Ciardelli1, F. Garofoli1, M. Angelini1, C. Cova1, A. Borghesi1, G. 
Merlini1, M. Stronati1 
1Fondazione IRCCS Policlinico San Matteo, Pavia, Italy 
Background: In Neonatal Intensive Care Units, infections remain important cause of 
neonatal morbidity and mortality. Early and accurate diagnosis improves the 
outcome. The aim of this study was to explore the performance of CD64 index and 
solubleTREM-1 as biomarkers of sepsis in a group of preterm neonates. Methods: 
We enrolled 54 neonates with gestational age < 32 weeks and weight <1500 gr. 
Sixteen newborns (septic group) developed late onset sepsis (culture positive) 
during the 16th to 25th days of life (T1); they were also tested between the 5th and 
15th days of life (T0, free from infection). Thirty-eight preterm, without clinical and 
laboratory signs of sepsis, were tested between day 5 to 20 of life as laboratory 
normal range. Fifty-microliter blood samples were processed using the Leuko64 
Assay kit and analyzed with an Abbott Cell-Dyn Sapphire hematology analyzer. 
Soluble TREM-1 was quantified using sandwich immunoassay kit. Statistical analysis 
was performed by Medcalc. Results: Clinical and laboratory data, whole blood 
leukocytes, neutrophils, monocytes and platelet counts were comparable in all the 
groups/conditions, besides a significant increase (P = 0.049) of neutrophils in septic 
group (T0 vs T1). CD64 index increased significantly in septic group T1 vs T0 (P = 
0.0002) and T1 vs control group (P = 0.0001) and ROC curve indicated cut-off 2.86, 
sensitivity 87.52%, specificity 97.1%, AUC 0.925. Soluble TREM-1 didn’t show any 
differences in septic group (T1 vs T0 P = 0.9) and T1 vs control group (P = 0.8). 
Conclusions: In preterm neonates CD64 index can be useful as biomarker of late-
onset sepsis whereas solubleTREM-1 showed less efficient diagnostic role. 
 
BM6. Senescence Markers 
D. Lio 
University of Palermo, Palermo, Italy 
Background: Evolutionary theory and empirical evidence suggest that aging is a 
process of gradual accumulation of damage in cells and tissues of the body. The 
progressive loss of ability to interact effectively with environmental stimuli is 
accompanied by progressive modification and adaptations that are influenced by 
lifestyle and genetic background of the individual. These affect the ability to age 
successfully, defined both as longevity and/or escaping the major age-related 
diseases. Some of the most important characteristics of adaptive immunity in aging 
are compatible with this assumption. Actually, the antigenic load results in the 
progressive generation of a chronic low grade inflammatory response involved in 
body and brain aging. Methods: Data on genetic background and immune system 
have been obtained in the last 10 years studying Sicilian centenarians and subjects 
affected by aging related diseases. Results: Studies have been focused on the 
genetic background predisposing to aging related diseases. Data gathered on gene 
variants in cytokine, pathogen-related pattern receptors or acute phase response 
genes allow the research group to define a complex trait in which the antagonistic 
pleiotropy of regulating immune-inflammatory mechanisms might play a central role 
in predisposing to a large array of age-related diseases and in determining lifespan 
expectancy. Conclusions: These findings suggest that different alleles at different 
immune-related genes coding for pro- or anti-inflammatory molecules may affect 
individual life-span expectancy and might be useful markers for the evaluation of 
aging-associated disease risk. 
 
BM7. Training Effects on Laboratory Parameters Are Independent of 
Genetic Polymorphisms of IL-10 and TNF-alpha (TNF-α) 
M. Palmeri1, G. Giganti2, F. Verna3, L. Vaccarino1, M. Bova1, G. Misiano1, S. Milano1, 
L. Scola1, D. Lio1, R. Verna4 
1University of Palermo, Palermo, Italy; 2Università “TorVergata”, Roma, Italy; 
3Univesità degli Studi di Roma “La Sapienza”, Roma, Italy; 4Università “La 
Sapienza”, Roma, Italy 
Background: It is well known that exercise has beneficial effects on health. 
Although intense exercise is experienced by the body as a condition of stress, a well 
designed training has long term beneficial effects on the organism of an athlete. Less 
is known about the effects that the genetic background might have on training 
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adaptation and on the consequent modification of laboratory parameters. Methods: 
In our study we evaluated the blood chemistry parameters of a group of 41 athletes 
compared with a group of 45 amateur athletes, to assess whether the training has 
effects on their variation. In addition we typed our subjects for polymorphisms 308 
A/G of the tumor necrosis factor-α (TNF-α) and 1082 A/G of Interleukin-10 (IL10). 
Results: After statistical analysis, performed with Mann-Whitney Test, we observed 
a statistically significant (p value< 0,05) increase of basophils, eosinophils, 
monocytes, and total bilirubin and decreased levels of neutrophils, glucose, 
electrolytes and AST in professionals compared to amateurs. These parameters 
were not modified by the genetic background. Actually the training modification 
observed were independent of the presence of pro-inflammatory (carrier allele A of 
1082 A/G of IL10) or anti-inflammatory alleles (subjects A negative for 308 A/G of 
TNFα). Conclusions: The genetic polymorphisms analyzed do not influence 
changes in laboratory parameters values induced by professional training. 
 
BM8. TGF-β Pathway Polymorphisms as Markers for Gender 
Differential Susceptibility to Sporadic Thoracic Aortic Aneurysm 
L. Scola1, L. Vaccarino2, C. Balistreri2, C. Pisano3, M. Palmeri2, M. Bova2, F. Di 
Maggio2, G. Candore2, G. Colonna Romano2, C. Caruso2, D. Lio2, G. Ruvolo3 
1University of Palermo, Palermo, Italy; 2University of Palermo, DpT DiBiMeF, 
Palermo, Italy; 3Department of Surgery and Oncology University of Palermo, 
Palermo, Italy 
Background: It has become increasingly evident that the immune system plays a 
pivotal role in the development of thoracic aortic aneurysm (TAA). The Transforming 
Growth Factor (TGF) -β isoforms might be involved in TAA pathogenesis inducing 
disruption of extracellular matrix, apoptosis of smooth cells in tunica media, 
metalloprotease production and remodelling tissues after inflammation. Methods: 
133 subjects affected by TAA (from Cardiac surgery Unit of Palermo University 
Hospital), 107 unrelated patients of the same unit without TAA and a group of 91 
healthy controls matched for age and gender, all living in western Sicily, were typed 
for TGF-β1, TGF-β2 and their receptors polymorphisms by a KASPar assay (the 
KBiosciences Competitive Allele-Specific PCR SNP genotyping system). Genotype 
and allele frequencies were compared by statistical analysis. Results: No 
differences in distribution between cases and controls were observed except for 
TGF-β2 rs900 TT genotype, whose frequency was increased in patients affected by 
aortic aneurysm in comparison to the controls (P =  0.037). In particular this 
genotype was significantly increased in women affected by TAA in comparison both 
to women of control patient group ( Pvalue = 0.042) and of health control group (P = 
0.010). Conclusions: TAA is a complex pathology with a greater prevalence among 
men. Our results suggest that rs900 TGF-β SNP might be a genetic factor involved 
in women’s susceptibility to TAA. 
 
BM9. Evaluation of Genome-Wide Expression Profiles of Blood 
Neutrophils in Cystic Fibrosis Patients Before and After Antibiotic Therapy 
M. Conese1, O. Palumbo2, S. Castellani1, G. Barbuti3, A. Polizzi4, T. Santostasi4, M. 
Mariggiò3, R. Fumarulo3, A. Manca4, P. Montemurro3, M. Carella2 
1Department of Biomedical Sciences, University of Foggia, Foggia, Italy; 2Medical 
Genetics Unit, IRCCS - ”CSS” Hospital, San Giovanni Rotondo, Italy; 3Department of 
Biomedical Sciences and Human Oncology, Univ. of Bari, Bari, Italy; 4Cystic Fibrosis 
Regional Center, University of Bari, Bari, Italy 
Background: Cystic fibrosis (CF) lung disease is characterized by massive 
extravasation of neutrophils into the airways that undergo apoptosis and thereby do 
not clear respiratory infections. The surrogate end-points that describe this process 
and the effect of antibiotic therapy, such as spirometry, are not sensitive and non- 
specific. We sought to evaluate the gene expression profile of circulating neutrophils 
in CF patients before and after antibiotic treatment. Methods: Microarray analysis 
(28,869 genes, Affymetrix GeneChip Gene 1.0 ST Array System) was performed in 
blood neutrophils from 10 CF patients before and after treatment for clinical 
exacerbation with antibiotics and 7 healthy control subjects. Results: Blood 
neutrophils before therapy presented 293 down-regulated genes and 57 up-
regulated genes as compared with control subjects (considering as cut-off P < 0.05 
by ANOVA). Comparison between the same patients before and after therapy (with 
the same cut-off by paired t test) showed instead that 1,422 genes were down-
regulated and 282 up-regulated following antibiotic treatment. Interestingly, three 
genes appeared to be sensitive to therapy and returned to “healthy” condition: 
phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1), hydrogen voltage-
gated channel 1 (HVCN1), and dom-3 homolog Z (DOM3Z). The up-regulation of 
these genes after therapy were confirmed by RT-PCR in blood neutrophils (n=5) and 
in sputum neutrophils obtained from the same patients (n=7). Conclusions: These 
results suggest the feasibility of investigating novel biomarkers of therapeutic 
efficacy by a global gene-wide platform and indicate more specific targets for future 
interventions involving respiratory burst and apoptosis. 
BM10. First Trimester Biochemistery to Predict Cesarean Section for 
Fetal Distress and Cardiotocographic Alterations During Labor at Term of 
Gestation 
A. Londero1, L. Driul2, M. Ceraudo3, S. Visentin4, M. Della Martina2, S. Bertozzi5, F. 
Curcio3, D. Marchesoni2 
1University of Udine, Udine, Italy; 2Clinic of Obstetrics and Gynecology, University of 
Udine, Udine, Italy; 3Institute of clinical pathology, University of Udine, Udine, Italy; 
4Department of Gynecological Sciences and Human Reproduction, Universit, Padua, 
Italy; 5Department of Surgery, AOU “SM della Misericordia” of Udine., Udine, Italy 
Background: At this time the literature tries to predict the outcome of pregnancy in 
the first trimester of pregnancy such as analyzing placental function. Our study 
compares first trimester clinical and biochemical characteristics between controls 
and pregnancies affected by cardiotocographic (CTG) anomalies or characterized by 
urgent Cesarean section (CS) during labor at term. Methods: In this study at term 
pregnancies were considered. Clinical and biochemical characteristics were 
evaluated during the first trimester. The blood examinations have been performed 
between 2004 and 2010. We collected data about all CTGs performed during labor 
classified in three categories based on the National Institute of Child Health and 
Human Development terminology of 2008: 1)normal; 2)intermediate; 3)abnormal. 
Results: In a multivariate logistic regression reduced PAPP-A is correlated with a 
higher frequency of urgent CS at term of pregnancy (P < 0.05), regardless of 
hypertensive disease of pregnancy, IUGR, BMI, maternal age, gestational age at 
delivery and other obstetric pathologies considered. Abnormal CTGs were 
associated with older maternal age, higher prevalence of nulliparous women, and 
lower placenta weight than normal ones (P < 0.05). First minute Apgar scores were 
lower in category 3 than in 1 and 2 (P < 0.05). Finally, CTG alterations defined in 
category 3 were correlated with lower free-beta-hCG and PAPP-A values during the 
first trimester, although without statistical significance. Conclusions: A low PAPP-A 
in the first trimester of pregnancy appears to be correlated with a higher frequency of 
urgent CS at term of pregnancy and fetal distress during labour. 
 
BONE METABOLISM 
 
BMT1. Nitric Oxide Mediates Low Magnesium Inhibition of Osteoblast-
Like Cell Proliferation 
S. Castiglioni1, W. Albisetti1, G. Banfi1, J. Maier1 
1University of Milan, Milano, Italy 
Background: An adequate intake of magnesium is important for bone cell activity 
and contributes to the prevention of osteoporosis. Because i) magnesium is 
mitogenic for osteoblasts and ii) reduction of osteoblast proliferation is detected in 
osteoporosis, we investigated the influence of different concentrations of 
extracellular magnesium on osteoblast-like SaOS-2 cell behavior. Methods: SaOS-2 
cells were cultured in media containing different concentrations of magnesium. Nitric 
oxide synthase (NOS) activity was evaluated by mass spectrometry and Griess 
assay. NOS isoforms were studied by western blot. Results: We found that low 
extracellular magnesium inhibited SaOS-2 cell proliferation. An addictive effect was 
observed when cells cultured in low magnesium were silenced for the magnesium 
transporter Transient Receptor Potential Melastatin (TRPM)7, which plays a 
prominent role in intracellular Mg homeostasis. In particular, we found that low 
magnesium inhibition of SaOS-2 cell proliferation was due to an increase of nitric 
oxide production through the up-regulation of inducible nitric oxide synthase (iNOS). 
Indeed, both pharmacological inhibition with the iNOS inhibitor L-NIL and genetic 
silencing of iNOS by siRNA restored the normal proliferation rate of the cells. 
Conclusions: Because a moderate induction of nitric oxide is sufficient to potentiate 
bone resorption and a relative deficiency in osteoblast proliferation can result in their 
inadequate activity, we conclude that maintaining Mg homeostasis is relevant to 
ensure osteoblast function and, therefore, to prevent osteoporosis. 
 
BMT2. Fragility Fractures and High Energy Fractures: Serum 
Concentrations of IL-6, TNF-Α, OPG, RANKL and Their Correlation with 
Radiographic Assessment 
M. Giganti1, F. Liuni1, M. Celi1, E. Gasbarra1, R. Zenobi1, I. Tresoldi1, A. Modesti1, R. 
Bei1, U. Tarantino1 
1University of Rome Tor Vergata, Rome, Italy 
Background: Stages of bone turnover during fracture repair can be assessed 
employing serum markers of osteoblastic and osteoclastic activity, inflammatory 
cytokines, clinical evaluation and imaging instruments. Our study compares the 
fracture healing process in fragility fractures and high energy fractures by evaluating 
serum changes of IL-6, TNF-α, OPG and RANK-L in combination with radiographic 
(RUST) and clinical (LEM) assessments. Methods: Subjects: femoral or tibial shaft 
fractures (group A,14), femoral fractures (group B,14), healthy (control A,14) and 
osteoporotic subjects (control B,14). Serum concentrations of IL-6, TNF-α were 
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quantified by Quantikine R&D Systems, RANK-L by BioVendor and OPG by 
Biomedica Medizinprodukte. Results: Results showed a significant decrease in IL-6 
and TNF-α during fracture healing, with their values higher in group A than B and 
lower in both controls compared to T0 (before surgery). OPG was significantly lower 
in each control group than that of the respective fractured group. In addition, OPG at 
T0A was significantly lower than at T0B whereas at T10A (after 10 weeks) OPG was 
less than at T10B. RANKL was significantly higher at T10 than at T0 only in group B. 
RANKL/OPG ratio was significantly higher in both controls than in fractured groups 
and significantly increased at T10. IL-6 and TNF-α correlated with RUST and LEM in 
fragility fractures and high energy fractures, whereas RANKL/OPG ratio was 
associated with these parameters only in fragility fractures. Conclusions: Our 
findings suggest that these serum parameters might be used to assess the stages of 
fracture healing. Further studies are required to clarify the complex fracture healing 
process. 
 
BMT3. FokI Polymorphism of the VDR Gene and Its Association with 
Intervertebral Disc Degeneration-Related Pathologies in the Italian Population 
S. Cauci1, A. Colombini2, G. Lombardi2, P. Nacci1, P. Lanteri2, D. Grasso2, L. Lodi3, 
G. Banfi4, M. Brayda-Bruno2 
1University of Udine, Udine, Italy; 2I.R.C.C.S. Istituto Ortopedico Galeazzi, Milano, 
Italy; 3CEDAL Lab, Gallarate, Gallarate, Italy; 4School of Medicine, University of 
Milan, Milan, Italy 
Background: Lumbar disc degeneration (LDD) is the main cause of low back pain 
and has a complex etiology. Several risk factors likely contribute to the genesis 
and/or acceleration of disc degeneration, however, there is some evidence for an 
influence of genetic factors and familiar predisposition. The vitamin D receptor (VDR) 
gene is one of the most studied genes involved in the predisposition to LDD. 
Hovewer, the data on the interplay between VDR genotypes, environmental factors 
and specific spine pathologies are still controversial. Methods: By using a case-
control design, 234 Italian LDD patients and 70 healthy controls were enrolled. MRI-
based patients’ clinical assessment was performed and a questionnaire assessing 
constitutional and environmental risk factors was obtained. Blood samples were 
collected, genomic DNA was extracted and VDR FokI polymorphism was detected 
by PCR-RFLP. Results: Preliminary data showed that the genotypes frequencies for 
FokI polymorphism, in patients versus controls, were 44.9% versus 35.7% for FF 
homozygosity , 44.9 versus 51.4% for Ff heterozygosity, 10.3% versus 12.9% for ff 
homozygosity, respectively. A significant association was found between the FF 
genotype and disc herniation (OR=1.82; CI=1.02-3.27), with 50.3% of patient with 
hernia versus 35.7% of controls presenting the FF genotype. Conclusions: The 
FokI FF genotype is a putative risk factor for disc herniation, but a larger control 
group is needed to better define the genotypes frequencies in the normal population. 
Moreover, study of other VDR polymorphisms (TaqI, BsmI and ApaI) is in progress 
together with the evaluation of the vitamin D status and the association with 
constitutional and environmental factors. 
 
CARDIOVASCULAR BIOMARKERS 
 
CVBM1. Circulating Lipid and Lipoprotein Levels Distinguish a Gender-
Related Response to Statins in Subjects in Primary and Secondary Prevention 
G. Mombelli1, M. Triolo1, L. Calabresi2, F. Pazzucconi1, M. Ruscica2, L. Steffani2, P. 
Magni2, C. Sirtori2 
1Niguarda Hospital, Milan, Italy; 2Università degli Studi di Milano, Milan, Italy 
Background: Cardiovascular risk in men rises around the fourth decade of life, 
whereas women appear to be protected by sex hormones until menopause, which 
however negatively affects the lipid profile and the related cardiovascular risk. Since 
the 1980s, the incidence of cardiovascular disease has been reported to 
progressively decline in men, but it persists almost unchanged in women. Major 
clinical trials (e.g., on statin therapy) have mostly been conducted in men and have 
fostered the introduction of these agents into clinical practice worldwide. Only a few 
reports have however evaluated a possible differential activity of statins in the two 
genders, providing in some cases divergent findings. Methods: The lipid profile 
changes in response to 1-year treatment with different statins in 378 dyslipidemic 
patients (189 men and 189 women, aged 20-82 years) were evaluated. Results: In 
this large series of patients, a significantly attenuated reduction of total cholesterol 
and low-density lipoprotein cholesterol (LDL-C) levels in women compared to men 
upon drug treatment was noted. A gender difference in the reduction of LDL-C was 
also noted according to baseline high-density lipoprotein cholesterol (HDL-C), which 
was particularly evident in women with baseline HDL-C > 60 mg/dl (-22.1% vs. -
26.4%, women vs. men). Conclusions: The present study suggests that statin 
treatment seems to have a reduced effectiveness in improving the plasma lipid 
profile in dyslipidemic women compared to men. Whether such gender difference 
may have an impact on health, leading to a lower preventive activity, remains to be 
elucidated. 
 
CVBM2. Anti-Lp(a) Antibody: For Diagnosis and Therapy 
M. Pasquetto1, V. Molina2, A. D'Angelo3, D. Geroldi4, L. Visai1, C. Scotti1 
1University of Pavia, Pavia, Italy; 2Neomed s.r.l., Monza, Italy; 3Fondazione IRCCS 
Policlinico San Matteo di Pavia, Pavia, Italy 
Background: The presence of the lipoprotein(a) in plasma was first described by 
Kare Berg in 1963 as an LDL-like particle. Lp(a) was later identified as a risk factor 
for atherosclerotic diseases because of its pro-atherogenic, prothrombotic and 
antifibrinolytic properties. Different epidemiological studies have also suggested that 
Lp(a) could increase the risk of cardiovascular disease and ischemic stroke if 
associated with other predisposing factors such as hypercholesterolemia, 
hypertension, diabetes mellitus and low level of HDL. There is also experimental 
evidence that lipoproteins have a role in degenerative diseases and not only in 
atherosclerosis. Today there are few therapeutic approaches for the treatment of 
hyperlipidemia(a). High-affinity monoclonal antibodies are an attractive therapeutic 
alternative. Due to their specificity, they have the ability to selectively bind the 
molecule of interest, and their structure, which includes an Fc region, allows complex 
binding to the Fc receptor localized on the surface of monocytes and macrophages. 
Methods: In this study, we sought to characterize the effect of anti-Lp(A) monoclonal 
antibody 2E8, directed toward KIV2, in an in vitro system. The ability of the antibody 
to induce internalization of Lp(a) in murine macrophages (RAW cells) has tested by 
an ELISA test and by microscopical evaluation of intracellular lipid accumulation. 
Results: The number of foam cells had increased five times compared to the non-
MAb control. Conclusions: This system will allow selection of new MAbs generated 
against human-Lp(a), and a fine characterization of the cellular response triggered 
by Lp(a)-MAb complexes. 
 
CVBM3. Protein Array Analysis of Pro-Inflammatory Status in Patients 
with Different Heart Diseases 
E. Vianello1, G. Dogliotti1, E. Galliera1, E. Dozio1, G. Schmitz2, E. Gulletta3, M. Corsi 
Romanelli1 
1Università degli Studi di Milano, Milano, Italy; 2Università di Regensburg, 
Regensburg, Germany; 3Università degli Studi Magna Grecia di Catanzaro, 
Catanzaro, Italy 
Background: Cardiovascular diseases (CVDs) have been associated with 
inflammation and cytokine modulation and altered levels of these have been 
observed in the plasma of patients with various heart diseases. Our goal was to 
investigate new possible markers of heart disease to better understand involvement 
of these in different pathology such as coronary artery disease (CAD) and cardiac 
valvular replacement (VR). Methods: We have studied 3 groups of subjects: the first 
consisted of 20 patient affected by CAD undergoing coronary artery bypass grafting 
(CABG); the second of 20 patient with no signs of CAD undergoing VR; and the third 
group of 20 healthy man without apparent pathologies as controls.The analytes of 
interest were quantified using a biochip array analyzer (Evidence,Randox Ltd., 
Crumlin,UK). Analytes researched in our study were:IL-1α,IL-1β,IL-6,IL-1,IL-10, TNF-
α, TNF R1, R2 and INF-γ. Results: Our data showed a statistically significant 
increase of plasma levels of IL-1α, IL-1β, IL-6, IL-1, TNF-α and INF-γ in CABG and 
VR patients compared to controls (P < 0.05). Our data also showed a statistically 
significant increase of IL-1α and IL-6 plasma levels in CABG patients compared to 
VR, whereas IL-1β, IL-1, TNF-α, and INF-γ were not different between the two 
groups. Conclusions: Our data suggest that CVD patients showed an inflammatory 
status due to an increase of pro-inflammatory and a reduction of anti-inflammatory 
mediators compared to healthy patients. 
 
CVBM4. The Epicardial Adipose Tissue as a Potential Source of IL-18 
E. Vianello1, E. Dozio1, E. Galliera1, G. Dogliotti1, G. Schmitz2, M. Corsi Romanelli1 
1Università degli Studi di Milano, Milano, Italy; 2Università di Regensburg, 
Regensburg, Germany 
Background: The observation that circulating levels of IL-18 are elevated in human 
obesity and that weight loss is associated with proportional reduction of its level 
suggested that a likely site for IL-18 production may be the adipose tissue. Due to 
the link between obesity, inflammation and cardiovascular diseases, we aimed to 
measure IL-18 circulating levels in patients with different degree of adiposity 
undergoing open-heart surgery both to coronary artery bypass grafting (CABG) 
surgery or to valve replacement (VR) and we also evaluated whether epicardial 
adipose tissue (EAT) may be a potential source of IL-18. Methods: Blood samples 
of patients undergoing elective CABG or VR surgery and of lean control subjects 
were collected after an overnight fasting to measure IL-18 levels by immune-
enzymatic assay. IL-18, IL-18 R1 and IL-18-RAP gene expression were evaluated on 
EAT biopsy harvested from CABG and VR patients. Results: Quantification of IL-18 
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protein indicated that patients had higher IL-18 level than controls, considered both 
together (303.76 ± 132.23 pg/mL vs.124.75 ± 15.03 pg/mL, mean ± SD, P < 0.0001) 
and after subdivision in CABG (282.89 ± 79.33 pg/mL, P < 0.001) and VR 
patients(354.79 ± 211.94 pg/mL, P < 0.01). Also after classification of the patients in 
subgroups according to their body mass index (BMI) (normal-weight and over-
weight/obese), IL-18 levels were higher than those in control group. Conclusions: It 
seems that although these two different groups of patients had similar increased 
circulating levels of IL-18, which were independent of the BMI status of the subjects, 
a different local biology for IL-18 may exist at EAT level. 
 
CVBM5. Interleukin-15, Coronary Arthery Disease and Epicardial Adipose 
Tissue: Possible Correlation 
E. Vianello1, G. Dogliotti1, E. Galliera1, E. Dozio1, G. Schmitz2, M. Corsi Romanelli1 
1Università degli Studi di Milano, Milano, Italy; 2Università di Regensburg, 
Regensburg, Germany 
Background: The epicardial adipose tissue (EAT) has been shown to increase in 
obesity and to play a potential role in the development of coronary artery disease 
(CAD) by secreting different mediators.Interleukin-15 (IL-15) is one of the cytokines 
expressed by the inflammatory cells located at atherosclerotic plaques.In our study 
we measured IL-15 plasma level in two groups of patients with different degree of 
adiposity:1)patients affected by CAD and undergoing coronary artery bypass grafting 
surgery (CABG); 2) patients without CAD undergoing valve replacement surgery 
(VR).We also compared gene expression levels of IL-15 and its receptor (IL-15RA) 
in EAT samples isolated from CABG and VR patients. Methods: Blood samples of 
patients CABG or VR were collected after an overnight fasting to measure IL-15 level 
by immune-enzymatic assay. IL-15 and IL-15RA gene expression were evaluated on 
EAT biopsy harvested from CABG and VR patients. Results: IL-15 plasma level 
resulted higher in CABG than in VR patients (3.70 ± 1.17pg/mLvs.2.52 ± 1.04 
pg/mL; mean ± SD; P < 0.05).After classification according to BMI, IL-15 level 
resulted higher in overweight/obese (OB) CABG compared to OB VR patients (4.54 
± 0.30 pg/mL vs.2.18 ± 0.52 pg/mL; P < 0.01). A trend of increase was also 
observed in normal-weight (NW) CABG compared to NW VR patients (3.58 ± 0.40 
pg/mL vs.2.63 ± 0.08pg/mL). Only in CABG group IL-15 level was higher in OB than 
in NW group (4.54 ± 0.30pg/mL vs.3.58 ± 0.40 pg/mL; P < 0.001). Conclusions: 
The increased IL-15 circulating level observed in CABG vs. VR patients seemed 
more correlated to the CAD pathology than to the obesity status of the patients. 
Whether EAT may significantly contribute to increase IL-15 circulating levels in these 
patients need further investigation. 
 
CVBM6. Pathophysiological Implications of Inflammation and Genetic 
Inflammatory Factors in Hypertensive and Old Patients Affected by Sporadic 
Thoracic Aortic Aneurysm 
C. Balistreri1, G. Candore2, C. Pisano3, L. Vaccarino2, L. Scola2, G. Colonna-
Romano2, E. Maresi4, G. Ruvolo3, C. Caruso2, D. Lio2 
1University of Palermo, Palermo, Italy; 2Department of Pathobiology and Medical and 
Forensic Biotechnologies, Palermo, Italy; 3Unit of Cardiac Surgery, Department of 
Surgery and Oncology, Palermo, Italy; 4Department of Pathologic Anatomy, 
University of Palermo, Italy, Palermo; Italy, Italy 
Background: Sporadic thoracic aortic aneurysm (S-TAA) is potentially devastating 
with severe morbidity and mortality. Current evidence suggests inflammation as main 
mechanism of its pathophysiology associated with both aging and age-related 
hypertension. Thus, we assessed whether inflammation is the principal mechanism 
of medial degeneration in hypertensive and old S-TAA. Methods: Histopathological 
and immunoistochemical aorta examination was executed. Furthermore, genotyping 
of ten SNPs in cases and controls was performed. Plasma inflammatory molecules 
were also detected in patients and controls using ELISA technique. Results: A 
significant inflammatory/immune CD3+CD4+CD8+CD68+CD20+ cellular infiltrate 
mainly in vasa vasorum of adventitia was observed in case aortas, suggesting its 
possible migration from these vessels into media and its role in destroying all 
components of extracellular matrix and vascular smooth muscle cells (VSCM)s. 
Consistent with these data, significant higher plasma levels of systemic inflammatory 
mediators characterized the cases. Different aorta abnormalities, apoptosis of 
VSCMs and severe MMP-9 amounts were also found in S-TAA aortas. In addition, 
five very significant associations with S-TAA risk were detected. Of these, D/I ACE 
and -1562 C/T MMP-9 SNPs are independent risk factors for S-TAA. Higher tissue 
and plasma levels of MMP-9 were also observed in -1562T MMP-9 allele carriers. A 
high S-TAA risk genotype was also detected significantly associated with high levels 
of systemic inflammatory mediators, immune/inflammatory cells and hypertension. 
Conclusions: Results obtained agree emerging evidence of inflammation as shared 
pathological mechanism for S-TAA, suggesting the role of inflammatory products and 
genetic profile as possible S-TAA risk biomarkers. 
 
CVBM7. Role of Oxysterols in the Progression of Atherosclerotic Lesions 
S. Gargiulo1, P. Gamba1, B. Sottero1, G. Testa1, G. Poli1, G. Leonarduzzi1 
1Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy 
Background: Atherosclerosis has been associated with chronic inflammation which 
contributes to atherosclerotic plaque progression and rupture. Matrix 
metalloproteinases (MMP), secreted mainly by macrophages, play a major role in the 
extracellular matrix remodeling. Dysregulation between MMP and tissue inhibitors of 
metalloproteinases (TIMP) can render the plaque vulnerable. Increased MMP-9 
expression has been found in atherosclerotic plaques of patients experiencing 
cardiovascular diseases. An association between oxidized LDL and coronary heart 
disease has also been demonstrated. Oxysterols, cholesterol oxidation products 
which are abundant in oxidized LDL, appear to be involved in the pathogenesis of 
atherosclerosis. Methods: Human promonocytic U937 cells were treated with an 
oxysterol mixture, whose composition is similar to that found in human plaques. 
MMP-9, TIMP-1/TIMP-2 expression was measured by real time RT-PCR whereas 
MMP-9 and TIMP protein levels were analyzed by Western blotting; MMP-9 
enzymatic activity was analyzed by zymography. The production of reactive oxygen 
species (ROS) was observed by confocal microscope. Results: Our results show 
that the oxysterols induce a significant increase of expression, synthesis and 
enzymatic activity of MMP-9, whereas they don’t affect the expression and synthesis 
of the inhibitors TIMP-1/TIMP-2. Using inhibitors or specific siRNAs, we 
demonstrated that oxysterols induce MMP-9 expression through: 1) PKC-mediated 
NADPH oxidase- and mitochondria-dependent ROS overproduction; 2) up-regulation 
of ERK1/2 and JNK signaling pathways; 3) up-regulation of AP-1- and NF-κB-DNA 
binding. Moreover, oxysterols induced inflammatory cytokine expression which might 
contribute to plaque vulnerability by inducing MMP-9 expression. Conclusions: In 
conclusion, oxysterols significantly contribute to the plaque vulnerability by promoting 
MMP-9/TIMP-1/2 imbalance in phagocytic cells. 
 
CELL DEATH PATHWAYS 
 
CDP1. Magnesium and Its Mitochondrial-Specific Channel (mrs2) in 
Doxorubicin-Induced Apoptosis of Mammary Epithelial Cells 
V. Trapani1, L. Mastrototaro1, A. Cittadini1, F. Wolf1 
1Università Cattolica del Sacro Cuore, Roma, Italy 
Background: Several apoptotic stimuli induce a magnesium release from 
mitochondria that seems to be functional to the apoptotic process. Mitochondrial 
RNA splicing gene 2 (mrs2) trascribes a channel protein, homologous to the 
bacterial CorA, which mediates a membrane potential-driven magnesium uptake into 
mitochondria. Interestingly, mrs2 expression has been associated to tumour 
multidrug resistant phenotype, although the mechanism remains unclear. We here 
investigated the role of mrs2 in doxorubicin-induced apoptosis in mammary epithelial 
cells. Methods: Mammary epithelial cells (HC11) were adapted to grow in low or 
high magnesium medium. Control HC11, high-Mg and low-Mg HC11 were assessed 
for sensitivity to doxorubicin-induced apoptosis (annexin-fitc, mitochondiral 
membrane potential and cytochrome c release) and mrs2 expression (Western blot). 
mrs2-siRNA cells were assessed for doxorubicin sensitivity and compared to wild 
type counterparts. Results: Our results show that sensitivity to doxorubicin depends 
on magnesium availability. High-Mg cells and magnesium-supplemented HC11 cells 
(10mM for 48h) are more resistant to doxorubicin-induced apoptosis. Interestingly, in 
both cell lines mitochondrial mrs2 protein was up-regulated compared to control or 
untreated cells. Silencing of the mrs2 gene enhanced doxorubicin-induced apoptosis 
in all cells. Conclusions: Our data suggest that increased magnesium availability 
protects HC11 cells from doxo-induced apoptosis. The expression of the 
mitochondrial protein mrs2 is involved in apoptosis resistance as mrs2-siRNA 
increased doxo sensitivity also in high-magnesium cells. Since mrs2 overxpression 
has been associated to multidrug resistance (Chen, 2009) we hypothesise that mrs2 
and the associated mitochondrial magnesium uptake have a crucial role in the 
mechanism of drug resistance. 
 
ENDOCRINE AND METABOLIC DISORDERS 
 
EMD1. Novel Mutations in SAR1B and MTTP Genes in Children with 
Chylomicron Retention Disease and Abetalipoproteinemia 
P. Tarugi1, E. Di Leo1, M. Najah2, L. Magnolo1, T. Fancello1, E. Pinotti1, I. Brini3, G. 
Neji4, N. Slimane2 
1Dept. of Biomedical Sciences, University of Modena & Reggio Emilia, Modena, Italy; 
2University of Monastir, Monastir, Tunisia; 3Service de Médecine Infantile B, Hôpital 
d’enfants de Tunis, Tunis, Tunisia; 4Service de Pédiatrie, CHU Fattouma Bourguiba, 
Monastir, Tunisia 
Background: Monogenic hypobetalipoproteinemias (mHBLs) include Familial 
Hypobetalipoproteinemia (FHBL) with a dominant transmission and 
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Abetalipoproteinemia (ABL) and Chylomicron Retention Disease (CMRD) with a 
recessive transmission. We investigated three children born from consanguineous 
parents, presenting with hypobetalipoproteinemia associated with chronic diarrhea 
and retarded growth. Methods: We resequenced the candidate genes for mHBLs 
and performed in vitro functional studies of mutant alleles. Results: Patient HBL-108 
had a moderate hypobetalipoproteinemia, apparently transmitted as dominant trait, 
suggesting the diagnosis of FHBL. However, she had no mutations in FHBL 
candidate genes (APOB, PCSK9 and ANGPTL3) nor in MTTP gene (ABL). She was 
found to be homozygous for a novel mutation in SAR1B gene resulting in a missense 
mutation (p.Glu62Lys), as a possible cause of CMRD. In patients HBL-103 and HBL-
148 the severity of hypobetalipoproteinemia and its recessive transmission 
suggested the diagnosis of ABL. The MTTP gene sequencing showed that these 
patients were homozygous for a nucleotide substitution in the donor splice site of 
intron 9 (c.1236 +2 T>G) (patient HBL-103) and intron 16 (c.2342+1G>A) (patient 
HBL-148) predicted in silico to obliterate the splice site. In vitro assay with splicing 
mutation reporter MTTP minigenes showed that intron 9 mutation caused the 
skipping of exon 10, whereas intron 16 mutation caused a partial retention of this 
intron in the mature mRNA. The products of these mRNAs are truncated proteins 
devoid of function. Conclusions: The diagnosis of the rare disorders ABL and 
CMRD should be considered in children born from consanguineous parents 
presenting with chronic diarrhea associated with hypobetalipoproteinemia. 
 
EMD2. Oxidative Stress During Prolonged Exercise in Insulin-Dependent 
Type 1 Diabetic Patients 
S. Cauci1, G. Stel1, F. La Marra1, R. Guerra1, M. Geat1, M. Francescato1 
1University of Udine, Udine, Italy 
Background: Several studies showed that diabetes mellitus (DM) is accompanied 
by increased formation of free radicals and decreased antioxidant capacity, leading 
to oxidative stress. Physical activity is part of the management of DM; however, the 
impact of exercise on oxidative stress is unclear. We aimed at investigating the 
oxidative stress during prolonged moderate exercise in a group of type 1 DM 
patients and a group of well-matched healthy controls. Methods: Nine patients (47 ± 
10 years, 73 ± 15 kg weight, 170 ± 10 cm stature; Hba1c 7.1 ± 1.1%) and 15 
healthy controls (46 ± 10 years, 75 ± 16 kg weight, 174 ± 10 cm stature) performed 
a 3-hrs constant intensity walk at 30% of the heart rate reserve. Patients were 
administered appropriate amounts of carbohydrates to avoid an excessive fall of 
glycemia. Venous blood samples were obtained before and at the very end of the 
trials for determination of glucose and insulin levels. Capillary blood samples were 
taken at the start of the walks and thereafter every 30 min to perform the Free 
Oxygen Radicals Test (FORT, CR-2000 Callegari1930, Italy). Results: Glucose and 
insulin levels were higher in patients than in controls. Type 1 DM patients showed 
higher oxidative stress values as compared to healthy controls (380.1 ± 14.7 vs 
293.1 ± 9.6 arbitrary units; P < 0.05). Nevertheless, oxidative stress remained 
constant in both groups of volunteers throughout the whole exercise (P = NS). 
Conclusions: The illustrated data show that, even if type 1 diabetic patients show 
higher oxidative stress values as compared to healthy people, prolonged moderate 
exercise does not exacerbate this potentially harmful condition. 
 
EMD3. Preliminary Evidence of a Peculiar Hormonal Profile in Men with 
Adverse Effects After Use of Finasteride Against Androgenetic Alopecia 
F. La Marra1, C. Di Loreto1, G. Mazzon2, G. Chiriacò2, C. Trombetta2, S. Cauci1 
1Dipartimento di Scienze Mediche e Biologiche, Università di Udine, Udine, Italy; 
2Clinica Urologica, Università di Trieste, Trieste, Italy 
Background: Finasteride is a 5-alpha-reductase inhibitor that impairs the conversion 
of testosterone (T) to dihydrotestosterone (DHT). At dosage of 1 mg/die finasteride is 
succefully used against androgenetic alopecia. In young men finasteride used 
against hair loss is reported to provoke reversible sexual side effects. However, 
some very recent reports highlighted long-term persistence of sexual dysfunctions. 
We aimed to hormonally characterize 9 patients with long-term post-finasteride 
syndrome. Methods: Nine patients (36 ± 5 years old) with persistent (over 6 
months) adverse effects including erectile dysfunction, infertility and depression, and 
10 healthy matched controls were enrolled. Testosterone, lutenizing hormone (LH), 
follicle stimulating hormone (FSH), estradiol (E2), progesterone and prolactin levels 
were evaluated in morning serum of all subjects. Results: Testosterone 
concentrations did not differ in cases and controls, P = 0.74. However, LH was 2-fold 
lower in cases (P = 0.03), whereas FSH was not statistically different between 
groups. Interestingly, the ratio of T/LH was 1.8-fold higher in cases than in healthy 
controls (P = 0.04). Conclusions: A concerning evidence is accumulating on severe 
long-term consequences of finasteride use in less than 50 years-old men. The 
percentage of subjects having post-finasteride syndrome is still to be determined and 
reasons of such persistent effects are unknown. We were the first to determine a 
peculiar hormonal profile in these patients suggesting an impairment of the 
endocrine interplay of hypothalamus, pituitary and the testis, which specifically 
dampens only one of the gonadotrophins released from the pituitary gland, i. e. LH. 
 
EMD4. Leptin-Induced mTOR Activation Defines a Specific Molecular 
and Transcriptional Signature Controlling CD4+ Effector T Cell Responses 
C. Procaccini1, V. De Rosa2, M. Galgani2, F. Carbone2, D. Greco3, S. Formisano4, G. 
Matarese4 
1Consiglio Nazionale delle ricerche, Napoli, Italy; 2IEOS-CNR, Napoli, Italy; 
3Department of Bioscience and Nutrition, Karolinska Institutet, Stockholm, Sweden; 
4Università di Salerno, Baronissi (SA), Italy 
Background: The sensing of T cells of metabolic and energetic changes in the 
microenvironment can determine the differentiation, maturation and activation of 
these cells. Although it is known that the mammalian target of rapamycin (mTOR) 
gauges nutritional and energetic signals in the extracellular milieu, it is not known 
how mTOR and metabolism influence CD4+CD25-FoxP3- effector T cell (Teff) 
responses. Methods: We characterized at cellular, biochemical and transcriptional 
level, the effect of leptin on Teff, both in vitro and in vivo. Results: Here we show 
that leptin-induced activation of mTOR, which in turn controls leptin production and 
signalling, causes a defined cellular, biochemical and transcriptional signature that 
determines the outcome of Teff responses, both in vitro and in vivo. The blockade of 
the leptin/leptin receptor signalling, induced by genetic means or by starvation, leads 
to impaired mTOR activity that inhibits in vivo the proliferation of Teff. Notably, the 
transcriptional signature of Teff cells in the presence of leptin blockade appears 
similar to that observed in rapamycin-treated Teff. Conclusions: These results 
identify a novel link between nutritional status and Teff responses through the leptin-
mTOR axis, and define a potential target for Teff modulation in normal and 
pathologic conditions. 
 
EMD5. A Metabolomic Approach to Selective Intrauterine Growth 
Restriction (sIUGR) in Monochorionic Pregnancies 
S. Visentin1, D. Favretto1, M. Tucci1, A. Londero2, A. Rossi2, S. Ferrara1, D. 
Marchesoni2, G. Nardelli1, E. Cosmi1 
1University of Padua, Padova, Italy; 2University of Udine, Udine, Italy 
Background: The aim of the present study was (1) to compare abdominal aorta 
intima-media thickness (aIMT) among selective intrauterine growth restricted 
(sIUGR) monochorionic (MC) twin fetuses with and without Doppler umbilical artery 
(UA) vasculopathy and AGA twin fetuses in utero, (2) to compare metabolomic 
profiles in MC sIUGR twins among the groups. Methods: 26 MC diamniotic (DA) 
twins pregnancies with and without sIUGR were included in the study. sIUGR in MC 
pregnancies was defined as an estimated fetal weight < the 10th percentile in the 
smaller twin. sIUGR twins were further divided in two groups based on abnormal UA 
Doppler waveforms. aIMT was determined for each twin at 32 weeks. Fetal blood 
samples were obtained from the umbilical vein from a doubly clamped segment of 
each cord immediately after fetal extraction. The metabolomic analysis was 
performed comparing the LC-HRMS spectra obtained with the three different groups 
of twin pregnancies. Results: MC twins were divided in three groups in base of 
sIUGR and Doppler UA waveforms. In the sIUGR MC twins presenting abnormalities 
of UA Doppler velocimetry aIMT was higher than in the AGA one. There was also an 
elevation of phenylalanine, tryptophan, sphingosine and glycerophosphocoline levels 
in this group. Conclusions: aIMT is higher in sIUGR twins with Doppler velocimetry 
anomalies. An elevation of phenylalanine, tryptophan, sphingosine and 
glycerophosphocoline levels in the first group could represent in part the clinical sign 
of endothelium dysfunction in fetuses with a low birth weight. 
 
HEMATOLOGY 
 
HEM1. Diagnostic Efficiency Improvement in Onco-Hematology Diseases 
Using Selected Cell Population 
M. Lotzniker1, N. Covini1, S. Stioui2, R. Busuito2 
1AO Legnano Laboratorio Analisi, Legnano, Italy; 2AO Legnano Laboratorio Analisi- 
SS Citogenetica, Legnano, Italy 
Background: In chronic myeloproliferative neoplasms (MPNs), Philadephia negative 
and multiple myeloma (MM), the choice of tissues to put through diagnosis/prognosis 
tests of molecular biology and molecular cytogenetics is of utmost importance. 
Methods: We wanted to confirm the improvement of the diagnostic effienciency by 
effecting molecular tests on the cell lines involved in the onset of the pathology, the 
granulocytes in the MPNs and the plasma cells of the MM against whole blood and 
bone marrow. The researched molecular markers are the V617F of the JAK2 gene 
within the MPNs, the deletion of the P53 gene, rearrangements of the IGH@ gene 
and the D13S25-D13S319 markers for MM. Results: The evaluation of the V617F 
mutation of JAK2 was performed on 110 samples, amplifying through Real-Time 
PCR both for the DNA extracted from whole blood and isolated granulocytes. We 
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identified two mutated samples only on the DNA extracted from the granulocytes. A 
selection of 10 cases of MM presenting one of the researched genetic anomalies 
was made. The percentage of anomalous clones encountered within the plasma 
cells was always higher than the one observed in the bone marrow, but especially 
identifiable in the first 100 analysed cells. However, 300 to 5,000 cells. should be 
analysed to observe the anomalous clone in the bone marrow. Conclusions: The 
selection of the cellular population on which to perform specific tests was essential to 
improve the diagnostic efficiency, either in terms of sensibility and in the precocity of 
the diagnosis. 
 
HEM2. Splenectomy Is a Risk Factor for Developing Hyperuricaemia and 
Nephrolithiasis in Thalassaemia Intermedia Patients: A Retrospective Study 
P. Ricchi1, T. Di Matola2, M. Ammirabile1, S. Costantini1, R. Verna3, A. Spasiano1, M. 
Genna1, P. Cinque1, L. Prossomariti1 
1AORN Cardarelli, Naples, Italy; 2Ospedale Dei Colli, Naples, Italy; 3Università 
Sapienza, Rome, Italy 
Background: In patients with thalassaemia major and intermedia, hyperuricaemia 
and nephrolithiasis have been already described; however, reliable data about their 
occurrence, pathophysiological basis and consequences are lacking. Methods: We 
retrospectively reviewed the charts and radiological studies of 89 patients with 
thalassaemia intermedia followed at our clinic with routine biochemical examination 
and radiological imaging of the urinary tract with the aim to analyze both the 
prevalence of hyperuricaemia and nephrolithiasis and their impact on renal function. 
Results: Renal calculi were identified in 11 patients (12%) and 22 patients (25%) 
were under uricosuric treatment for hyperucemia. The prevalence of nephrolithiasis 
increased with age but not in a statistically significant manner. Major risk factors for 
renal stone formation were splenectomy (in 91% of the cases, O.R. =13.6 ) and 
higher number of erythroblasts. Patients with renal stones had lower GFR value and 
had significantly higher level of urate with respect to those observed in patients not 
affected. Stone formers had higher mean creatinine level and lower GFR value with 
respect to those observed in patients without urolithiasis although the difference was 
nearly statistically significant (P = 0.051) only for creatinine level. Conclusions: Our 
data suggest that splenectomy, by further increasing erythrocyte turnover and 
number, may be directly involved in the pathogenesis of hyperuricemia and 
nephrolithiasis observed in thalassaemia intermedia patients; our findings attributed 
additional disease-related complications to age and to splenectomy in thalassaemia 
intermedia patients. 
 
HEM3. Endogenous Thrombin Potential in Trombophilic and Non-
Trombophilic Women with History of Complications During Pregnancy 
G. Vitale1, S. de Michele1, P. Consiglio1, G. Calabrò1, S. Amato1, A. Aiosa1, N. 
Colasanto1, O. Consiglio1, R. Giarratana1, B. Palma1 
1ARNAS Ospedale Civico, Palermo, Italy 
Background: Thrombophilia increases the risk of complications during pregnancy: 
IUGR, miscarriage, MEF, eclampsia. These complications can be present in healthy 
women too, and the hypercoagulable state, not detected in common tests, has been 
invoked as an alternative cause. Endogenous Thrombin Potential (ETP) may 
constitute a valuable diagnostic aid in defining a hypercoagulable condition. 
Methods: Out of the 84 women with complications, 41 were thrombophilic and 43 
were not. Thrombophilic condition showed: 7 x FV Leiden, 11 x F II, 15 with ACA, 1 x 
LA, 1 x Protein S deficit, 1 x Protein C deficit, 3 x FV + FII, 1 x FV + 
hyperhomocysteinemia, 1 x ACA + Protein S deficit. In thrombophilic patients the 
complications were: 2 women with eclampsia, 33 with more miscarriages, 1 IUGR, 4 
MEF, 1 premature delivery; in patients with no thrombophilia: 9 women with 
eclampsia, 17 with more miscarriages, 4 IUGR, 8 MEF, 5 premature delivery. 36 
healthy women with normal pregnancy were used as control. No patient in this study 
had cardiovascular risk or took any antithrombotic medication. ETP was measured 
by the chromogenic method (SIEMENS) on platelet-poor plasma. Results: ETP 
evaluation did not show significant differences between thrombophilic women 
(median 93% (range 74%-130%)] and non-thrombophilic women [median 97% 
(range 71%-124%)]. ETP in the control group is comparable to the two populations 
studied [median 108.3% (range 80.9%-127.9%)]. Conclusions: ETP shows no 
correlation between thrombophilia and complications in pregnancy. 
 
HEM4. Pretest Clinical Score (4Ts) and Laboratory Testing for Reliable 
Diagnosis of Heparin-Induced Thrombocytopenia 
G. Vitale1, P. Consiglio1, S. de Michele1, M. di Quattro1, A. Tagliavia1, G. Calabrò1, S. 
Amato1, A. Aiosa1, P. Consiglio2, M. Buscetta2, B. Palma1 
1ARNAS Ospedale Civico, Palermo, Italy; 2ARNAS University of Palermo, Palermo, 
Italy 
Background: Heparin-induced thrombocytopenia (HIT) is an uncommon but 
potentially devastating complication of anticoagulation with unfractionated heparin 
(UHF) or low molecular weight heparin (LMWH). HIT is defined as a decrease in 
platelets to less than 50% or to less than 100 x 109/L and positive laboratory HIT 
assay. Early diagnosis of HIT leads to rapid interruption of the eparinic treatment, 
substituted by alternative anticoagulant therapies, reducing mortality from 23 to 
1.1%. When HIT is suspected (score 4Ts) rapid and highly sensitive diagnostic tests 
are required. ELISA and functional cytofluorimetric tests are highly specific and 
sensitive, but are time- and labor-consuming. Methods: We re-evaluated 61 
samples from patients from 2011, showing high or moderate HIT, as assessed by 
4Ts clinic test. The turbidimetric immunological test (Hemosil HIT-Ab-IL) was 
performed on all of them and showed the presence of anti-PF4/Eparine antibodies in 
6 patients (9.8%). These samples were subsequently functionally tested at the 
cytofluorometer and by chemiluminescence (Hemosil AcuStar-IL). Results: Both 
tests were positive in only 3 patients (4.9%); there was a strong correlation between 
the chemiluminescent immunological test and the functional cytofluorimetric one. 
Conclusions: The chemiluminescence test, being as sensitive and specific as the 
cytofluorimetric one, but easier and faster, might represent the elective test for HIT 
diagnosis. However, this test is suitable only for patients who scored high or 
moderate for HIT at the clinical test. 
 
HEM5. Bioinformatics as a Starting Point for the Analysis of ALK1 
Missense Mutations 
L. Vecchia1, C. Olivieri1, L. Boeri1, C. Canzonieri1, F. Ornati1, E. Buscarini1, F. 
Pagella1, C. Danesino1, C. Scotti1 
1Università di Pavia, Pavia, Italy 
Background: Activin A receptor, type II-like kinase 1 (also called ALK1), is a serine-
threonine kinase predominantly expressed on endothelial cell surface, involved in 
TGF-β signalling. It is encoded by the ACVRL1 gene (12q11-14), whose mutations 
cause type 2 Hereditary Hemorrhagic Telangiectasia (HHT2), an autosomal 
dominant multisystem vascular dysplasia. Although an X-ray structure of ALK1 
intracellular domain has recently become available (PDB ID: 3MY0), structure 
determination of ALK1 ectodomain (ALK1EC) has been elusive so far. Methods: We 
recently described the building of a homology model for ALK1EC, followed by an 
extensive bioinformatic analysis, based on a set of 38 methods, of the effect of 
missense mutations at the sequence and structural level. ALK1EC potential 
interaction with its ligand BMP9 was then predicted combining modelling and 
docking data. Results: Major structural changes and loss of stability of the protein 
were predicted for several mutations, whereas others were found to interfere mainly 
with binding to BMP9 or other interactors, like Endoglin (CD105), whose encoding 
ENG gene (9q34) mutations are known to cause type 1 HHT. Conclusions: Building 
on these predictions, we are now creating a library with the most interesting 
mutations, both by gene synthesis and site-directed mutagenesis, to try to express 
them and analyse their effects on endothelial cells by in vitro and in vivo tests, as 
well as to determine the real crystal structures. 
 
IMMUNITY AND INFLAMMATION – AUTOIMMUNE DISEASES 
 
IAD1. Advances in Anti-Topoisomerase I Antibodies Evaluation 
M. Lotzniker1, S. Finazzi1, G. Re1, C. Alpini2, P. Faggioli1 
1AO Ospedale Civile di Legnano, Legnano, Italy; 2IRCCS San Matteo, Pavia, Italy 
Background: Positivity of Anti-topoisomerase I (anti-topo I) antibodies in systemic 
sclerosis is historically correlated with disease activity and severity. On the contrary, 
a small number of studies are focused on the "quantity" of these antibodies. Our 
study aims at evaluating the relations between the "quantity" of antibody and the 
activity/severity of the disease. Methods: In 30 scleroderma patients, anti-topo I 
antibodies were consecutively measured in an observation time from 2-6 years. 
Naifold videocapillaroscopy was made at baseline. Clinical evaluation was performed 
by Eustar score for disease activity and Medsger scale for disease severity. Anti-
topo I were tested by EliA technology (Phadia, Germany). Results: For each patient 
we calculated the median value of anti-topo I. Median values were categorised in 3 
groups: lower tertile 164 U/ml. Eustar evaluation: the median values of anti-topo I 
showed a positive correlation with Eustar score and a significant difference emerged 
in the patients of the lower tertile in comparison with the upper tertile. Medsger 
evaluation: in presence of low levels of anti-topo I the organ-system involvement is 
often absent or at least limited. Also videocapillaroscopy findings agree with anti-
topo I levels. Conclusions: Our data show differences mostly between low and high 
levels of anti-topo I. Despite this limitation a routinely quantitative expression of anti-
topo I results seems to be a useful tool for clinical evaluation until the first 
observation at diagnosis. 
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IAD2. Serum Matrix Metalloproteinase-3 Assessment in Rheumatoid 
Arthritis: Two Methods Compared 
M. Fabris1, A. Cottone1, L. Quartuccio1, F. Curcio1, E. Tonutti1 
1Azienda Ospedaliero-Universitaria of Udine, Udine, Italy 
Background: Several recent papers highlighted the possible role of serum matrix 
metalloproteinase-3 (MMP-3) assessment in rheumatoid arthritis (RA) as a reliable 
tool in the diagnosis, prognosis and to detect therapeutic efficacy (Houseman, 
Arthritis Res Ther 2012). Here we tested 2 different ELISA methods to analyse 
MMP-3 serum levels in routinely attending patients with rheumatoid arthritis. 
Methods: 23 RA patients were enrolled (17 females, age range 33-79), tested more 
times in the follow-up, total samples n. 95. 42 age and sex-matched healthy donors 
(HDs - 27 females, age range 20-64). MMP-3 serum levels were analysed by two 
ELISA kits: DiaMetra MMP-3 ELISA (DiaMetra, Segrate, Milano, Italy) and 
AESKULISA MMP-3 (AESKU.diagnostics, Germany). Results: As expected, MMP-3 
serum levels in HDs were significantly more elevated in males than in females, as 
assessed by both methods, even with slightly different ranges(25.4 ± 5 ng/ml vs 12.7 
± 3.4 ng/ml by DiaMetra; 86 ± 24.2 ng/ml vs 36.3 ± 10.5 ng/ml by AESKU). RA 
patients generally disclosed higher levels than HDs, either by DiaMetra (45.5 ± 39 
ng/ml) and by AESKU (200 ± 203 ng/ml) and a good correlation between serum 
MMP-3 and disease activity was found in the follow-ups. A very good correlation was 
found between the results obtained in the same sera by the two methods (Spearman 
r 0.97, 95%CI 0.95-0.98, P < 0.0001). Conclusions: Both the MMP-3 ELISA 
methods work well in the assessment of MMP-3 serum levels in routinely attending 
RA patients and this test may be useful to better characterize disease outcome in the 
follow-up. 
 
IAD3. A Single Non-Synonymous Polymorphism of TLR2 Is responsible 
for Variability of Experimental Multiple Sclerosis in SJL and B6 Mice 
C. Nicolò1, G. Di Sante1, G. Migliara1, A. Piermattei1, M. Valentini1, G. Delogu2, S. 
Borrello1, M. Geloso3, A. Cittadini1, F. Ria1 
1Università Cattolica del S. Cuore - Institute of General Pathology, Roma, Italy; 
2Università Cattolica del S. Cuore - Institute of Microbiology, Roma, Italy; 3Università 
Cattolica del S. Cuore - Institute of Anatomy and Cell Biology, Roma, Italy 
Background: Multiple sclerosis is characterized by variability of course and lesions 
distribution. The complexity of its presentation may reflect differences in either 
environment or genetic. In rodents challenge with peptides of myelin drives distinct 
forms of EAE in each strain/peptide pair, but it is difficult to assess the relative role of 
genetic background and antigens in determining the course of the disease. In all 
EAE models the administration of mycobacterium –derived motives is essential for 
disease development. TLR2 is the main receptor recognizing motives from M 
tuberculosis. Methods: To study the contribution of TLR2 genetics to EAE, we 
crossed SJL (TLR2 83Ile) and B6 (TLR2 83Met) mice, generating F1 of SJLxB6wt 
(heterozygous for TLR2 Ile83Met) and F1 of SJLxB6tlr2- (TLR2 83Ile). We then 
immunized both groups of F1 mice with PLP139-151 and examined course and 
lesion distribution of EAE. Results: TLR2 83Ile increases secretion of IFN-γ (P = 
0.043) and IL-17 (P = 0.041), whereas IL-13 and FoxP3 are similar in both groups. 
Consequently there are significant differences in the EAE. F1 mice of SJLxB6tlr2- 
display a more severe EAE (P = 0.0004) in the absence of PTx administration. 
SJLxB6wt mice are sensitive to PTx administration, whereas F1 mice of SJLxB6tlr2 
are not. EAE developed in SJLxB6wt mice has a clear progressive/chronic clinical 
course, whereas that obtained in SJLxB6tlr2- mice often show incomplete and of 
short duration signs of remission.SJLxB6tlr2- mice frequently display inflammatory 
lesions and demyelination in the frontal lobes. Conclusions: Thus, a single 
polymorphism of TLR2 modifies significantly clinical and histology of EAE. 
 
IAD4. Phenotypic Characterization of Circulating B- and NK-Cell 
Subsets as a Marker Of Primary Sjögren’s Syndrome (pSS) 
E. Pontarini1, M. Fabris2, L. Quartuccio3, S. De Vita3, F. Curcio4, M. Cappelletti5, S. 
Della Bella5, D. Mavilio5 
1IRCCS Istituto Clinico Humanitas, Rozzano, Italy; 2Clinical Pathology, Dep 
Laboratory Medicine University-Hospital Udine, Udine, Italy; 3Clinic of Rheumatology, 
DSMB, University of Udine, Udine, Italy; 4Institute of Clinical Pathology, University of 
Udine, Udine, Italy; 5IRCCS Istituto Clinico Humanitas, Lab Clinical Experimental 
Immunology, Milano, Italy 
Background: Primary Sjögren's syndrome (pSS) is an autoimmune disorder 
characterized by chronic inflammation and loss of function of salivary/lachrymal 
glands. pSS patients show increased circulating levels of BLyS, able to prevent B 
cell apoptosis and increase NK cell functions. Here, we characterize the phenotype 
of B and NK cells in pSS. Methods: 14 pSS patients fulfilling the new American-
European Consensus Group diagnostic criteria and 14 age/sex-matched healthy 
controls were studied. PBMCs were analyzed through an 8-colors flow-cytometry 
approach and the serum level of B-Lymphocyte Stimulator (BLyS) was assessed by 
ELISA. Results: All pSS patients were SSA/SSB-positive, 12 were RF-positive and 
they had higher BLyS serum levels. Histologically, 8 patients presented MESA and 4 
had a history of MALT-type lymphoma in the parotid glands. In the pre-immune B-
cell compartment, patients showed a significant reduction of marginal-zone-like B 
cells (CD27+ IgD+ IgM+) compared to controls (2.96 ± 2.15% vs 4.75 ± 1.89%; *P = 
0.0328) and an increased percentage of naive B cells (CD27- IgD+ IgM+) (70.76 ± 
14.40% vs 60.36 ± 7.63%; *P = 0.0126). In the antigen-experienced B-cell 
compartment, patients exhibited a significant reduction of the IgM-only memory 
(CD27+ IgD- IgM+, 0.62 ± 0.77% vs 2.01 ± 1.05%; *P = 0.0013), switched-memory 
(2.52 ± 2.54% vs 7.90 ± 4.28%; ***P = 0.0003) and CD27- memory (7.85 ± 5.49% 
vs 11.82 ± 5.49%; *P = 0.037) subpopulations. CD56+/CD16+ NK cells were 
significantly reduced in patients (11.20 ± 17.54% vs 16.29 ± 7.86; *P = 0.0224), as 
well as the CD56-/CD16+ NK cells (0.73 ± 1.67% vs 0.78 ± 0.45; *P = 0.0192). 
Conclusions: In summary, pSS patients showed significant alterations in circulating 
B- and NK-cell compartments, possibly associated with the high levels of serum 
BLys and aberrancies of cell homeostasis at tissue gland level. 
 
IAD5. Clinical and Serological Response to Tocilizumab in Rheumatoid 
Arthritis Patients 
M. Lotzniker1, C. Alpini2, S. Valaperta2, S. Finazzi1, O. Epis3, E. Bruschi3, G. Merlini2 
1Clinical Chemistry Ospedale Civile di Legnano, Legnano, Italy; 2Clinical Chemistry 
Fondazione IRCCS S.Matteo, Pavia, Italy; 3Rheumatology Unit, Niguarda 
“Ca'Granda” Hospital, Milano, Italy 
Background: Rheumatoid factor (RF) IgM and antibodies to citrullinated proteins 
(ACPA) are serological markers of rheumatoid arthritis (RA), currently assessed in 
clinical practice. Yet the measurement of IgG- and IgA-RF is not performed routinely 
because of conflicting data on the clinical relevance of these isotypes. Data 
confirming a definite relationship between decreased RF levels and clinical response 
are scarse. The aim of the present observational longitudinal study was to 
investigate whether RF isotypes and ACPA are related to clinical response in RA 
patients treated with tocilizumab (TCZ, anti-IL6R). Methods: The study population 
was composed by 27 subjects (24 females, mean age 56,4 ± 10,7 years). The 
subjects were studied at baseline (T0), and at follow up visits at 3 (T1) 6 (T2), and 12 
months (T3) after the beginning of the treatment with TCZ 8 mg/Kg. Each patient 
was assessed at each time point through clinical scales (VES, PCR, HAQ, DAS28-
VES, DAS28-PCR, CDAI, and SDAI). IgM-, IgA- and IgG-RFs and anti-CCP 
antibodies were assessed by enzyme linked immunosorbent assay at T0, T1, T2, T3. 
Results: All patients showed a rapid, significant, and sustained clinical response to 
treatment throughout the observation period. Whereas the clinical scales (except 
HAQ) significantly decrease during time, the antibody counts do not. We only found 
a significant correlation (P = 0.03) between ACPA and SDAI changes from baseline 
at T1 and T2. We found no significant correlation between the antibodies count at T0 
and the changes of the DAS-28 VES at T1 and at T2. Conclusions: Tocilizumab, 
although effective in treating RA, does not decrease antibody levels.  
 
IAD6. Proliferative Potential of FoxP3+ Regulatory T Cells in Multiple 
Sclerosis Patients 
F. Carbone1, V. De Rosa2, C. Procaccini2, C. La Rocca3, M. Galgani2, P. Carrieri4, S. 
Montella4, S. Formisano5, G. Matarese5 
1Istituto di endocrinologia e oncologia sperimentale-CNR (IEOS-CNR), Naples, Italy; 
2Istituto di Endocrinologia e Oncologia Sperimentale, Naples, Italy; 3Dipartimento di 
Biologia e Patologia Cellulare e Molecolare, Naples, Italy; 4Dipartimento Scienze 
Neurologiche e Medicina Clinica e Sperimentale, Naples, Italy; 5Dipartimento di 
Medicina, Facoltà di Medicina e Chirurgia, Baronissi (SA), Italy 
Background: In autoimmune diseases there are no reliable markers able to predict 
either loss of self-antigen tolerance or clinical progression of pathology. We 
investigated the relationship between the proliferative capacity of regulatory T cells 
(Treg), a cellular subset that controls the immune response, with clinical progression 
in multiple sclerosis (MS). Methods: Since proliferation of Treg cells is inhibited by 
the adipocytokine leptin we investigated the capacity of Treg cells to expand upon 
leptin-neutralization in vitro and correlated this phenomenon with the clinical 
stage/progression of disease. Results: Purified Treg cells from MS patients, showed 
a reduced proliferative capacity during anti-CD3CD28-stimulation upon leptin-
neutralization when compared with healthy controls. Interestingly the patients clinical 
state inversely correlated with the in vitro expanding capacity and proliferative 
potential of Treg cells. Indeed, patients with a higher Expanded Disability Status 
Scale (EDSS) showed a reduced expansion of Treg cells upon leptin neutralization. 
We applied the multinomial logistic model to calculate the relative risk for MS 
patients to develop a worst clinical progression of pathology in function of the 
observed expansion index at diagnosis. Thanks to this model we found a higher risk 
to develop a more severe MS in patients with a lower expansion of Treg cells. 
Conclusions: Our findings could be of relevance in understanding the pathogenesis 
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of MS and introduce the use of the in vitro Tregs expansion index as marker for 
evaluation of immunological tolerance and disease progression in MS patients. 
 
IAD7. Meta-immunological Profile of Children with Type 1 Diabetes: 
Toward the Possibility to Predict Progression of Autoimmune Diabetes 
M. Galgani1, R. Nugnes2, M. Santopaolo3, A. Franzese4, S. Formisano5, G. 
Matarese5 
1Consiglio Nazionale delle Ricerche, Naples, Italy; 2Dipartimento di Biologia e 
Patologia Cellulare e Molecolare, Naples, Italy; 3Università di Napoli, Napoli, Italy; 
4Dipartimento di Pediatria Università di Napoli, Naples, Italy; 5Dipartimento di 
Medicina Facolta di Medicina e Chirurgia, Baronissi - Salerno, Italy 
Background: Type 1 Diabetes (T1D) is an autoimmune disease characterized by a 
T cell-mediated destruction of pancreatic β-cells. The time course and the precise 
mechanisms of progressive β-cells failure are still not completely elucidated. 
Methods: Nine circulating biological compounds, at the interface between immune 
and metabolic regulation, and twenty immune cell populations were investigated over 
time as markers associated with disease progression at different disease stages 
(high-risk subjects, T1D at onset, 12 and 24 months after diagnosis). The correlation 
matrix among the different biological parameters was statistically evaluated and 
visually assessed on 2-dimensional graphs. Finally, we built a multivariate logistic 
regression model to identify markers able to predict residual β-cell function. Results: 
We observed that the meta-immunology profile significantly differed among the 
different study groups and during disease progression, thus defining a specific 
signature typical of disease progression. Further, we defined a simple and robust 
decision rule, based on the multivariate logistic regression model, by measuring the 
number of circulating CD3+CD16+CD56+ cells and the percentage of myeloid 
Dendritic Cells (mDCs) at disease onset. This model was able to predict pancreatic 
residual C-peptide production by β-cells up to one year after disease onset. 
Conclusions: This study defines a specific meta-immunology asset in T1D changing 
during disease progression and provides a simple decision rule that predicts residual 
β-cell function and monitors the meta-immunology status typical of T1D. 
 
IMMUNITY AND INFLAMMATION – HOST DEFENSE 
 
IHD1. Hepatitis B Virus Isolates of Different Genotype May Vary in Their 
Capacity to Limit Effectiveness of Endogenous and Therapeutic Interferon-α 
A. Restuccia1, M. Lanza1, G. Raimondo1, T. Pollicino1 
1University Hospital of Messina, Messina, Italy 
Background: Several clinical studies suggested that Hepatitis B Virus (HBV) 
genotype may affect response to IFNα-treatment of chronic hepatitis B (CHB). Aims 
of our study were: (a) To investigate and compare in vitro the transcriptional and 
replicative capacity of three wild-type HBV isolates of genotype A, C, and D, 
respectively; (b) to verify whether these three HBV genotypes display different IFNα–
mediated induction of antiviral defence mechanisms in human hepatoma cells. 
Methods: HBV genomes isolated from three naïve CHB patients infected with HBV 
of genotype A, C, and D, respectively, were full-length amplified and cloned in 
accordance with the method described by Gunther et al (J Virol 1995). Comparison 
among their transcriptional/replicative activities (Southern and Northern blot, real 
time-PCR and ELISA assay), recruitment of Stat1/phospho-Stat1, Stat2/phospho-
Stat2 onto the HBVcccDNA (cccDNA-ChIP) and expression profile of innate immune 
response genes (TaqMan low-density array) were assessed after transfection of 
untreated- and IFNa-treated HepG2 cells. Results: Genotype A isolate produced 
higher levels of replicative intermediates and showed a better response to IFNα 
treatment than genotype C and D ones. Both genotype C and D HBVcccDNAs 
showed a reduced binding of Stat1/2 and phospho-Stat1/-Stat2 compared to 
genotype A both in untreated and INFα-treated cells. The three genotypes were able 
to impair TLR7, TLR9 and IRF7 expression in IFNα-treated cells. These three factors 
were down-regulated to a greater extent both in genotype C- and D-replicating cells. 
Conclusions: Our data indicate that each HBV genotype may possess different 
phenotypic and biological characteristics and may differently impair pathways of the 
interferon response. 
 
IHD2. Hepatitis B Virus Causes Epigenetic Induction of Interleukin-8 
Production which in Turn Inhibits Interferon-alfa Antiviral Activity 
T. Pollicino1, L. Bellinghieri1, G. Raffa1, A. Restuccia1, C. Musolino1, D. Teti1, G. 
Raimondo1 
1University Hospital of Messina, Messina, Italy 
Background: Serum interleukin-8 (IL-8) concentrations are increased in chronic 
hepatitis B (CHB) patients during hepatic flares. Aims of this study were: (1) to 
determine IL-8 amounts in sera and liver tissues of CHB patients, inactive HBV 
carriers (IBC) and healthy controls (HC), (2) to analyse the mechanisms implicated in 
HBV-induced IL-8 gene expression, (3) to study the possible antagonistic activity of 
IL-8 on INFα-treatment response. Methods: Serum IL-8 amounts were analysed by 
an ELISA assay. IL-8 mRNA quantification in liver tissues and HBV-replicating cells 
was performed by real-time PCR. An IL-8 promoter-driven luciferase assay was used 
to study IL-8 promoter transactivation. The ChIP-assay was applied to analyse IL-8 
promoter acetylatilatio/methylation status. A cell-based HBV replication system was 
used to test the potential antagonistic effect of IL-8 on INFα-treatment response. 
Results: CHB patients had higher amounts of IL-8 both in serum and liver tissue 
compared to controls. In HBV-replicating cells, IL-8 promoter transcriptional activity 
was stimulated up to 100-fold and IL-8 transcription was significantly increased. The 
luciferase-reporter-assay showed that NFkB and AP-1 are essential for IL-8 
induction by HBV. HBx viral protein was recruited onto the IL-8 promoter. 
Acetylation/methylation status of IL-8 promoter was strongly correlated with IL-8 
amounts both in serum and liver tissue. Inhibition of IL-8 by anti-IL8 monoclonal 
antibodies or IL8-siRNA increased IFN-alfa inhibitory action on HBV replication in 
transfected cells. Conclusions: (1) Highly replicating HBV is able to induce IL-8 
transcription by targeting the epigenetic regulation of IL-8 promoter. (2) The induction 
of IL-8 by HBV inhibits the INFα antiviral activity. 
 
IHD3. Local Interleukin-1 beta (IL-1β) Levels in Early Pregnancy and 
Preterm Birth 
1S. Cauci, J. Culhane2 
1University of Udine, Udine, Italy; 2Children's Hospital, Philadelphia, Philadelphia, 
PA, United States of America 
Background: Preterm birth (PTB) is considered a research priority. The rate of PTB 
has not declined in the last decades. Non-invasive early biomarkers for PTB risk are 
highly warranted to possibly perform a personalized treatment. Methods: To assess 
if vaginal interleukin-(IL)-1 beta (IL-1β) in early pregnancy is associated with adverse 
outcome among bacterial vaginosis (BV)-positive women, 1,806 women were 
enrolled at <20 weeks’ gestation in 5 Philadelphia Hospitals (Philadelphia, PA). 800 
women were BV-positive (by Gram evaluation according to Nugent score 7-10), 707 
of them had birth outcome data. Vaginal IL-1β concentrations were measured in 105 
BV-positive women who had an adverse preterm outcome, including 66 preterm 
births (20-<37 weeks, of which 52 were spontaneous) and 14 late miscarriages (12-
<20 weeks), and in 295 BV controls (term normal birth weight infants). The upper 
(>66th percentile) and lower (<33rd percentile) tertiles of IL-1β concentrations were 
compared with the middle tertile (33rd to 66th percentile) to assess whether the risk 
profile is U-shaped. Results: None of the IL-1β tertiles was associated with 
increased risk for any adverse preterm outcome, nor preterm birth and miscarriage 
with or without exclusion of women with concurrent STDs. Conclusions: Vaginal IL-
1β is not a risk marker for preterm birth among BV-positive women in early gestation, 
likely because of large overlapping of events producing actual levels of the pro-
inflammatory cytokine IL-1β in vaginal fluid. 
 
IHD4. Viral N-linked Glycans Contribute to Alphavirus-induced Myositis 
and Arthritis 
B. Gunn1, R. Shabman1, A. Whitmore1, L. Blevins1, T. Morrison2, M. Heise1 
1University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of 
America; 2University of Colorado at Denver Health Sciences Center, Denver, CO, 
United States of America 
Background: Mosquito-borne alphaviruses chikungunya virus (CHIKV) and Ross 
River virus (RRV) cause outbreaks of debilitating infectious arthritis in humans in the 
Indian and Pacific Ocean regions, and CHIKV has recently become endemic in parts 
of Europe. CHIKV- and RRV-induced disease is characterized by severe 
inflammation and immunopathology within joints and muscle. Recent studies 
demonstrated that the mannose binding lectin (MBL) pathway of the host 
complement system is essential for RRV-induced immunopathology. MBL binds to 
terminal carbohydrates, such as mannose found on glycosylated viral proteins, to 
activate the complement system. There are three N-linked glycosylation sites on the 
RRV envelope glycoproteins that are glycosylated with high mannose and complex 
glycans in mammalian cells. We hypothesized that these RRV glycans are ligands 
for MBL binding and complement activation, contributing to development of disease. 
Methods: Using a panel of RRV mutants lacking one or more glycans, we evaluated 
and characterized the RRV-induced disease in mice infected with the glycan mutant 
viruses. Results: Mice infected with a virus lacking both E2 N-linked glycans exhibit 
reduced disease, reduced tissue damage, and reduced levels of MBL and 
complement activation within infected tissue compared to wild-type RRV infected 
mice. However, virus-induced inflammation and viral replication within infected 
tissues were similar between the two viruses. Conclusions: These results suggest 
that interactions between the viral N-linked glycans and MBL play a central role in 
the development of severe alphavirus-induced arthritis and may be an effective 
target for therapeutic treatment in patients infected with arthritogenic alphaviruses. 
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IHD5. Mycobacterium tuberculosis in the Adjuvant Modulates 
Trafficking of Effector T Cells Through a Polymorphic Site of TLR2 
C. Nicolò1, G. Di Sante1, A. Procoli, G. Migliara1, A. Piermattei1, M. Valentini1, G. 
Delogu3, G. Pani1, S. Fusco1, S. Borrello1, A. Cittadini1, G. Constantin4, F. Ria1 
1Università Cattolica del S. Cuore - Institute of General Pathology, Roma, Italy; 
2Università Cattolica del S. Cuore - Inst. Obstetrics and Gynecology, Roma, Italy; 
3Università Cattolica del S. Cuore - Institute of Microbiology, Roma, Italy; 4Università 
di Verona, Section of General Pathology, Verona, Italy 
Background: The role of infectious agents in the regulation of T cell trafficking is 
currently unknown. Methods: We examined this issue using immunoscope and TCR 
transgenic mice. Results: The amount of M tuberculosis in the adjuvant modulates 
rapid relocation of PLP139-151 (p139)-specific T cells carrying a public TCR-beta 
chain BV10-CASS SGS NTE JB1.1 from draining lymph nodes (LN) to spleen in the 
SJL mouse. In the presence of low dose of M tuberculosis in the adjuvant, T cells 
mostly reach the spleen by day 28 after immunization (“late relocation”), whereas the 
same T cells reach the spleen by day 14 after immunization with high dose of M 
tuberculosis (“early relocation”). The B6 background confers a dominant “early 
relocation” phenotype to F1 (SJL x B6) mice, allowing early relocation of T cells in 
the presence of low dose M tuberculosis. A single non-synonymous polymorphism of 
TLR2 (Ile83Met) is responsible for “early/late” relocation phenotype. By transferring T 
cells from F1 mice obtained crossing SJL mice transgenic for the TCR-beta chain 
indicated above (SJLBV10) with C57/B6wt or C57/B6tlr2-, we determined that 
egress of antigen specific lymphocytes is modulated by TLR2 expressed on T cells. 
We also examined the expression of some markers regulated by activation and 
involved in T cell trafficking. Early relocation is associated with an intermediate 
expression of CD44 and that TLR2 also regulates processing of CD44 pre-mRNA. 
Conclusions: Pathogens engaging TLR2 on activated T cells through a polymorphic 
site modulate expression of activation/adhesion molecules and regulate effector T 
cells trafficking in vivo. 
 
IHD6. Analysis of the Polymorphisms of Th1 and Th17 Cytokines in 
Mediterranean Spotted Fever 
M. Bova1, C. Colomba1, L. Vaccarino1, M. Palmeri1, G. Misiano1, L. Scola1, G. 
Giammanco1, D. Lio1, L. Titone1 
1University of Palermo, Palermo, Italy 
Background: We have recently reported that the susceptibility for Mediterranean 
spotted fever (MSF) caused by Rickettsia conorii, is influenced by the Th2 and Th1 
cytokine genetic polymorphism profiles. Less it is known on the effect of gene 
polymorphisms of cytokine produced by the Th17. Methods: 70 Sicilian patients 
affected by MSF and 239 control subjects matched for age, gender, and geographic 
origin were typed for functionally relevant single nucleotide polymorphisms (SNPs) of 
IFN-γ (+874 T/A), IL-18 (-137 G/C and -607A/C ) and IL-17 (7488T/C) according to 
our laboratory procedures. Results: No significant differences in IL-18 -137 G/C, 
-607A/C and in IFN-γ +874 T /A genotype frequencies were observed. On the 
contrary a statistically significant (p value= 0.0126) increase of the IL-17 TT 
genotype frequency of in MSF was observed. Conclusions: Cytokines play a crucial 
role in modulation of the host defense and genetically determined differences in 
cytokine production seem to influence the extent and severity of a large number of 
infectious diseases. 7488T/C SNP impinge on IL-17 signaling and might play a 
crucial role in neutrophil recruitment, induction of IFN-γ and IL-12 production in 
macrophages and in the induction of T regulatory cells. Our results suggest that a 
genetically determined increase of IL-17 dependent activation pathways might 
interfere with R. Conorii infection control. 
 
IHD7. The Alarmin Interleukin-33 Is a Notch Target in Quiescent 
Endothelial Cells 
G. Haraldsen 
Oslo University Hospital, Oslo, Norway 
Background: The molecular mechanisms that drive expression of the alarmin 
interleukin-33 (IL-33) in endothelial cells are unknown. Because nuclear IL-33 is a 
marker of endothelial cell quiescence (corroborated in this study by showing co-
expression of cyclin-dependent kinase inhibitor p27Kip1), we hypothesized that 
Notch signaling might be involved in regulating IL-33 expression. Methods: 
Umbilical vein-derived endothelial cells, rtPCR, immunocytochemistry, recombinant 
Notch ligands, siRNA, in vivo experiments. Results: Here we show that activation of 
Notch1 by immobilized Notch ligands was sufficient to induce nuclear IL-33 
expression in cultured endothelial cells. Conversely, IL-33 expression was inhibited 
by the γ-secretase inhibitor DAPT or by inhibiting the function of Dll4, Jagged1, 
Notch1, or the canonical Notch transcription factor RBP-Jκ. Sensitivity to 
cycloheximide indicated that IL-33 was a direct target of Notch signaling, well in line 
with the identification of several conserved RBP-Jκ binding sites in the IL-33 gene. 
The in vivo expression of Dll4 but not Jagged1 was well correlated with expression of 
IL-33 in quiescent vessels, and subcutaneous injection of DAPT in healthy skin 
reduced IL-33 expression, indicating that Notch signaling was involved. On the other 
hand, loss of IL-33 during angiogenesis occurred in spite of sustained Dll4 and 
Notch1 expression, suggesting that other signals may override the IL-33-driving 
signal in this context. Conclusions: Taken together, our data demonstrate that 
endothelial nuclear IL-33 is induced by Notch and that Dll4 may be the dominant 
ligand responsible for this signaling in vivo. 
 
IHD8. Recognition of Fungal β-glucan by Human Neutrophil CR3 
(CD11b/CD18) Results in Homotypic Cell Aggregation and Rapid Formation of 
Extracellular Traps by a Mechanism That Depends on α5β1 
A. Byrd1, K. Yu2, C. Johnson1, X. O'Brien2, L. Lavigne2, A. Salomon3, J. Reichner1 
1Brown University/Rhode Island Hospital, Providence, United States of America 
2Rhode Island Hospital, Providence, RI, United States of America; 3Brown University, 
Providence, United States of America 
Background: The armament of neutrophil-mediated host defense against fungal 
and bacterial pathogens includes the extrusion of a lattice of DNA and microbicidal 
enzymes known as Neutrophil Extracellular Traps (NETs). The receptor-mediated 
interactions and intracellular signaling events responsible for elaborating NETs are 
not well characterized and were determined in this study for the response to Candida 
albicans. Moreover, as the host response of extravasated neutrophils to deep-seated 
mycotic infections necessitates contact with ECM, this study identified an important 
regulatory function for the ubiquitous matrix component fibronectin (Fn) in anti-fungal 
NET release. Methods: Global tyrosine phosphoproteomic analysis mitigated the 
quantitative analysis of phosphorylated sites of neutrophils adherent to immobilized 
Fn vs. Fn + β-glucan and was validated via Western blot analysis. Light, confocal 
and transmission electron microscopy was implemented to observe NET formation 
after addition of Sytox Green, indicating a breach in membrane integrity. Results: 
Recognition of the purified fungal cell wall pathogen associated molecular pattern β-
glucan by human neutrophils resulted in formation of cell aggregates and NET 
release that required Fn. NET formation was dependent on CR3 (CD11b/CD18), but 
not Dectin-1 or reactive oxygen species (ROS). Fifty-four phosphopeptides were 
differentially regulated by β-glucan and validation revealed a role for ERK in 
aggregation and NET release. NET formation to C. albicans hyphae was also 
dependent on Fn, CR3, and ERK but not ROS. We also report a regulatory role for 
α5β1 in mediating NET release. Conclusions: This study identified key 
receptor:ligand interactions that induce NET formation rendering insight into 
understanding host defense mechanisms against fungal infections. 
 
IHD9. Signaling Molecules Involved in Homotypic Aggregation of 
Human Neutrophils in Response to Fungal β-Glucan 
C. Johnson1, A. Byrd1, J. Reichner1 
1Brown University, Pawtucket, RI, United States of America 
Background: Complement receptor 3 (CR3), an integrin found on neutrophils, 
regulates firm cell adhesion to the extracellular matrix and serves as a pattern 
recognition receptor for the fungal Pathogen Associated Molecular Pattern (PAMP) 
β-glucan. Coincident ligation of CR3 with fibronectin and β-glucan is possible due to 
spatially distinct ligand binding domains. Current work demonstrates that dual 
ligation of CR3 with fibronectin at its I-domain and β-glucan at its lectin-like site 
causes homotypic aggregation of primed human neutrophils. Methods: Using 
phosphoproteomics, we have identified several proteins that are significantly 
phosphorylated when ligated with fibronectin and β-Glucan but not fibronectin alone. 
From these data, we propose a signaling pathway in which increased 
phosphorylation of phosphoinositol 3 kinase (PI3K), protein kinase Cδ (PKCδ), 
glycogen synthase kinase 3β (GSK3β), and ERK could lead to the observed 
homotypic aggregation of neutrophils via CR3 on immobilized fibronectin and β-
glucan. Western Blotting validated our initial phosphoproteomic findings for each 
protein and use of inhibitors obviated homotypic aggregation of neutrophils for all 
aforementioned proteins except for GSK3β in which a partial inhibition was 
observed. Results: To quantify such partial inhibition, a computer algorithm was 
created to help quantify the number of cells clustered in a field. With this program, 
we were able to determine that despite our observation GSK3β inhibition has no 
effect on cell clustering. Conclusions: Thus PI3K, PKCδ, and ERK are all 
components of the signaling pathway of dually ligated CR3 that are also relevant to 
homotypic aggregation. 
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IMMUNITY AND INFLAMMATION – IMMUNITY 
 
IMM1. Structural Basis of Affinity Maturation of Antibodies in the 2-
Phenyl-5-Oxazolone System 
C. Scotti1, V. Pasquetto1, D. Covini1, E. Gherardi1 
1University of Pavia, Pavia, Italy 
Background: Affinity maturation of antibodies is the process whereby more efficient 
antibodies are produced through somatic hypermutation and antigen-guided 
selection. No extensive study is available at the moment concerning the relationship 
between somatic mutations and their structural counterpart. The antibody response 
to 2-phenyl-5-oxazolone has been thoroughly investigated from the genetic point of 
view. It consists of three antibody classes, with each member of each class derived 
from a unique pair of VH and VL germline genes by somatic hypermutation. In this 
project, we are investigating the structure of the VH and VL domains of 10 
representative antibodies. Methods: The VH and VL domains of each antibody are 
being expressed as recombinant scFvs, crystallised, and their structure determined 
by X-ray crystallography. Results: The structures and models available allow an 
initial definition of the strategies adopted. In class I, maturation is bound to 
improvement of surface complementarity, especially at the top of the binding pocket, 
and in surface charge changes. In class II the maturation strategy seems to be 
based on the increase of the interacting surface, and on the introduction of a specific 
bond with the oxazolone ring. In class III, where the low and high affinity antibodies 
differ by 8 mutations, the increase in affinity is mainly determined by the 
improvement in the surface complementarity by removal of a bulky phenylalanine, 
which allows a better tightening of the two sides of the binding site. Conclusions: 
These results are relevant to determine the principles underlying affinity maturation 
of antibodies. 
 
IMM2. Identification Of CIKS/ACT1 New Interacting Partners 
D. Somma1, P. Mastrovito1, M. Grieco1, S. Mellone1, R. Acquaviva1, A. Leonardi1 
1Federico II University of Naples, Napoli, Italy 
Background: CIKS (Connection to IKK and SAPK/JNK; a.k.a. Act1) is a putative E3 
ubiquitin ligase required for signaling by IL-17. IL-17 is an inflammatory cytokine 
product by T helper lymphocyte type 17 (Th17), involved in the development of some 
inflammatory diseases like rheumatoid arthritis, psoriasis and multiple sclerosis. 
CIKS mediated NF-κB activation requires the binding to IKKγ/NEMO (a key protein 
involved in NF-κB pathway) via the SEFIR domain; CIKS also interacts with TRAF6 
(an E3 ubiquitin ligase) by its evolutionary conserved motif at the N-term. Methods: 
Immunoprecipitations of FLAG-CIKS interactors were performed with anti-FLAG 
antibody. The immunoprecipitation products were electrophoresed by SDS-PAGE 
and analyzed by mass spectrometry. Results: The aim of the present project is the 
identification of new CIKS interactors. To this purpose we infected CIKS -/- MEFs 
with a lentiviral expression vector containing the cDNA encoding FLAG-CIKS. The 
potential CIKS interactors obtained by co-immunoprecipitation were analyzed by 
mass spectrometry. Conclusions: We identified about 30 CIKS interactors whose 
characterization is currently under investigation. 
 
IMMUNITY AND INFLAMMATION – IMMUNOPATHOLOGY BIOMARKERS 
 
IMBM1. Antiprothrombin/phosphatidylserine Complex Autoantibodies in 
Antiphospholipid Syndrome: Prevalence in Routinely Attending Patients in 
Udine 
M. Fabris1, D. Visentini1, J. Peresan1, S. De Vita1, F. Curcio1, E. Tonutti1 
1Azienda Ospedaliero-Universitaria of Udine, Udine, Italy 
Background: Antiphospholipids (aPL) are a heterogeneous family of antibodies 
reacting with serum phospholipid-binding proteins, including prothrombin. Antibodies 
against prothrombin alone, or the phosphatidylserine/antiprothrombin complex may 
be detected. The prevalence of IgG/IgM prothrombin/phosphatidylserine complex 
antibodies (aPT/PS) in consecutive patients, focusing on lupus-anticoagulant (LA)-
positive/anticardiolipin(aCL)-negative patients, was compared with the routinely used 
test for anti-prothrombin antibodies. Methods: 136 patients were enrolled, 78% 
female, age range 18-88, 109 (78.9%) LA-positive (72.4% of which aCL-negative), 
24 LA/aCL-negative, 3 unknown LA, aCL-negative. Clinically: 81 lupus (SLE) or 
undifferentiated connective tissue diseases (UCTD), 21 with aPL syndrome (APS), 
26 systemic autoimmune diseases (AID), 19 with accidental arterial and venous 
thrombosis (AVT), 10 LA-positive cancer-related arterial and venous thrombosis. 
Normal ranges were assessed on 52 healthy donors (55.8% female; age range 18-
65). Quanta Lite aPS/PT IgG/IgM (Inova Diagnostics Inc, San Diego, CA). 
Antiprothrombin IgG/IgM (Orgentec Diagnostika, Mainz, Germany). Results: The 
overall prevalence IgG and/or IgM in LA-positive patients was in line with previous 
data (57.8%; Zigon, Clin Chem Lab Med 2011). The highest prevalence was found in 
APS (73.3%), followed by SLE/UCTD (70.4%, that were 57.4% aCL-negative) and 
other systemic AID (53.8%, that were 92.3% aCL-negative). aPS/PT were positive 
also in 2/4 seronegative APS, in 31.6% AVT and 50% of oncologic patients. In LA-
positives, the sensitivity of the new phosphatidylserine-dependent antiprothrombin 
ELISA was significantly higher than the anti-prothrombin alone ELISA (55.8% vs. 
15.4%). Conclusions: Testing anti-PT/PS antibodies improves the capability to 
identify unrecognized aPL antigens, helping to better characterize APS patients. 
 
IMBM2. Laboratory Screening of Helicobacter pylori in Stool Samples 
Suggest a Relationship with Graves’ Disease, but Not Hashimoto’s Thyroiditis 
O. Fattoruso1, A. Iengo1, V. Bassi1, F. Schiano1, C. Lucchese1, M. Polistina1 
1ASL NA1 Centro - Ospedale San Giovanni Bosco, Naples, Italy 
Background: Helicobacter pylori (HP) infection has been epidemiologically linked to 
some extra-digestive conditions, including autoimmune thyroid diseases (ATDs), 
although there are contradictory data about relationship between HP infection and 
these disorders. The aim of study was to investigate the correlation between 
prevalence of Cag-A positive strains of HP in stool samples and ATDs. Methods: 
We investigated 112 consecutive patients: 48 females and 4 males with Graves’ 
Disease (GD), 54 females and 6 males with Hashimoto’s thyroiditis (HT), at first 
diagnosis of ATDs. The control group was composed of 100 class-matched 
individuals. Thyroid hormones and autoantibodies for ATDs diagnosis were 
measured by chemiluminescent immunoassay, using Liaison instrument (Diasorin, 
Italy). To evaluate HP infection, stool samples were tested by amplified enzyme 
immunoassay (Amplified IDEIA H. pylori StAR, Oxoid, United Kingdom). To detect 
Cag-A antibodies, serum samples were tested by enzyme-linked immunoassay 
method (ELISA, Radim, Pomezia, Italy). Results were analyzed by two-sided 
Fisher’s exact test and the respective odds ratio (OR) calculated. P ≤ 0.05 was 
considered significant. Results: The presence of HP in stool samples was higher in 
GD group (43/52, 82%) than in HT group (28/60, 46%) and control group (43/100, 
43%). A statistically significant interaction was found between HP positivity and 
Graves’ disease (P ≤ 0.0001 vs control, OR 6.3), but not Hashimoto’s thyroiditis. 
Conclusions: A possible role of HP infection in GD could be dependent on the 
different expression of adhesion molecules in the gastric mucosa, but further studies 
needs to display such hypothesis. 
 
IMMUNITY AND INFLAMMATION – INFLAMMATION 
 
IMIN1. Study of the Modulation of Cytokine Release by Natural 
Compounds with Pharmacological Properties Using Cell-Based Systems 
M. Ruscica1, G. Beretta2, F. Gelmini2, L. Steffani2, E. Rizzi3, R. Maffei Facino2, P. 
Magni2 
1Università di Milano, Milan, Italy; 2Università degli Studi di Milano, Milan, Italy; 
3MD’E s.r.l., Castelnuovo Vomano, Italy 
Background: The screening of the pharmacological properties of natural 
compounds (i.e., anti-inflammatory effects) may take advantage of some specific 
cell-based systems. Parthenolide (PTN) and Copaifera langsdorfii (Copaiba) are 
natural compounds used to prevent and treat headache and migraine and in 
inflammatory diseases involving respiratory airways, genital-urinary apparatus and 
skin, respectively, but their effects at the cellular level are poorly understood. 
Methods: Mouse BV-2 microglia and human THP-1 monocyte cell lines were used. 
The nuclear translocation of nuclear factor (NF)-kB was evaluated by Western 
blotting analysis. The secretion of inflammatory cytokines (interleukin (IL)-1β, IL-6, 
tumor necrosis factor-α (TNFα)) was evaluated by immunometric assays (ELISA). 
Results: Treatment of BV-2 cells with 1 µM PTN and of THP-1 cells with 10 µM 
Copaiba oleoresin (OR), containing diterpene acids, diterpenes and sesquiterpenes, 
strongly reduced the NF-kB translocation to the cell nucleus induced by 1 µg/mL 
lipopolysaccaride (LPS). In BV-2 cells, PTN reduced IL-6 secretion in a dose-
dependent manner (-29% at 200 nM, P < 0.001; -45% at 1 μM, P < 0.001; -98% at 5 
μM, P < 0.001; ANOVA). Moreover, at 5 μm (highest concentration tested) PTN also 
reduced TNF-α secretion (-54%, P < 0.001). Preincubation of LPS-stimulated THP-1 
monocytes with OR (dose-range: 0.1-10 mM), reduced the release of all tested 
cytokines (IL-1β, IL-6, TNF-α). Conclusions: The results obtained provide strong 
evidence that both cell-based models are useful to validate the anti-inflammatory 
properties of PTN and OR at the cellular level and suggest that they are related to 
inhibition of cytokine secretion and NF-κB nuclear translocation. 
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IMIN2. Origins and Significance of Elevated Gamma-glutamyltransferase 
in Cystic Fibrosis Sputum 
A. Corti1, M. Franzini2, S. Cianchetti1, G. Bergamini3, E. Lorenzini1, P. Melotti3, A. 
Paolicchi1, P. Paggiaro1, A. Pompella1 
1Scuola Medica dell'Università di Pisa, Pisa, Italy; 2Scuola Superiore S. Anna, Pisa, 
Italy; 3Centro Fibrosi Cistica, Azienda Ospedaliera di Verona, Verona, Italy 
Background: Cystic fibrosis (CF) is an autosomal recessive disorder characterized 
by a chronic neutrophilic airways inflammation, increasing levels of oxidative stress 
and reduced levels of antioxidants such as glutathione (GSH). Gamma-
glutamyltransferase (GGT), an enzyme induced by oxidative stress and involved in 
the catabolism of GSH and its derivatives, is increased in the airways of CF patients 
with inflammation, but the possible implications of its increase have not yet been 
investigated in detail. Methods: Sputum samples from 7 CF patients were analyzed 
by cytochemistry, HPLC-gel filtration, western blot and enzymoloy techniques. 
Results: GGT activity was found both in neutrophils and in ELF fluid, the latter 
significantly correlating with myeloperoxidase expression. In neutrophils, GGT was 
associated with intracellular granules. In the fluid, gel-filtration chromatography 
showed the presence of two distinct GGT fractions, the first corresponding to the 
human plasma b-GGT fraction, the other to the free enzyme. The same fractions 
were also observed in the supernatant of ionomycin and fMLP-activated neutrophils. 
Western blot analysis confirmed the presence of a single band of GGT 
immunoreactive peptide in the CF sputum samples and in isolated neutrophils. 
Conclusions: In conclusion, our data indicate that neutrophils are able to transport 
and release GGT, thus increasing GGT activity in CF sputum. The prompt release of 
GGT may have consequences on all GGT substrates, including major inflammatory 
mediators such as S-nitrosoglutathione and leukotrienes, and could participate in 
early modulation of inflammatory response. 
 
IMIN3. Multi-step Regulation of Toll-Like-Receptor 4 Signalling by IL-10-
dependent Anti-inflammatory microRNAs 
G. Curtale1, M. Rossato2, T. Renzi1, M. Mirolo3, L. Mori1, F. Bazzoni2, M. Locati1 
1University of Milan, Rozzano, Italy; 2University of Verona, Verona, Italy; 3Istituto 
Clinico Humanitas IRCCS, Rozzano, Italy 
Background: Toll-like receptors (TLRs) play a key role in detecting pathogens and 
initiating inflammatory responses that subsequently prime specific adaptive 
responses. To avoid excessive inflammation and consequent immunopathology, 
TLR signalling must be tightly regulated. Though microRNAs (miR) have emerged as 
important regulators in several biological processes, their functional role in the 
control of inflammatory responses remains incompletely understood. Methods: 
Bioinformatic analysis was performed using MiRanda software, luciferase assays 
were performed on target 3’-UTRs cloned in psi-Check2, THP-1 transduction was 
achieved using pRRL-based lentiviral constructs. Results: Stimulation of human 
monocyte/macrophages with LPS induced the expression of miR-187, miR-146b, 
and the cluster 99b/125a-5p/let7e at late time-points. Blocking experiments indicated 
that these miRs are all induced as part of the IL-10-dependent feedback loop, and all 
substantially decreased under chronicization conditions, mimicked by IFNγ 
exposure. Bioinformatic analysis predicted and luciferase assays confirmed that 
receptors (TLR4, CD14), signal transducers (MyD88, IRAK1), transcription factors 
(IK-Bzeta), and effector molecules (TNF, IL-6, chemokines) involved in the TLR4 
pathway are direct targets of these IL-10-dependent miRs. The biological relevance 
of this finding was confirmed by the significant reduction of LPS-dependent cytokine 
production achieved by overexpression of individual miRs in THP-1 cells. 
Conclusions: We have identified a set of anti-inflammatory miRs, activated by IL-10 
in human monocytes and macrophages, which are able to modulate TLR signalling 
acting at multiple steps of the signalling cascade, by direct targeting of receptors, 
adaptor/signalling proteins, and effector molecules. These miR candidate as new 
modulators of the response to LPS and are potentially involved in the resolution of 
inflammation. 
 
IMIN4. Recombination Is a Major Source of Genetic and Pathogenic 
Diversification of Group A Streptococcus Serotype M89 Strains 
M. Di Luca1, S. Beres2, D. Petrelli1, M. Prenna1, S. Ripa1, L. Vitali1, J. Musser2 
1Università di Camerino, Camerino, Italy; 2The Methodist Hospital Research Institute, 
Houston, TX, United States of America 
Background: Group A Streptococcus pyogenes (GAS) is a genetically diverse 
human pathogen having > 150 serotypes. Serotype M89 strains are a common 
cause of GAS pharyngeal and invasive infections. Recent studies indicate M89 
strains may be increasing in prevalence. Over the last 15 years in Italy, two large 
epidemic outbreaks were caused by macrolide resistant M89 strains. M89 epidemic 
strains differed in gene content encoding virulence factors and macrolide resistance. 
We used comparative genomics to assess serotype M89 genetic diversity and its 
contribution to GAS pathogenesis. Methods: Next-generation DNA sequencing was 
conducted for 22 isolates (Italy = 5, Canada = 1, New Zealand = 1, US = 15). 
Complete genomes were determined for 1 Italian and 1 US strain. Polymorphisms 
were identified genome-wide for the cohort and used to infer genetic relationships. 
Results: The genome of Italian strain 11610 is 1,709,407 bp and lacks prophages. 
Italian epidemic isolates differed pairwise by ~32 core-genome SNPs. The genome 
of US strain MGAS11027 is 1,786,881 bp and has 2 prophages encoding secreted 
virulence factors. US M89 strains differed pairwise by ~397 SNPs. Italian M89s 
differed from US M89s by ~2064 SNPs. SNPs among US M89s, and differing US 
from Italian M89s, were nonrandomly clustered. Conclusions: SNPs among the 
M89 strains exceeded that among other GAS serotypes. Most SNPs were attributed 
to discrete recombination events involving genes encoding virulence factors 
including surface adhesins, antimicrobial peptides, and secreted anti-immune 
response proteins. These findings demonstrate that genetic recombination strongly 
contributes to diversification of M89 pathogenic capacity. 
 
IMIN5. Platelets Amplify IL-6 Trans-signaling 
M. Marino1, F. Scuderi1, E. Ponte2, M. Maiuri1, S. Rose-John3, A. Cittadini1, E. 
Bartoccioni1 
1Università Cattolica S. Cuore, Rome, Italy; 2San Camillo Forlanini Hospital, Rome, 
Italy; 3Christian-Albrechts-Universität, Kiel, Germany 
Background: Human platelets are a key element linking hemostasis, inflammation, 
and tissue repair. Produced by a broad spectrum of cell types in the cardiovascular 
system, IL-6 has become a marker of vascular inflammation, associated with a 
variety of clinically significant outcomes. Recent literature showed a trans-signaling 
molecular mechanism by which IL-6 could affect leukocyte-recruitment through the 
release of soluble IL-6 receptor (sIL-6R). We investigated the potential role of 
platelets in this mechanism. Methods: For each experiment human platelets were 
isolated from healthy donor single buffy-coat, free of leukocytes. Short time 
stimulations were performed with thrombine, IL-6, the soluble specific IL-6Rs and 
Hyper-IL6, alone or in combination; Hyper-IL6 is a fusion protein of human IL-6 
covalently linked to the human sIL-6R and is 100- to 1000-fold more active than the 
natural complex, usually used for in vitro experiments. Western blotting, FACS and 
ELISA were used to analyze platelet reactivity. Results: a) activated platelets can 
release biologically active sIL-6R, b) the complex IL-6/sIL-6R increases platelet IL-
6R and gp130 expression, and c) the complex IL-6/sIL-6R induces STAT3 
phosphorylation. Conclusions: We point out the potential role of platelet/IL-6 trans-
signaling interaction, which could be another not irrelevant link between inflammation 
and hemostasis. 
 
IMIN6. Inhibition of Cytokine-Induced Signaling Pathways and Target 
Gene Expression by Plant Components in Pancreatic Beta Cells 
M. Novelli1, P. Beffy2, M. Menegazzi3, S. Porozov4, A. Sgarbossa3, M. Masini1, V. De 
Tata1, L. Martino1, P. Masiello1 
1Dept. of Experimental Pathology B.M.I.E. University of Pisa, Pisa, Italy; 2Institute of 
Clinical Physiology, Pisa, Italy; 3Dept. of Life and Reproductive Sciences, Verona, 
Italy; 4Institute of Clinical Physiology, CNR, Pisa, Italy 
Background: We have previously found that the extract of Hypericum perforatum 
(St John’s wort), SJW) and its component hyperforin (HPF) protect pancreatic beta 
cells against the cytotoxic effects of cytokines, by acting as powerful inhibitors of the 
transcription factors STAT-1 and NF-kB. Aims of this study were: a) to explore the 
time course of STAT-1 inhibition in the INS-1E cell line; b) to further clarify the 
mechanisms of the regulatory activity of SJW and HPF on the cytokine signaling 
pathways and expression of target genes. Methods: INS-1E cells, exposed to 
mixtures of IFN-γ, IL-1β and TNF-α with/without SJW or HPF, were used for RT-
qPCR gene expression analysis and assessment of phosphorylated components of 
STAT-1, NF-kB and MAPK pathways by western blotting. Results: SJW and HPF 
down-regulated STAT-1 even after their removal from the incubation medium before 
the addition of cytokines or when added 15-30 min following cytokines. The vegetal 
compounds dose-dependently prevented cytokine-induced STAT-1 phosphorylation 
in both tyrosine and serine residues. NF-kB activation was hindered through 
suppression of the p65 subunit phosphorylation and interference with the inhibitory 
subunit IkB. MAPK cascade was also modulated by SJW and HPF through dose-
dependent restriction of ERK1/2 and p38 MAPK phosphorylations. SJW and HPF 
restrained cytokine-induced mRNA expression of pro-inflammatory genes (e.g., 
iNOS, CXCL9, CXCL10, ICAM-1) and partially corrected the cytokine-induced 
unbalance between anti- and pro-apoptotic factors. Conclusions: SJW and HPF, by 
counteracting crucial mechanisms of cytokine-induced inflammatory and apoptotic 
alterations, represent interesting pharmacological tools for prevention or limitation of 
dysfunction and beta-cell loss in diabetes. 
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KIDNEY DISEASES 
 
KD1. Study of Molecular and Functional Effects Induced in Tubular 
Primary Cell Cultures by High Glucose Treatment 
B. Torsello1, S. Bombelli1, V. Di Stefano1, S. Minniti1, S. Buscone1, M. Zipeto1, G. 
Bovo2, G. Cattoretti3, R. Perego1, C. Bianchi1 
1Department Experimental Medicine - Milano-Bicocca University, Monza, Italy; 
2Department of Pathology - S. Gerardo Hospital, Monza, Italy; 3Department of 
Surgical Sciences - Milano-Bicocca University, Monza, Italy 
Background: Tubulointerstitial fibrosis is an important component of renal injury in 
diabetic nephropathy. Tubular and tubulointerstitial cells may contribute in different 
ways to the fibrotic phenotype. We analyzed the effects of high glucose treatment on 
epithelial tubular cells in vitro to evaluate their contribution to development of renal 
fibrosis. Methods: Control (DMEM 100mg/dl D-glucose) and treated (DMEM 
450mg/dl D-glucose) tubular primary cell cultures have been analysed for gene and 
miRNA expression by Real Time PCR, FACS, Western blot, Immunofluorescence, 
and functionally characterized by adhesion and migration assays. Conditioned media 
from control and treated cells were submitted to Multiplex Cytokine analysis and 
evaluated for their ability to activate NIH3T3 fibroblasts. Results: Treated tubular 
cells show a few phenotypic features of EMT, an increase of proliferation and a 
decrease of migration properties. In these treated cells actin filaments are 
reorganized in stress fibers with an increase of focal adhesions. The expression of 
nonreceptor tyrosine kinase Arg, known to regulate cellular morphology and 
adhesion through RhoGTPases, is decreased and show a different isoform pattern in 
treated cultures respect to control. Finally, cytokine analysis of culture media 
evidences an increase of MCP-1, GM-CSF and TGF-β1 level in treated cells. 
Conditioned media from treated cells are able to increase fibroblast proliferation. 
Conclusions: Although high glucose treatment induced cytoskeletal changes and 
the secretion of pro-inflammatory and fibrotic cytokines in tubular primary cell 
cultures, it was unable to induce a complete EMT phenotype. 
 
KD2. Exposure to Low- Versus Iso-Osmolar Contrast Agents Induces 
NADPH-dependent Reactive Oxygen Species (ROS) Generation in a Cellular 
Model of Renal Injury 
G. Netti1, C. Prattichizzo1, E. Montemurno2, S. Simone2, G. Grandaliano1, L. 
Gesualdo2, E. Ranieri1 
 1University of Foggia, Foggia, Italy; 2University of Bari, Bari, Italy 
Background: Contrast-induced nephropathy (CIN) represents the third cause of 
hospital-acquired acute-renal-failure.In this study we aimed to determine whether the 
use of iso-osmolar iodixanol is less nephrotoxic than low-osmolar iohexol and 
iopamidol in a cellular model. Methods: X-ray attenuation of iohexol,iopamidol and 
iodixanol was assessed at equimolar iodine concentrations. Human renal proximal 
tubular cells were incubated with equally attenuating solutions of CM. Cytotoxicity 
was assessed by trypan-blue-testing, MTT-assay and AnnV/PI-assay to detect 
apoptosis and necrosis.ROS-production was assessed by DCF-assay and NADPH-
oxidase-activity was checked by chemiluminescence method. Results: Yielding the 
same x-ray attenuation, CM-cytotoxicity was assessed at equimolar iodine-
concentrations. At trypan-blue-testing, there were more necrotic cells after incubation 
with 50,100,150 and 270mgI/mL of iohexol and iopamidol than after incubation with 
equal concentrations of iodixanol (P < 0.005). Iohexol and iodixanol at 20 and 
50mgI/mL induced comparable inhibition of MTT-conversion with a dose-dependent-
effect, whereas iopamidol showed a marked cytotoxic effect, as compared with 
iodixanol (26.0 vs. 54.9% at 20mgI/mL and 23.2 vs. 36.8% at 50mgI/mL of 
undamaged control cells for iohexol and iodixanol, respectively; P < 0.05). Moreover, 
both iohexol and iopamidol induced more necrosis and apoptosis than iodixanol with 
a dose-dependent effect (iodixanol vs. iopamidol: for necrosis 1.9 vs. 1.1% at 
20mgI/mL and 2.8 vs. 0.9% at 50mgI/mL, P < 0.05; for apoptosis 45.6 vs. 36.9% at 
20mgI/mL and 52.0 vs. 40.0% at 50mgI/mL, P < 0.05). ROS-generation was higher 
for iopamidol and iohexol as compared with iodixanol (after 40min 21263 ± 2124 and 
8985 ± 1601 vs. 4430 ± 801 AU at 20mgI/mL, P < 0.05; 9844 ± 1124 and 8113 ± 
101 vs. 4076 ± 601 AU at 50mgI/mL, P < 0.05). NADPH-oxidase-activity significantly 
increased after exposure to iopamidol and iohexol with a dose-dependent effect, as 
compared with iodixanol (27.6 and 50.5 vs. 8.9% over the basal at 20mgI/dL, P < 
0.05; 50.5 and 71.1 vs. 35.8% over the basal at 50mgI/dL, P < 0.05). Conclusions: 
At angiographic concentrations, iodixanol induces fewer cytotoxic effects on cultured 
tubular cells than iohexol and iopamidol by inducing lower amount NADPH-
dependent ROS-genereration. 
 
NEOPLASIA – ADVANCES IN MOLECULAR CANCER THERAPIES 
 
NAMT1. Photochemical and Photobiological Evaluation of 
Fluoroquinolones as Anticancer Agents 
L. Stivala1, C. Maccario1, D. Ferraro1, S. Sommatis1, R. Mocchi1, L. Pretali1, M. 
Savio1, P. Perucca1, O. Cazzalini1, R. Pizzala1, E. Fasani1, A. Albini1 
1Università di Pavia, Pavia, Italy 
Background: Fluoroquinolones are antimicrobial agents used against many 
infectious diseases. When UVA-irradiated, some of them exert phototoxic and 
mutagenic effects and those showing the strongest photogenotoxicity have a second 
fluorine atom in position 8 (other than the one in position 6). The mechanism of 
action proposed is based on ROS formation, but studies in solution demonstrated a 
new photochemical reaction producing a triplet-aryl cation able to attack DNA bases. 
An oxygen-independent photodynamic agent would be a good strategy against 
cancer, because of its low oxygen pressure. In this study, the photobiological activity 
of commercially available or newly synthesized fluoroquinolones, optimized to act via 
aryl cation, have been investigated. Methods: Ciprofloxacin, lomefloxacin and 
ofloxacin photoactivity were evaluated in A431 and HeLa cancer cells in terms of 
intracellular localization, phototoxicity, DNA damage, cell growth inhibition and 
apoptosis induction. Cells were incubated with each compound for 24h, then UVA-
irradiated both at normal oxygen partial pressure and under hypoxic conditions. 
Results: Fluoroquinolones appeared as small blue spots within the cytoplasm. Most 
of them colocalized with lysosomes and less with mitochondria. Among the three 
fluoroquinolones, ciprofloxacin showed the highest photocytotoxicity, whereas both 
ciprofloxacin and lomefloxacin markedly impaired cell cycle progression inducing 
apoptotic cell death. Ciprofloxacin showed a higher damaging potential on DNA 
plasmid, followed by lomefloxacin, then by ofloxacin. Considerable amount of DNA 
damage, both as SSBs and oxidized pyrimidine or purine bases, was detected in 
lomefloxacin- or ciprofloxacin-treated cells. Conclusions: Fluoroquinolones' 
photobiological effect was influenced by the oxygen pressure. A bi-phasic 
mechanism of action can be envisaged. 
 
NAMT2. A Novel Molecular Pathway for Caveolin-1 as an Oncopromoter in 
Glioblastoma Cells 
F. Pancotti1, L. Roncuzzi2, A. Gasperi-Campani3 
1Department of Experimental Pathology, Bologna, Italy; 2Istituto Ortopedico Rizzoli, 
Bologna, Italy; 3University of Bologna, Bologna, Italy 
Background: Caveolin-1 is an essential structural constituent of caveolae implicated 
in mitogenic signalling, oncogenesis, angiogenesis, neurodegenerative diseases and 
senescence. Its role as a tumor suppressor gene or as a tumor promoter seems to 
strictly depend on cell type and tumor stage/grade. The high expression of caveolin-
1 in some tumors in vivo is associated with increased tumor aggressiveness, 
metastatic potential and suppression of apoptosis. Methods: In glioblastoma A172, 
CRS-A2, LI cell lines we found Cav-1 expressed at high levels. Silencing of Cav-1 
gene was performed using small interfering RNA (siRNA). Cells were grown to 30-
40% confluence and transfected for 72 h with 40 nM siRNA using Oligofectamine 
Reagent. Non-specific siRNA was used as a negative control. Cav-1 expression was 
assayed by immunoblot analysis. Cell proliferation was tested by MTT assay. 
Results: Results in the A172 cell line are presented here and show that siRNA-
mediated down-regulation of Cav-1 caused stable arrest of proliferation. A marked 
reduction of cyclin D1 and of CDK4 expression was evident in the cells transfected 
with Cav-1 siRNA and consequently of phosphoRb. Furthermore, a significant 
decrease of the expression of Src and p38α and of their down-stream effector 
STAT3 was evident. Conclusions: Together, these findings indicate that Cav-1 
silencing induces an arrest of human glioblastoma cells proliferation by a new 
inhibitory pathway in this tumor, the most aggressive of the primary central nervous 
system tumors, and provide new insights into the molecular mechanisms underlying 
the pro-survival and tumor-promoting functions of Cav-1. 
 
NAMT3. Synergy Between HDACi and PARP Inhibitor on Breast Cancer 
Cells 
C. Puppin1, E. Lavarone1, F. Baldan1, G. Damante1 
1Università di Udine, Udine, Italy 
Background: An important strategy for cancer treatment consists of the 
contemporary use of different compounds. In this research we have investigated the 
combination of suberoylanilide hydroxamic acid (SAHA), a histone deacetylases 
inhibitor (HDACi), and a PARP Inhibitor (PJ34) on proliferation and gene expression 
of breast cancer cell lines. HDAC inhibitors and PARP Inhibitors have shown 
antitumor activity across a broad variety of hematologic and solid tumors in both 
preclinical studies and clinical trials. Methods: MDA 468, MDA 231, MDA 157 and 
T47D breast cancer cell lines, were investigated. In a first set of experiments we 
tested whether various doses of SAHA and PJ34 have synergic effect on cell 
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proliferation and apoptosis. Then the synergic dose has been used to treat the cell 
lines to quantify the mRNA of the NIS gene, with real time PCR. Results: On MDA 
157 we observed a strong synergy on cell viability between the two compounds. On 
this cell line synergy between SAHA and PJ34 is observed also at levels of 
apoptosis. The effect of SAHA and PJ34 was investigated also on the expression of 
Sodium Iodide Symporter (NIS) in MDA 157 and MDA 468 cell line. On MDA 468 cell 
line synergy among the two compounds, on NIS gene expression, was very strong. 
Conclusions: These results suggest that combinations between HDACi and PARP 
inhibitors may be proposed in breast cancer treatment. 
 
NAMT4. PDGFRα Signaling in Liver Regeneration Reveals Novel 
Redundancies: Implications in Hepatocellular Cancer 
P. Awuah1, K. Nejak-Bowen1, S. Monga1 
1University of Pittsburgh School of Medicine, Pittsburgh, PA, United States of 
America 
Background: Platelet derived growth factor receptor-α (PDGFRα) is known for its 
role in mesenchymal cells such as fibroblasts and endothelial cells and other cells 
like neurons. We have recently identified low expression of PDGFRa in adult 
hepatocytes, which is up-regulated in hepatocellular cancer. Methods: To determine 
the role and regulation of PDGFRa in hepatocyte biology, we generated hepatocyte-
specific PDGFRA knockout mice (KO). We examined liver regeneration (LR) in KO 
and control (WT) mice after partial-hepatectomy (PH). Results: Loss of PDGFRα in 
hepatocytes was evident at 2 months, albeit no gross, histological or biochemical 
anomaly was discernible. We identified increased total and active PDGFRα protein 
at 24hr post PH. Loss of PDGFRα in hepatocytes did not engender any changes in 
hepatocyte viability (TUNEL) at any timepoint during LR; however, we observed 
increased hepatocyte proliferation (PCNA) at 72hr during LR after PH. Interestingly, 
we observed enhanced expression of both EGFR and MET in the KO livers at 
various timepoints during LR. In addition, in vitro analyses using primary mouse 
hepatocytes shows that activation of hepatocyte PDGFRα abrogates, whereas its 
blockade enhances, EGF/HGF induced hepatocyte proliferation. Conclusions: 
Thus, although PDGFRα increase is conspicuous during LR, its loss in hepatocytes 
appears to be possibly compensated for by both EGFR and MET, which may explain 
the lack of overt phenotype in KO mice during LR. Also, targeting PDGFRα in HCC 
cells may lead to EGFR/Met activation necessitating sequential inhibition of these 
pathways for improved therapies. (CATER fellowship (NIH T32 EB001026-05) to PA; 
1R01DK62277 and 1R01CA124414) 
 
NAMT5. Impact of Histone Deacetylase Inhibitors SAHA and MS-275 on IL-
8 Synthesis in Human Melanoma Cells 
I. Venza1, M. Visalli1, M. Cucinotta1, G. DE Grazia1, R. Oteri1, C. Saoca1, D. Teti1, M. 
Venza1 
1University of Messina, Messina, Italy 
Background: Elevated interleukin-8 (IL-8) levels have been observed in patients 
with metastatic melanoma, and histone deacetylases inhibitors (HDACis) have been 
shown to influence melanoma progression. In most instances, HDAC inhibitors were 
positively acting in cooperation with inducers of IL-8, whereas in other cases IL-8 
expression was down-regulated by HDACis. This study aims at investigating whether 
the HDACis SAHA and MS-275 affect IL-8 expression in melanoma cells. Methods: 
Cutaneous and uveal melanoma cell lines were treated with HDACis and IL-8 mRNA 
and protein were determined by real time-PCR and enzyme-linked immunosorbent 
assay. The protein content of the main transcription factors involved in IL-8 gene 
regulation and their binding to IL-8 promoter were evaluated by western blot and 
chromatin immunoprecipitation assay. Cell proliferation and apoptosis rates were 
also investigated. Results: HDACis strengthened IL-8 mRNA and protein 
expression. In parallel, increased cell proliferation and reduced rate of apoptosis 
were observed. The observed activation of IL-8 by HDACis correlated with increased 
protein levels of c-Jun. On the contrary, CHOP, Rel-A and C/EBPβ synthesis was 
not affected. Interestingly, SAHA and MS-275 induced c-Jun binding to the IL-8 
promoter as well as c-Jun transcription by favoring the recruitment of the preinitiation 
complex (RNA polymerase II and TFIIB) to the c-Jun promoter. Conclusions: Data 
reported here indicate that the inhibition of class I HDAC activity is a requisite to 
activate IL-8 expression in cutaneous as well as uveal melanoma. The increase of 
IL-8 was mediated by c-Jun promoter activation and was accompanied by enhanced 
cell proliferation and reduced apoptosis. 
 
NAMT6. Development of a Leptin Antagonist Peptide: Implications for 
Breast Cancer 
L. Gelsomino1, I. Barone1, A. Leggio1, R. De Marco1, C. Giordano1, D. Bonofiglio1, A. 
Liguori1, S. Catalano1, S. Andò1 
1University of Calabria, Arcavacata di Rende, Italy 
Background: The role of the obesity cytokine leptin in breast cancer progression 
has raised interest in interfering with leptin’s actions as a valuable therapeutic 
strategy. Leptin interacts with its receptor through three different binding sites: I-III. 
Site III is crucial for the formation of an active leptin-leptin receptor complex and in its 
subsequent activation. Amino acids 39-42 (LDFI) were shown to contribute to leptin 
site III and their mutations in alanine resulted in muteins acting as typical 
antagonists. Based on this design strategy, we synthesized the unmodified leptin 
fragment LDFI and evaluated its activity in both estrogen receptor-positive and -
negative breast cancer cells. Methods: The peptide was synthesized by CEM-
Liberty microwave-assisted automated-synthesizer, and characterized by 1H-NMR 
spectroscopy. We assessed signaling pathway activation by immunoblotting 
analysis, proliferation by anchorage-dependent and -independent growth assays and 
migration by wound-healing assays. Results: The LDFI-peptide abolished the leptin-
induced phosphorylation of its downstream effectors, as JAK2/STAT3/Akt/MAPK, 
without any agonistic activity. These results correlated with a reduction in anchorage-
dependent and -independent growth as well as migration of breast cancer cells. 
Importantly, the LDFI fragment reversed the leptin-mediated up-regulation of its gene 
expression, as an additional mechanism able to enhance the peptide antagonistic 
activity. The described effects were specific for leptin signaling, since the developed 
peptide was not able to antagonize the other growth factors’ actions on signaling 
activation, proliferation and migration. Conclusions: We demonstrate that the 
unmodified LDFI-peptide acts as a full leptin antagonist and could become an 
attractive option for breast cancer treatment, especially in obese women. 
 
NAMT7. β-Catenin-Mutated Human Hepatocellular Carcinoma (HCC) Cells 
Show Features of Glutamine Addiction 
M. Chiu1, S. Tardito1, R. Franchi-Gazzola1, M. Bianchi1, L. Ottaviani1, J. Uggeri1, A. 
Arcangeli2, S. Pillozzi2, O. Bussolati1 
1Università di Parma, Parma, Italy; 2Università di Firenze, Firenze, Italy 
Background: High consumption of anaplerotic substrates is a hallmark of cancer 
cells, which must couple energy production with macromolecular synthesis to sustain 
a rapid growth. Although most tumors use glucose for anaplerosis, some cancer 
cells rely on glutamine and, hence, are defined glutamine-addicted. Methods: 
HepG2 and Huh-7 were grown in low-glucose DMEM supplemented with 10% FBS, 
4mM Gln and antibiotics. Glutamine depletion was obtained with L-asparaginase 
(1U/ml) w/wo the GS inhibitor MSO (1mM). Glutamine Synthetase (GS) and SNAT2 
mRNA levels were measured with qRT-PCR. Amino acid content was assessed with 
HPLC. mTOR activation was evaluated determining downstream target 
phosphorylation with Western Blot. Results: We found that β-catenin-mutated 
human hepatocellular carcinoma (HCC) HepG2 cells express high mRNA levels for 
GS and the Gln transporter SNAT2, even when exposed to supra-physiological Gln, 
and maintain a larger intracellular Gln pool than β-catenin w/t Huh-7 counterparts. 
However, paradoxically, HepG2 cells also exhibit enhanced sensitivity to Gln 
starvation and increased accumulation of Gln-mimetic GS inhibitors, leading to 
inappropriate signalling through amino acid dependent pathways, such as mTOR. 
Consistently, GS inhibitors synergise the cytotoxic effect of the glutaminolytic 
enzyme L-asparaginase. Preliminary evidence in vivo shows that the combined 
treatment of nude mice with L-asparaginase and the GS inhibitor MSO was well 
tolerated and lowered Gln content in serum, liver and xenografted HepG2 tumors, 
leading to impaired tumor growth. Conclusions: Thus, the glutamine addicted 
phenotype, exhibited by β-catenin-mutated HCC cells in vitro, may indicate tumor 
sensitivity to glutaminolytic treatments in vivo. 
 
NAMT8. Farnesoid X Receptor Activation Induces Apoptosis and Inhibits 
Leydig Xenograft Tumor Growth 
S. Panza1, R. Malivindi1, C. Giordano1, I. Barone1, G. Bossi2, D. Bonofiglio1, M. 
Lanzino1, I. Casaburi1, S. Catalano1, S. Andò 
1University of Calabria, Arcavacata di Rende, Italy; 2Regina Elena, Roma, Italy 
Background: Leydig cell tumors are the most common tumors of the gonadal 
stroma and represent about 3% of all testicular neoplasms. In most cases, Leydig 
cell tumors are benign; however, if the tumor is malignant, no effective treatments 
are currently available. We have recently reported that farnesoid X receptor (FXR) is 
expressed in R2C Leydig tumor cells, and it reduces the estrogen-dependent R2C 
cell proliferation by negatively regulating aromatase expression. Methods: R2C 
tumor xenograft models for in vivo studies. Immunoblotting, DNA laddering and 
Tunnel assays for apoptosis. Immunoblotting, RT-PCR, reporter-gene assays, 
mutagenesis experiments, EMSA and ChiP analysis to investigate the molecular 
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mechanisms. Results: We demonstrated that treatment with GW4064, a specific 
FXR agonist, markedly reduced tumor growth in R2C xenograft models and induced 
apoptosis in R2C Leydig cells both in vitro and in vivo. Indeed, FXR ligands induced 
an enhanced PARP clevage, a marked DNA fragmentation and a strong increase in 
the number of apoptotic nuclei. Moreover, FXR activation up-regulated p53 mRNA 
and protein levels along with an increased expression of its downstream effector 
p21WAF1/Cip1. Functional experiments showed that FXR ligands up-regulated p53 
promoter activity. This occurs through an increased binding of FXR/NF-kB complex 
to the NF-kB site located within p53 promoter region. Conclusions: These data 
demonstrate that the induction of apoptotic pathways may represent an additional 
mechanism through which FXR ligands inhibit Leydig tumor cell growth. From a 
therapeutic standpoint, strategies aimed to activate FXR might be useful for the 
treatment of Leydig cell tumors. 
 
NAMT9. Omega-3 Ethanolamides Induce Autophagy through PPAR-
gamma Activation in Breast Cancer Cells 
D. Rovito1, D. Vizza1, I. Barone1, C. Giordano1, I. Casaburi1, M. Lanzino1, S. 
Catalano1, D. Bonofiglio1, S. Andò1 
1University of Calabria, Arcavacata di Rende, Italy 
Background: The omega-3 long chain polyunsaturated fatty acids, 
docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), elicit 
antiproliferative effects in cancer cell lines and in animal models. Dietary DHA and 
EPA can be converted to their ethanolamide derivatives, DHEA and EPEA, 
respectively; however, few studies are reported on their anticancer activities. 
Methods: Proliferation of MCF-7 and MCF-10 breast cells using MTT-assays. 
Apoptosis and autophagy by DNA fragmentation and monodansylcadaverine 
labelling, respectively. Transfection experiments using peroxisome proliferator-
activated receptor (PPAR)-response-element-reporter plasmid. mRNA and protein 
levels by RT-PCR, immunoblotting and immunofluorescence analyses. Results: We 
demonstrated that DHEA and EPEA reduced cell viability in MCF-7 breast cancer 
cells whereas they did not elicit any effects in MCF-10A non-tumorigenic breast 
epithelial cells. Since, DHA and EPA are both ligands of PPAR-gamma, we sought to 
determine whether PPAR-gamma may mediate DHEA and EPEA actions. In MCF-7 
cells, both compounds enhanced PPAR-gamma expression, stimulated the 
transcriptional activity of a PPAR-response-element-reporter plasmid and increased 
the expression of the oncosuppressor PTEN, a well known PPAR-gamma target 
gene. PTEN up-regulation caused the inhibition of Akt-mTOR pathways which in turn 
leads to the activation of either apoptotic or autophagic processes. DHEA and EPEA 
induced phosphorylation of Bcl-2 promoting its dissociation from beclin-1 which 
resulted in autophagy induction. We also observed an increase of beclin-1 and LC3 
expression. These effects appeared to be PPAR-gamma dependent. Conclusions: 
DHEA and EPEA acting as PPAR-gamma ligands exert antiproliferative effects by 
inducing autophagy in breast cancer cells highlighting their potential use in adjuvant 
breast cancer therapies. 
 
NAMT10. AntiTtumor Activity of Epratuzumab/Saporin-S6 
M. Bortolotti1, L. Polito1, V. Farini1, M. Pedrazzi1, M. Battelli1, A. Bolognesi1 
1Dipartimento di Patologia Sperimentale - Università di Bologna, Bologna, Italy 
Background: CD22 represents an attractive molecular target for B-cell neoplasm 
therapy with immunoconjugates. Epratuzumab, a humanized anti-CD22 mAb has 
induced tumor regression in preclinical and phase I/II clinical evaluations in patients 
with indolent or aggressive lymphoma. The results obtained in clinical studies 
encourage the attempts to improve the Epratuzumab effectiveness, i.e. by 
conjugation to toxic molecules (immunotoxins). Among plant toxins, the most 
frequently employed to generate immunotoxins are ribosome-inactivating proteins 
(RIPs). Saporin-S6 is a RIP often used to construct immunotoxins tested in clinical 
trials. Methods: The humanized anti-CD22 mAb epratuzumab was conjugated to the 
toxic enzyme saporin-S6, a type I ribosome-inactivating protein (RIP). The antitumor 
effect of this immunotoxin has been studied in vitro on CD22+ cell lines and in vivo in 
an NHL/SCID mice model. Results: The epratuzumab/saporin-S6 immunotoxin was 
specifically toxic to five different CD22+ lymphoma cell lines while sparing non-target 
CD22- cells. The cytotoxic effect was demonstrated in vitro by the complete inhibition 
of protein synthesis, strong induction of caspase activity, complete loss of viability 
and total suppression of clonogenic growth of CD22+ cell lines. The immunotoxin 
showed potent antitumor activity in a SCID mouse Raji xenograft model of human 
aggressive lymphoma. Conclusions: Our results indicate that it is possible to 
augment epratuzumab toxicity in target cells by linking the antibody to saporin-S6. 
An excellent therapeutic index was achieved by this immunotoxin in animals. These 
results may encourage further evaluation of this conjugate in a phase I clinical trial. 
 
NAMT11. Cell Therapy of Human Cancer: uPAR truncation by Engineered 
Endothelial Progenitor Cells (EPC) as Intra-Tumoral Shuttles of Anti-
Invasion/Anti-Metastatic MMP12 
A. Laurenzana1, A. Chillà1, S. Serratì1, F. Margheri1, B. Mazzanti2, R. Saccardi2, F. 
Bianchini1, S. Peppicelli1, L. Calorini1, N. Pimpinelli1, S. D'Alessio3, G. Fibbi1, M. Del 
Rosso1 
1University of Florence, Florence, Italy; 2Careggi University Hospital, Florence, Italy; 
3Fondazione Humanitas per la Ricerca, Rozzano, Italy 
Background: The onset of angiogenesis (“angiogenic switch”) is a critical step in 
tumor development and plays a relevant role in cancer progression. The term 
“angiogenesis” connotes the development of new vessels from pre-existing ones. 
Identification of bone marrow-derived endothelial progenitor cells (EPCs) in 
peripheral blood has highlighted an alternative mechanism of angiogenesis 
(“postnatal vasculogenesis”). However only a subset of EPC, termed endothelial 
colony-forming cells (ECFCs), have been shown to display the characteristic of a 
true endothelial cell (EC) progenitor and to possess the ability to form de novo blood 
vessels in vivo. Many studies suggest an important role of EPC in tumor 
vascularization and metastasis. ECFCs have been shown to home within tumors and 
therefore can be used as cellular vehicle to deliver anticancer agents. The 
membrane-associated plasminogen activation system (urokinase-type plasminogen 
activator, uPA; uPA receptor, uPAR) is critical in angiogenesis as well as in invasive 
properties of cancer cells. Only full length uPAR fosters invasion and angiogenesis. 
Truncation of uPAR domain 1 by matrix metalloprotease-12 (MMP12) impairs cell 
invasion and angiogenesis. Methods: Design and contruct of lentivirus encoding 
MMP12 and delivery of the vector into ECFC. Results: Our preliminary data show 
that the “gain of function” of MMP12 activity in ECFC shuttles can control tumor 
progression and angiogenesis on several melanoma cell lines Conclusions: Ex vivo 
manipulated ECFCs overexpressing MMP12 could be used as cellular vehicle to 
deliver MMP12 anticancer agent, providing a new way to block growth and 
metastasis of those tumor which heavily depend on uPAR to perform invasion. 
 
 
NAMT12.  Inhibition of p38MAPK: A Combined Strategy for Sensitizing 
Neuroblastoma Cells to Etoposide Through the Modulation of Pro-
Inflammation Markers 
B. Marengo1, C. De Ciucis1, R. Ricciarelli1, A. Furfaro1, M. Nitti1, R. Colla1, E. 
Canepa1, N. Traverso1, U. Marinari1, M. Pronzato1, C. Domenicotti1 
1University of Genoa, Genoa, Italy 
Background: The tumor-associated inflammatory response has the paradoxical 
effect of enhancing tumorigenesis and tumor progression. In this regard, there is 
increasing evidence that the interaction of several pro-inflammatory chemokine 
receptors with corresponding chemokine ligands are implicated in the growth and 
invasive phenotype of neuroblastoma (NB). Moreover, it has been reported that in 
NB cells COX-2 increases migration and modulates the expression of the ICAM-1, 
an inducible surface glycoprotein that mediates adhesion-dependent cell-to-cell 
interactions. Methods: The present study has been performed on HTLA-230, a 
MYCN-amplified NB cell line exposed to etoposide alone or in association with the 
drugs targeting the intracellular signaling pathways. The oxidative and pro-
inflammatory markers have been evaluated by fluorescence microscopy analysis 
and molecular biology techniques. Results: We provide the evidence that HTLA-230 
are highly resistant to etoposide which induces a dose-dependent ROS over-
production, DNA double-strand breaks and p38MAPK activation. Therefore, the 
treatment with etoposide combined with SB203580, an inhibitor of p38MAPK activity 
has been found to decrease cell viability and tumorigenicity, counteract stem cell 
development and slow down the cell migration and invasion. In this context, the 
expression of COX-2, ICAM-1 and CXCR4 is down regulated, the formation of 
capillary-like structures is prevented, by generating a phenotype inadequate for 
tumor development. Conclusions: Collectively, our results suggest that clinical trials 
of p38MAPK inhibitors, in combination with standard chemotherapy, acting on the 
modulation of pro-inflammation markers, could be a novel strategy to counteract NB 
resistance and relapse. (Grants from PRIN 2008N9N9KL_002, PRIN 
2009M8FKBB_002 and Genoa University). 
 
NAMT13. Epigallocatechin Gallate as a New Effective Estrogen Receptor 
Alpha (ER-α) Down-Regulator in Breast Cancer 
F. De Amicis1, A. Russo1, P. Avena1, M. Santoro1, S. Aquila1, S. Andò1 
1University of Calabria, Rende, Italy 
Background: Increasing exposure of the breast to estrogens and other sex 
hormones is an important cancer risk factor and since estrogens are mitogenic to 
breast epithelial cells, the magnitude of their effects may be determined by the levels 
of estrogen receptors (ERs) expressed in the breast. The strong correlation between 
ER-α expression, breast disease pathophysiology and therapeutic response, make 
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ER down-regulators of significant clinical interest. In recent years epigallocatechin 
gallate (EGCG), a polyphenolic compound found in green tea, evidenced chemo-
preventative and antitumor properties. Methods: Here we investigate whether 
EGCG effects on breast cancer cell proliferation could be detected following 
extended treatments with low doses of the catechin. We tested ER+ PR+ breast 
cancer cell lines, including T47D and MCF-7 cells. Results: We report that EGCG 
causes concomitant PR nuclearization and down-regulation of ER-α protein, mRNA 
and gene promoter activity. These events appear specifically PR-B dependent, since 
they are drastically abrogated with PR-B siRNA. EMSA and ChIP assay reveal that, 
upon EGCG treatment, PR-B is recruited at the half PRE site on ER-α promoter, 
together with a corepressor complex containing NCoR and HDAC1. RNA 
polymerase II is displaced, indicating that the chromatin in this region is in a less 
permissive environment for gene transcription. Finally we define the functional 
significance since EGCG produces a significant inhibition of ER+ PR+ breast cancer 
cell proliferation and anchorage independent growth. Conclusions: These results 
address how EGCG/PR-B signaling may be considered as useful tool to be exploited 
in the adjuvant settings for treatment of breast cancer. 
 
NAMT14. Generation of Mutants of Helicobacter pylori L-Asparaginase 
D. Covini1, M. Pasquetto1, E. Tarasco1, L. Vecchia1, M. Maggi1, G. Valentini1, L. 
Chiarelli1, C. Scotti1 
1University of Pavia, Pavia, Italy 
Background: Helicobacter pylori L-asparaginase is a recently isolated bacterial 
factor able to inhibit the cell-cycle of exposed cells, but also a potential platform to 
develop new anti-cancer drugs, due to its remarkable selectivity for L-asparagine. 
Methods: To generate new, useful variants of the enzyme, site directed 
mutagenesis and random mutagenesis are being used to introduce modifications of 
the protein. The latter method required finding a powerful selection method to isolate 
interesting mutants. Results: Site-directed mutants generated for L-asparaginase 
show different levels of activity both towards L-asparagine and L-glutamine. 
Selecetion of random mutants is still ongoing. Conclusions: Dissection of L-
asparaginase activity towards different substrates can be useful to generate better 
anti-cancer therapeutics. 
 
NAMT15. The Prolyl-Isomerase Pin1 Represents a Regulator of Notch3 
Protein Functional Activity 
S. Checquolo1, R. Palermo1, G. Franciosa1, F. Del Gaudio1, D. Bellavia1, A. Gulino1, 
I. Screpanti1 
1University Sapienza of Rome, Latin, Italy 
Background: Pin1 is a prolyl-isomerase involved in the regulation of signal 
transduction. Its activity is crucial in the control of DNA damage checkpoint pathways 
and in the modulation of cell proliferation. Alterations of Pin1 are often associated 
with human malignancies. In particular, a recent report demonstrated the specific 
role of Pin1 in regulating Notch1 activity, finally contributing to the development of 
human breast cancer. Deregulated Notch3 signalling has been implicated in T cell 
leukemogenesis; however, the mechanisms underlying Notch regulation in leukemia 
remain incompletely clarified. Our purpose is to demonstrate that: a) Notch3 is a new 
target of Pin1 prolyl-isomerase; b) Pin1 may represent a novel target in T-ALL 
therapeutic approach. Methods: Transient co-trasfection in HEK293T cells; 
immunoprecipitation assay; Pin1 silencing with lentivirus plasmids and Pin1 inhibitor 
(Juglone) treatment of established Notch3 transgenic murine cell line (N3-232T). 
Results: In this study we demonstrate that Notch3 protein is a new target of Pin1 
isomerase and that their direct interaction depends on the presence of crucial 
phosphorylated sites (Ser/Thr-Pro) within Notch3 protein. Importantly, the inhibition 
of Pin1 function influences the intracellular localization of Notch3 protein in Notch3-
IC overexpressing T lymphoma cell line, by sequestering Notch3 in cytoplasmic sub-
organelles, finally markedly interfering with Notch3-dependent cell proliferation. 
Conclusions: We previously showed that the overexpression of Notch3 sustains T 
cell leukemogenesis and characterizes murine and human T-ALL. Together our 
present observations suggest a specific role of Pin1 in the regulation of Notch3 
protein activity, offering new insight into the pathogenesis and therapeutical 
approach of Notch3-dependent T-cell leukemia. 
 
NAMT16. The Maintenance of Gefitinib Inhibits Migration and Epithelial-
Mesenchimal Transition of Non-Small Cell Lung Cancer Cell Lines that Have 
Become Resistant after Prolonged Gefitinib Treatment 
R. Alfieri1, S. La Monica1, M. Galetti2, M. Tiseo3, A. Ardizzoni3, P. Petronini1 
1Dept Experimental Medicine, University of Parma, Parma, Italy; 2Dept Italian 
Workers Compensation Authority (INAIL) Research Center, Parma, Italy; 3Division of 
Medical Oncology, University Hospital of Parma, Parma, Italy 
Background: It is well known that in patients harbouring EGFR activating mutations, 
disease progression occurs after a median of 10-14 months after the beginning of 
TKIs therapy. The most frequent mechanisms of resistance are the acquisition of the 
T790M mutation and MET amplification. In standard oncology practice, progression 
during a specific therapy leads to initiation of a different treatment. Nevertheless, 
there are indications suggesting that a second EGFR-TKI treatment could be 
effective in patients who had benefited from the initial gefitinib therapy. This 
preclinical study has been designed to test the effects of maintaining gefitinib in 
NSCLC cell lines that have become resistant to gefitinib treatment. Methods: 
Experiments were performed on HCC827GR5, a cell line carrying activation mutation 
but with acquired resistance to gefitinib. Proliferation was determined by MTT, 
migration and invasion were determined by using Boyden chambers; signaling 
transduction proteins and epithelial- mesenchymal transition (EMT) markers were 
evaluated by Western blotting. Results: Gefitinib withdrawal did not modify 
resistance phenotype regarding the proliferation index and resistance to the drug. On 
the contrary, in the absence of gefitinib, resistant cells showed more migrating and 
invasion capability and the induction of typical EMT markers. The maintenance of 
gefitinib, instead, reduced cell migration, cell invasion and EMT. Conclusions: 
These results indicate that the maintenance of gefitinib might be important to control 
important malignant phenotypes of tumour cells such as loss of epithelial features 
and the acquisition of invasiveness. 
 
NAMT17. DAX-1 at the Crossroads Between Androgens and Aromatase: A 
Novel Mechanism in the Inhibition of Estrogen-Dependent Cancer Cell 
Proliferation 
P. Maris1, R. Sirianni1, A. Chimento1, C. Morelli1, C. Giordano1, I. Barone1, G. 
Trombino1, I. Casaburi1, D. Sisci1, D. Bonofiglio1, S. Catalano1, M. Lanzino1 
1University of Calabria, Arcavacata di Rende, Italy 
Background: Sex hormones, estrogens and androgens, are trivial to determine 
biological response in a tissue- and gender-specific manner. Estrogens, synthesized 
from androgens by aromatase, influence the pathological processes of several 
hormone-dependent cancers since they are thought to be the driving force for the 
formation of breast, endometrial, ovarian and Leydig cell tumors. Likely, the 
adequate androgen/estrogen ratio represents the most clinically relevant factor in 
this process; however the molecular mechanism underlying the androgen/estrogen 
essential balance still needs to be clarified. Here, we investigated the androgen-
dependent modulation of DAX-1, a transcriptional corepressor of genes regulated by 
steroidogenic factor-1 (SF-1), such as aromatase, as well as of agonist-bound 
estrogen-receptor. Methods: Cell proliferation by MTT-assays. mRNA and protein 
levels by RT-PCR, immunoblotting and immunofluorescence analyses. Functional 
studies by luciferase/DAPA/EMSA/ChIP assays. Results: Using human breast 
cancer and rat Leydig tumor cells as experimental systems we demonstrated that 
ligand-activated androgen receptor (AR) induces the expression of DAX-1 by 
enhancing its promoter activity. These effects are mediated by direct binding of AR 
to a newly identified androgen response element within the DAX-1 proximal 
promoter. In turn, increased DAX-1 inhibits SF-1-mediated aromatase expression, 
thus reducing in situ estrogen production which is responsible for the estrogen-
dependent proliferation of carcinoma cells. Conclusions: DAX-1 appears to be a 
specific androgen-target gene in breast and Leydig tumor cells. Since DAX-1 
expression has been shown to influence cell growth by reversing estrogen-
dependent proliferative effects, our study is expected to provide clues for a better 
comprehension of the AR-dependent inhibition of estrogen-related cancer cell 
proliferation. 
 
NAMT18. Effects of New Compounds from Marine Sources in Human 
Colorectal Cancer Cell Lines 
D. Fiore1, G. Gangemi1, M. Proto1, P. Gazzerro1, A. Ianora2, A. Fontana3, M. Bifulco1 
1University of Salerno, Fisciano (SA), Italy; 2Stazione Zoologica Anton Dohrn, 
Naples, Italy; 3CNR - Istituto di Chimica Biomolecolare (ICB), Pozzuoli (NA), Italy 
Background: Several agents originating from marine sources, both plants and 
animals, have shown anticancer activities. To date, at least 40 compounds isolated 
from marine sponges have shown anticancer effects, mainly pro-apoptotic, in 
human. Methods: In this preliminary study, we tested the effects of new compounds 
from marine microorganisms cultured by SZN of Naples and extracted by the 
Institute of Biomolecular Chemistry ICB, CNR, Naples. In particular, we evaluated 
the potential antiproliferative effects of five extracts from marine source (MC1, MC2, 
MC3 MC4 and MC5) in DLD1 and SW620 human colorectal cancer cell (CRC) lines, 
through MTT and BrdU incorporation assays. Results: Results showed that the 24 h 
and 48h-treatment of DLD1 and SW620 cells with MC5 at concentrations from 1 μM 
significantly inhibited cell proliferation that was reduced of about 20% by comparison 
with untreated CRC cells. For MC5 doses higher than 5μM strongly inhibited colon 
cancer cell proliferation inducing a percentage of inhibition higher than 90%. 
Treatment with MC3 10μM significantly reduced the proliferation after 48h of 
treatment in both cell lines. Finally, the extract MC2 used at doses higher than 5 μM 
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significantly reduced the proliferation in DLD1 but not in SW620. Conclusions: 
Obtained data indicate that MC5, MC3 and MC2 extracts interfere with CRC cell 
proliferation in a dose- and time-dependent manner. Although further research needs 
to be focused on clarifying the pathways induced by the observed antiproliferative 
effects, the results showed that the extracts from marine source evaluated in this 
study are promising for development of new anticancer drugs. 
 
NEOPLASIA – CANCER STEM CELLS 
 
NSC1. CD133 Protein Regulates Cell Proliferation, Tumorigenicity and 
Drug Resistance in Human Colon Cancer Cells 
M. Corbi1, M. Svelto1, M. Ravo2, A. Boninsegna1, V. Cufino1, E. Caredda1, M. De 
Filippo3, C. Fanali1, M. Farina1, A. Weisz2, A. Cittadini1, A. Sgambato4 
1Catholic University, Rome, Italy; 2Università degli Studi di Salerno, Salerno, Italy; 
3Fondazione IRCCS SDN, Naples, Italy; 4Università Cattolica del Sacro Cuore, 
Rome, Italy 
Background: CD133 is a transmembrane pentaspan molecule considered a 
putative stem cell marker in several normal and cancer tissues. Surface expression 
of CD133 identifies a subpopulation of tumor-initiating cells, having the properties of 
self-renewal, proliferation and multilineage differentiation, in a variety of human 
cancers, including colon cancer. Although CD133 is considered a useful marker to 
identify cancer stem cells (CSC), its exact role(s) in human colorectal tumorigenesis 
remain unknown. Methods: We found that positive CD133 staining is an 
independent predictor of shorter survival in colorectal cancer patients. Thus, to shed 
light on CD133 function(s) and its involvement in the definition of colon CSC 
phenotype, HCT116 human colon cancer cells were engineered to stably express an 
exogenous CD133 cDNA, as confirmed by flow cytometry, quantitative real-time 
PCR and western blot analyses. Results: Increased CD133 expression was 
associated with an increased anchorage-dependent and independent growth in vitro, 
an increased mobility and invasiveness and an increased tumorigenicity in vivo. 
CD133 were also less prone to differentiate when exposed to sodium butyrate. Gene 
expression profiling identified several genes differentially expressed between 
CD133-overexpressing derivatives and control cells, including the multidrug 
resistance-associated protein 2 (MRP2/ABCC2), which was up-regulated in CD133-
overexpressing cells, as confirmed by quantitative real-time PCR, and conferred an 
increased resistance to antineoplastic drugs. Conclusions: These results suggest 
that, besides its role as a potential CSC marker, CD133 might have an important 
functional relevance in the definition of colon cancer cell phenotype and might 
represent a useful molecular target for the development of novel anticancer 
therapies. 
 
NSC2. MicroRNA Profiles in Different Contexts of Sonic Hedgehog 
Signaling: Neuronal and Cancer Stem Cells 
E. Ferretti1, E. Miele1, A. Po1, N. Garg1, M. Silvano1, F. Begalli1, F. Cicconardi1, M. 
Chinappi1, G. Canettieri1, L. Dimarcotullio1, E. De Smaele1, D. Cucchi1, A. 
Tramontano1, A. Gulino1 
1Sapienza Università Di Roma, Rome, Italy 
Background: Sonic hedgehog controls behavior of stem cells neuronal and cancer 
stem cells (NSCs and CSCs) identified in medulloblastoma (MB). Aim of the study is 
to provide new insight in the molecular regulatory circuits involved in maintenance of 
stemness with particular regard to microRNAs. Methods: To this end high-
throughput miRNAs profiles have been performed in NSCs, differentiated NSCs and 
MB-CSCs. NSCs were isolated from wild type mice neonatal cerebellum. CSCs were 
isolated from both MB arised in Ptc+/- mice and human MB. Results: The 
sequencing analysis includes the determination of both known and unknown 
microRNAs in NSCs, in differentiated NSCs and in MB-CSCs. The analysis of 
miRNA profiling in NSCs versus differentiated NSCs has revealed specific pattern of 
microRNAs expression correlated to different Sonic hedgehog signaling activation 
context. On the other side we were able to determine microRNA features unique to 
both normal and cancer stem cells implicated in the establishment and/or 
maintenance of stemness. Conclusions: miRNAs differentially expressed in cancer 
stem cells versus normal stem cells could be those required only in cancers stem 
cells potentially necessary to neoplastic transformation. The results of this study 
provide a broad overview of NSC and CSCs microRNAs. 
 
NEOPLASIA – HOST PATHOGEN INTERACTIONS IN CANCER 
 
NHP1. Analysis and Characterization of Hepatitis B Virus (HBV) DNA 
Integration into Chromosomal DNA of Patients with Occult HBV Infection and 
Hepatocellular Carcinoma. 
C. Saitta1, G. Tripodi1, G. Raffa1, A. Bertuccio1, A. Ciancio2, A. Smedile2, N. 
Giuseppe3, G. Raimondo1, T. Pollicino4 
1University Hospital of Messina, Messina, Italy; 2Department of Gastroenterology and 
Hepatology, University of Turin, Turin, Italy; 3Oncological Surgery, University 
Hospital of Messina, Messina, Italy; 4University of Messina, Messina, Italy 
Background: Hepatitis B virus (HBV) DNA integration into the host genome is an 
important pro-oncogenic event in chronic HBV infection. There is evidence that viral 
integration may occur also in HBsAg-negative patients with occult HBV infection 
(OBI). Aim of this study was to investigate and characterize HBV DNA integration in 
OBI patients with hepatocellular carcinoma (HCC). Methods: Tumour specimens 
from 65 HCC patients were examined (10 HBsAg-positive, 45 OBI-positive and 10 
HBsAg-negative/OBI-negative). HBV integration was investigated by Alu-PCR 
technique. Molecular characterization of virus-genome junctions was performed by 
cloning and sequencing. Results: Integrated HBV DNA was detected in 31/45 (69%) 
OBI-positive, 8/10 (80%) HBsAg-positive and 0/10 OBI-negative HCC samples, 
respectively. In OBI cases, HBV integrants were found both in intergenic (50%) and 
in intragenic genomic regions (50%). HBV integration frequently targeted genes 
involved in cell growth and adhesion, angiogenesis and cell signaling (i.e. PI4K2A, 
ADCY5, SCARB1, DNTTIP1, TMEM107, CD 93). Viral integrants were characterized 
in 20 cases: HBx gene sequences were found in 12 cases, 4 of whom included viral 
enhancer-II and basal-core promoter; preS1 region including preS1 promoter was 
found in 1 case; the carboxy-terminal end of the S region plus a portion of the Pol 
gene were detected in 2 cases; the preCore region in 1 case; S gene sequences in 
the remaining 4 cases. Conclusions: HBV DNA integration is a frequent finding in 
HCC from OBI patients. This evidence leads to hypothesize that HBV DNA 
integration may play a pro-oncogenic role in all HBV-infected cases independently of 
the HBsAg status. 
 
NEOPLASIA – MICROENVIRONMENT-DRIVEN TUMOR PROGRESSION 
 
NMTP1. Bone Morphogenetic Protein-14 Regulates TGF-β-Dependent 
Angiogenesis in Breast Carcinoma MCF-7 Cells: In Vitro and in Vivo Control by 
Anti-TGF-β Peptides 
F. Margheri1, N. Schiavone1, L. Papucci1, L. Magnelli1, S. Serratì1, A. Chillà1, A. 
Laurenzana1, F. Bianchini1, L. Calorini1, J. Dotor2, E. Feijoo2, G. Fibbi1, M. Del 
Rosso1 
1University of Florence, Florence, Italy; 2Digna Biotech, Pamplona, Spain 
Background: TGF-β overproduction by breast cancer cells is one of the main 
characteristics of the late phase of tumor progression and is implicated in 
metastasis, tumor growth, angiogenesis and immune response. We investigated the 
therapeutic efficacy of anti-TGF-β peptides in the control of TGF-β angiogenesis. 
Methods: We have inserted in human MCF-7 mammary cancer cells a mutated 
TGF-β gene in a tetracycline-repressible vector to obtain conditional expression of 
mature TGF-β in the absence of tetracycline upon transient transfection and have 
evaluated the efficacy of anti-TGF-β peptides in the control of MCF-7 TGF-β -
dependent angiogenesis. Results: TGF-β overexpression induced in MCF-7 several 
markers of the epithelial-to-mesenchymal transition. Conditioned-medium of TGF-β-
transfected MCF-7 stimulated angiogenesis in vivo and in vitro by subsequent 
activation of ALK5-SMAD2/3 and ALK1-SMAD1/5 signaling in endothelial cells (EC), 
as well as SMAD4 nuclear translocation, resulting in overexpression of the pro-
angiogenic bone-morphogenetic-protein-14 (BMP14/GDF5). Antibody inhibition and 
siRNA silencing of BMP14 in TGF-β-stimulated EC resulted in impairment of BMP14 
expression and of TGF-β-dependent urokinase-plasminogen activator receptor 
(uPAR) overproduction, leading to angiogenesis impairment. Two different TGF-β 
antagonist peptides efficiently inhibited all the angiogenesis-related properties 
elicited in EC by exogenous and conditionally-expressed TGF-β in vivo and in vitro, 
including SMAD1/5 phosphorylation, SMAD4 nuclear translocation, BMP14 and 
uPAR overexpression. Antagonist peptides efficiently inhibited in vivo angiogenesis 
either when co-injected with tumor cells or upon systemic administration. 
Conclusions: These preclinical data provide a basis to support using anti–TGF-β 
peptides as a therapeutic agent for TGFβ–dependent breast cancer angiogenesis. 
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NMTP2. An Unexpected Role of the Organic Cation Transporter OCTN1 in 
Autophagy May Underlie Genetic Variant Association with IBD and Colorectal 
Cancer. 
G. Pani1, G. Maulucci2, M. Mele3, S. Fusco1, G. Toietta4 
1Universita' Cattolica Istituto di Patologia Generale, Rome, Italy; 2Università Cattolica 
Istituto di Fisica, Rome, Italy; 3Universita' Cattolica Istituto di Farmacologia, Rome, 
Italy; 4Ospedale Pediatrico Bambino Gesu', Rome, Italy 
Background: We have recently demonstrated that the L503F form of the cation 
transporter OCTN1, a variant conferring genetic predisposition to intestinal 
inflammatory bowel disease (IBD), is hyper-represented in ulcerative colitis patients 
progressing to colorectal cancer (CRC), and also in young CRC patients without 
overt IBD. Unfortunately, molecular mechanisms linking OCTN1 and its variants to 
bowel inflammation and to its malignant progression are unknown. Methods: The 
two OCTN1 variants 503L and 503F were overexpressed in in 293T cells, and 
endogenous OCTN1 (503L) was knocked down in human monocytic THP-1 cells 
and colon carcinoma Caco-2 cells. Inflammasome activation/secretion of IL-1 and 
autophagy, two phenomena largely involved in IBD genetic risk, were examined in 
these cell populations. In addition, bone marrow macrophages from wild- type and 
OCTN1 KO mice were purified and analysed. Results: Maturation/secretion of IL-1β 
by 293T cells was significantly increased by OCTN1, with Crohn’s associated 503F 
variant having the strongest effect; conversely, IL-1β release was impaired in 
OCTN1 depleted THP-1 cells and in OCTN1 KO macrophages. Surprisingly 
autophagy, monitored by western blotting and LC3A-GFP immunofluorescence, 
followed the same trend in the different cell lines. Moreover, in 293T cells, OCTN1 
colocalized with the lysosomal marker cathepsin B, and inhibition of autophagy by 3-
MA reduced the processing of pro-IL-1 to mature IL-1β. Conclusions: Taken 
together these results suggest an unexpected role for OCTN1 in the autophagic 
control of inflammation. Moreover, since autophagy is often deregulated in cancer 
cells, our findings may explain OCTN1 association with both IBD-related and 
sporadic CRC. 
 
NMTP3. NGAL, a NF-κB-Regulated Gene, Is a Chemotactic Factor in 
Thyroid Cancer 
Z. Raia1, V. Volpe1, F. Moscato2, A. Leonardi1, F. Pacifico2 
1DBPCM, Università degli Studi “Federico II”, Naples, Italy; 2Istituto di Endocrinologia 
e Oncologia Sperimentale CNR, Naples, Italy  
Background: NF-κB plays an important role in thyroid cancer. In fact, the inhibition 
of its activity determines the block of the oncogenic potential of anaplastic thyroid 
carcinoma (ATC) cells. NGAL, a gene under NF-κB transcriptional control, is an 
acute phase protein able to mediate some of the pro-tumorigenic functions of NF-κB 
in thyroid cancer, such as the resistance to apoptosis. Methods: Monocyte migration 
was evaluated by transwell assays. Inflammatory infiltrate in tumor specimens was 
analyzed by immunohistochemistry. Results: In the effort to investigate the role of 
NGAL in cancer-related inflammation, we analyzed the ability of NGAL, secreted in 
the conditioned medium of ATC cells, to induce monocyte migration in vitro. 
Conditioned medium from NGAL-null ATC cells showed a marked decrease of its 
chemotactic activity compared to that from parental cells, suggesting a potentially 
chemotactic role for NGAL in thyroid cancer microenvironment. To test this 
hypothesis, we down-regulated NGAL expression in the CT26 mouse colon-
carcinoma cell line and inoculated parental and NGAL-null CT26 cells in syngenic 
mice to analyze the inflammatory infiltrate during tumor development. The 
immunohistochemical analysis of tumors from injected mice showed that the number 
of lymphocytes and macrophages in tumors developed by NGAL-null CT26 mice 
was strongly reduced respect to that of parental CT26 mice. Conclusions: These 
data suggest that NGAL secretion by cancer cells could serve as chemoattractant 
factor for inflammatory cells in tumor microenvironment. 
 
NMTP4. Mechanism of Action of Metformin as a Potential Angiopreventive 
Compound 
A. Cantelmo1, L. Ruggiero1, D. Noonan2, V. Mirisola3, U. Pfeffer3, A. Albini4 
1Science and Technology Pole, IRCCS MultiMedica, Milan, Italy; 2Dept of 
Biotechnologies and Life Sciences, University of Insubria, Varese, Italy; 3Functional 
Genomics, National Cancer Research Institute, Genova, Italy; 4IRCCS Tecnologie 
Avanzate e Modelli Assistenziali in Oncologia, Reggio Emilia, Italy 
Background: A significantly decreased risk for cancer in diabetics taking metformin, 
an antiglycemic drug, has been observed. Inhibiting angiogenesis is a key and 
common effect of many agents able to repress cancer in pre-clinical and clinical 
studies and appears to be a key strategy for cancer prevention. However, conflicting 
data concerning the anti-angiogenic action of metformin have been reported and 
mechanistic aspects remain to be addressed. Methods: We investigated the effects 
of metformin on angiogenesis in vivo with the matrigel sponge assay and in vitro 
using human umbilical vein endothelial cells (HUVEC) to verify the capability of 
metformin to interfere with endothelial proliferation, cell death, migration and 
invasion. Results: Our data clearly show that in vivo metformin inhibited VEGF 
induced angiogenesis. To examine the mechanisms underlying this activity, we 
found that metformin inhibited endothelial cell proliferation without inducing apoptosis 
by exerting effects on key determinates of cell cycle regulation. Metformin inhibited 
endothelial cell invasion and repressed the ability of HUVE cells to organize into 
capillary-like networks in the presence of angiogenic stimuli. These effects were 
largely reverted by compound C, a specific inhibitor of AMPK, suggesting that the 
mechanism involves activation of AMPK signaling. Gene expression profiles of 
endothelial cells treated with metformin showed down-regulation of several 
angiogenesis-related genes. Conclusions: Taken together, our results show a clear 
anti-angiogenic action of metformin that appears to act directly on endothelial cells 
that may in part explain the reduced tumor incidence in patients on metformin. 
 
NEOPLASIA – NOVEL BIOMARKERS IN ONCOLOGY 
 
NBM1. Molecular and Functional Characterization of Annexin A3 in 
Human Normal Cortex and Renal Cell Carcinoma Primary Cultures 
V. Di Stefano1, S. Buscone1, S. Bombelli1, S. Minniti1, B. Torsello1, M. Zipeto1, S. 
Ferrero2, G. Albo3, R. Perego1, C. Bianchi1 
1Department Experimental Medicine- Milano-Bicocca University, Monza, Italy; 
2Pathology Unit - IRCCS Policlinico - University of Milano, Milan, Italy; 3Depatment of 
Urology - IRCCS Policlinico - University of Milano, Milao, Italy 
Background: Annexin A3 (AnxA3) is a member of the annexin protein family 
involved in the regulation of membrane trafficking, ion channels and proliferation. 
The role of AnxA3 in kidney and in renal carcinomas is still unclear, even if it has 
been described its possible involvement in the enhancement of the transactivating 
activity of HIF-1α, involved in the pathogenesis of renal carcinomas (RCC) and 
constitutively expressed in 80% of clear cell RCC because of the biallelic inactivation 
of VHL. Methods: For molecular and functional characterization of AnxA3 in normal 
kidney and RCC, we used primary cell cultures established in our laboratory and 
submitted to gene silencing, immunofluorescence and western blot analysis. 
Results: Normal cortex and RCC primary cultures show a differential expression 
pattern, correlated with HIF-1α level, of two AnxA3 isoforms of 33 and 36 kDa. 
Moreover, total AnxA3 protein level results down-regulated in RCC respect to cortex 
cultures. SiRNAs specific to 36kDa AnxaA3 isoform induced a down-regulation of 
Lysyl oxidase transcript level, a direct target of HIF-1α, in cortex and HIF-1α negative 
RCC primary cultures. Immunofluorescence analysis evidenced in normal cells a 
cytoplasmic vesicular distribution of AnxA3, particularly in the perinuclear area, and 
also inside the nucleus. Instead in HIF-1α positive RCC cells AnxA3 showed only a 
vesicular cytoplasmic signal, as confirmed by western blot analysis on purified 
subcellular fractions. Moreover, AnxA3 colocalized in cytoplasm with endosomal 
markers. Conclusions: The different subcellular distribution of AnxA3 in normal and 
RCC cells might differently modulate HIF -1α nuclear uptake and its transactivating 
activity. 
 
NBM2. Kaiso, a Key Regulator in EMT and Cancer Progression 
J. Jones1, H. Wang1, W. Grizzle2, C. Yates1 
1Tuskegee University, Tuskegee, AL, United States of America; 2University of 
Alabama at Birmingham, Birmingham, AL, United States of America 
Background: Advanced stages of cancer are characterized by increased 
aggressiveness, invasiveness, and the down-regulation of tumor suppressor genes 
via methylation. Kaiso, a bimodal transcription factor, interacts with DNA through 
either a DNA consensus sequence or methylated CpG dinucleotides, thus regulating 
gene expression. A clinical role for Kaiso expression in advanced stages of breast 
and prostate cancer remain unclear. Here we hypothesize that there will be a 
correlation between Kaiso expression, localization, and breast and prostate cancer 
progression. Methods: Immunohistochemistry was performed to examine protein 
expression and localization human breast and prostate tissue. Kaiso-specific siRNA/ 
small hairpin (sh) RNA was used to decrease Kaiso expression levels in MDA-MB-
231, MDA-MB-468, DU-145, DU 145WT, PC3 cell lines. Subsequently, mRNA, 
protein and localization were measured using qRT-PCR, western Blot and 
immunofluorescence. Cell motility and invasion was assessed in the siRNA/sh-RNA 
Kasio transfected cells. Results: An overall increase in Kaiso expression was found 
in primary tumor samples and this increased as cancer progressed to distant sites. 
Additionally, nuclear localization of Kaiso was observed in primary tumor and lymph 
node metastasis. siRNA/sh-RNA Kaiso treated cell lines showed a delay in cell 
motility, invasion. 5- aza-2'-deoxycytidine treated cells showed a re-expression of 
tumor suppressor E-cadherin, which correlated with E-cadherin re-expression in 
siRNA/sh-RNA Kaiso treated cells. Conclusions: Down-regulation of E-cadherin, 
migration and invasion are key to cancer progression and metastasis. The ability of 
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Kaiso to regulate these key characteristics of cancer progression suggests it is a 
relevant therapeutic target and a potential indicator of breast and prostate cancer. 
 
NBM3. Blood Cholesterol and Sphingomyelin in Patients with Cancer 
A. Lazzarini1, F. Curcio2, R. Spelat1, R. Lazzarini3, S. Cataldi3, F. Ambesi-
Impiombato1, E. Albi3 
1Universita' di Udine - DSMB, Udine, Italy; 2Universita' di Udine, Udine, Italy; 
3Laboratory of Nuclear Lipid BioPathology Sphingolipid Club - CRABioN, Perugia, 
Italy 
Background: It is generally believed that high levels of blood cholesterol are harmful 
to health, whereas low levels seem to be positive and therefore are often neglected. 
Unfortunately this assumption is far from true, since severe hypocholesterolemia can 
be indicative of cancer. Cancer cells avidly incorporate serum cholesterol, favouring 
the expression of proteins involved in cell proliferation such as RNA polymerase II, 
STAT3, PKCz and cyclin D1 (Pugliese et Al. Eur. J. Cancer 46:1735). Numerous 
studies have shown that a strong interaction exists between unesterified cholesterol 
and saturated fatty acid sphingomyelin, which arises from the Van der Waals 
interaction. Since sphingomyelin and cholesterol association is responsible for 
formation of membrane lipid rafts involved in cell signalling we have studied the 
possible hyposphingomyelinemia associated to hypocholesterolemia in patients with 
cancer. Methods: The blood of 25 patients with monoclonal gammopathy were 
analyzed for their proteins and lipids content. Results: The results demonstrated 
that the patients with high level of gamma proteins present a strong decrease of both 
cholesterol and sphingomyelin content in blood. Conclusions: The results 
suggested the possible incorporation of cholesterol-sphingomyelin nano-sized 
vesicles that could change the structure/function of cell membrane or intracellular 
virtosomes. To investigate the reason for increased lipid incorporation by tumor cells, 
we performed lipidomicic study on the serum of the same patients. Initial results 
show a lipid profile different from that of healthy subjects. 
 
NBM4. B-Lymphocyte Stimulator Versus Chromogranin A in the Follow-
Up of Patients with Neuroendocrine Tumors 
M. Fabris1, F. Grimaldi1, D. Visentini1, F. Curcio1, E. Tonutti1 
1Azienda Ospedaliero-Universitaria of Udine, Udine, Italy 
Background: Chromogranin A (CgA) is the most recommended marker in 
neuroendocrine tumors (NET), but generally presents low sensitivity and specificity. 
We recently (Fabris et al. Immun Endoc & Metab Agents in Med Chem 2011) 
described high levels of B-lymphocyte stimulator (BLyS) in patients with 
neuroendocrine tumors (NET). Here we assessed BLyS role in the follow-up of NET 
patients compared to CgA. Methods: We enrolled 109 NET patients (25.7% lungs, 
74.3% gastro-enteropancreatics, 56% low grade, 44% high grade), 66.7% with 
pathological CgA serum levels and 37.6% metastatic. Patients were classified in 3 
subgroups: in remission (19), with evidence of persistent but stable disease (42), 
relapsing or further progressive disease (48). BLyS and CgA were analyzed by 
ELISA, in 41 patients also after 8 ± 6 months. Results: We confirmed BLyS up-
regulation in NETs, 65% presenting pathological levels. BLyS did not correlate 
significantly with CgA. Progressive patients presented higher BLyS than stable and 
remission (P < 0.0001). Compared to CgA, BLyS appeared slightly less specific (high 
BLyS in 29.4% vs. CgA pathological in 17.6% of remission cases; P = ns), but 
significantly more sensible for progression (high BLyS in 87.5% vs. CgA pathological 
in 68.8% of progressive patients; P = 0.019). In CgA-negative cases, 86.7% of 
progressive patients presented high BLyS levels compared to 28.6% of remission 
cases (P = 0.0025). In the follow-up, BLyS remained unchanged in stable patients, 
decreased in improving patients (P = 0.0078) and increased significantly in relapsing 
(P = 0.03). CgA did not change significantly in relapsing. Conclusions: BLyS 
appears as a new useful marker in the follow-up of NET patients. 
 
NBM5. Gelatinolytic Activities in the Sera and in the Urine from Patients 
with Prostate Diseases  
“Sapienza” University of Rome, Latina, Italy 
Background: It is widely recognized that the serum prostate-specific antigen (PSA) 
as a biomarker of prostate cancer is imperfect, in that it can have many false positive 
elevations attributable to benign hyperplasia and subclinical prostatic inflammation. 
There are increasing data that support a positive correlation between gelatinase 
(MMP-2 and-9) activity and tumor cell invasion and tumor aggressiveness. Methods: 
By gelatin zymography we verified MMP activity in the sera and in the concentrate 
urine of patients with prostate disease. Of these patients, 30 had cancer, consisting 
of 13 Gleason score 6, twelve Gleason 7, two Gleason 8, three Gleason 9, and 8 
had benign prostate hyperplasia (BPH). Results: Four dominant gelatinolytic bands 
were detected migrating at ~ 240, 130, 92 and 72 kDa. The most abundant lytic 
activity is at 92 kDa (MMP-9); whereas MMP-2 is present in lesser quantities. MMP-9 
activity is enhanced in the sera from patients with cancer compared with BPH 
patients. On the contrary in the urine specimens, MMP-9 activity is enhanced in the 
patients with BPH compared with cancer patients. No correlation between 
gelatinolytic activity and Gleason score or pathological findings was found. 
Conclusions: These results suggest that the inexpensive measurement of MMPs 
may serve as a suitable supplementary tool to distinguish between patients with 
prostate cancer and patients with BPH, and the addition of this enzyme to currently 
available PSA and/or f-PSA/t-PSA ratio might provide clinicians additional objective 
information on prostate carcinomas. 
 
NBM6. PGE2 Induces Epigenetic Modifications and Up-Regulation of IL-8 
Gene in Astrocytoma 
I. Venza1, M. Visalli1, C. Fortunato1, M. Ruggeri1, S. Ratone1, D. Teti1, M. Venza1 
1University of Messina, Messina, Italy 
Background: It is now well recognized that chronic inflammation is a risk factor for 
cancer. Several pro-inflammatory gene products, among which interleukin-8 (IL-8), 
have been linked to tumorigenesis, promotion, proliferation, invasion, angiogenesis, 
and metastasis. We previously reported that astrocytomas express high levels of this 
chemokine in response to an increased synthesis of prostaglandin E2 (PGE2). Here, 
we investigated whether the PGE2-induced IL-8 activation is mediated by epigenetic 
modifications. Methods: DNA methylation status of the 6 CpG sites within IL-8 
promoter region and histone acetylation levels were analyzed in two astrocytoma cell 
lines of different malignancy grade and normal astrocytic cells by bisulphite 
sequencing and chromatin immunoprecipitation, respectively. IL-8 mRNA was 
quantized by real-time PCR and protein levels were measured by enzyme 
immunoassay. Results: PGE2 activated IL-8 transcription through specific 
demethylation of an individual CpG residue (nucleotide -83) located within the 
C/EBP-beta consensus sequence in the IL-8 promoter and abnormal acetylation of 
histone H3 in this region of chromatin. These events promoted the recruitment of 
C/EBP-beta transcription factor which, in turn, formed a docking platform for p300 
cofactor, leading ultimately to enhanced transcriptional potential of IL-8. 
Conclusions: Our findings have elucidated an orchestrated mechanism triggered by 
PGE2 whereby concurrent association of site-specific demethylation and histone H3 
hyperacetylation resulted in derepression of IL-8 gene expression in astrocytomas. 
These observations imply that anti-inflammatory agents that suppress IL-8 or IL-8-
regulated products should have a potential in both the prevention and treatment of 
this cancer. 
 
NBM7. Polymorphisms of Genes of TGF-β Pathway and Susceptibility to 
Colorectal Cancer  
L. Vaccarino1, M. Palmeri1, L. Scola1, S. Palmeri1, M. Bova1, C. Caruso1, G. Colonna 
Romano1, G. Candore1, C. Balistreri1, D. Lio1, G. Forte2 
1University of Palermo, Palermo, Italy; 2CNR, Palermo, Italy 
Background: Genetic background implicated in cytokine network may have a key 
role in the susceptibility to colorectal cancer (CRC). The TGF-β pathway is involved 
in several biological processes, including cell proliferation, differentiation, migration 
and apoptosis. Methods: rs1800471 SNP polymorphism of TGF-ß1 rs334348 and 
rs334349 of TGF-βR1, rs900 of TGF-β2 and rs4522809 of TGF-β2R2 were typed in 
a group of 82 patients affected by sporadic CRC and in 237 age- and sex-matched 
healthy controls, using a competitive allele specific PCR assays (KASPar), 
developed by KBioscience (England). Results: No significant genetic contribution 
has been observed for 3 of the 5 SNPs tested. Indeed, a significant different allelic 
distribution between patients and controls has been observed for the polymorphism 
G→C (rs1800471) responsible for an arginine vs. proline missense change (R25P) 
in codon 25 of the TGF-β gene (P = 0.021). By this analysis, a weak protective role 
would emerge for the minor allele C in the susceptibility to the disease. Furthermore 
the analysis of genotype and allelic frequencies of rs4522809 showed a statistically 
significant difference (p =0,0016 and P = 0,0019 respectively) between patients and 
controls. Conclusions: All together these results, suggest that functional relevant 
SNPs of TGF-beta pathway might be involved in susceptibility to CRC, influencing 
the extension and severity of the disease. 
 
NBM8. Differential Expression Profiling of MicroRNAs in Human 
Cutaneous and Uveal Melanoma 
M. Venza1, M. Visalli1, C. Dell'Aversana2, L. Altucci3, D. Teti1, I. Venza1 
1University of Messina, Messina, Italy; 2CNR-IGB, Naples, Italy; 3Second University 
of Naples, Naples, Italy 
Background: Over the past decade, microRNA (miRNA)-mediated epigenetic 
regulation of tumour suppressor genes and oncogenes has been shown to play a 
central role in melanomagenesis. Here, we examined the miRNA signature 
discriminating cutaneous and uveal melanoma. Methods: Genome-wide profiling of 
miRNAs was performed in cutaneous and uveal melanoma cell lines by human 
miRNA microarray platform (Agilent Sanger miRBase-release 10.1) with 723 human 
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and 76 human viral miRNAs represented. Agilent Feature Extraction Software was 
used for background subtraction. LOWESS and Quantile normalizations were 
performed. miRNA microarray expression data were validated by RT-PCR. Results: 
Relative to normal melanocytes, in uveal melanoma cells, miR-130b, miR-193b, miR-
320a, and miR-9* significantly decreased, and miR-654-3p markedly increased; in 
cutaneous melanoma cells, miR-199a-3p and miR-22 were down-regulated, whereas 
let-7g was up-regulated. Two of these miRNAs, mir-193b and let-7g, were previously 
shown as potential regulators in melanoma, whereas the other ones have not been 
related to melanoma yet. Conclusions: Our analysis enables us to identify miRNAs 
that have not previously been associated with melanoma. In addition, the 
comprehensive survey of differentially expressed miRNAs shows remarkable 
differences between cutaneous and uveal melanoma. Although the study is 
preliminary, we believe the results add to the present knowledge on miRNA 
dysregulation in melanoma carcinogenesis. As such the results would serve as a 
starting point for identifying the direct targets of key miRNAs and elucidating their 
mechanisms of regulation. Understanding the functional roles of miRNAs in 
melanoma will contribute to the development of targeted therapy. 
 
NBM9. Higher Frequency of Hypermethylation of p16INK4A Compared to 
p14ARF among Cutaneous Melanoma Patients from Southern Italy 
T. Catalano1, M. Ruggeri1, C. Fortunato1, S. Ratone1, G. Sirna1, G. De Grazia1, D. 
Teti1, M. Venza1 
University of Messina, Messina, Italy 
Background: Epigenetic deregulation due to p14ARF and p16INK4A promoter 
hypermethylation has been previously reported in many cancers, including 
cutaneous melanoma (CM). Nevertheless, discriminating the involvement of these 
genes in CM still remains an open question. Methods: p14ARF and p16INK4A were 
analyzed in 60 CM formalin-fixed paraffin-embedded tissue sections and in G-361 
and GR-M cutaneous melanoma cell lines by methylation-specific PCR and 
sequencing. Gene expression was evaluated by qReal-time PCR. Cell lines were 
treated with demethylating agent 5-aza-2’-deoxycytidine. Results: p16INK4A gene 
promoter methylation was found in 36 of 60 (60%) melanoma tissues, 12 of which 
were heterozygous and the others homozygous. Conversely, p14ARF was found 
methylated in heterozygous status in 19/60 (31.67%) cases. Hypermethylation of 
both genes showed low frequency (10%). G-361 and GR-M cell lines were identified 
as homozygous methylated in p16INK4A and unmethylated in p14ARF. Loss and 
decrease gene expression was observed in homozygous and heterozygous status, 
respectively. All cells exhibited demethylation and induction of gene expression after 
5-aza-dC treatment. Conclusions: Here we showed a higher frequency of 
methylated CpGs in p16INK4A compared to p14ARF in cutaneous melanoma, unlike 
other studies that have reported the opposite. As this is the first detailed investigation 
of the frequency of p16INK4A and p14ARF methylation in CM in Southern Italy, it is 
likely that the well-known high occurrence of melanoma in this region may be 
associated to aberrant methylation of p16INK4A. To note, CM tissue analysis 
facilitates a heterogeneity of results not otherwise demonstrable in cell lines. 
 
NBM10. A New High-Speed Nested PCR-RFLP Method for the Screening 
Of V600E BRAF Mutation in Thyroid Tissue and Cytological Samples 
L. Postiglione1, B. Covelli1, B. D'Andrea2, T. de Cristofaro3, G. Varriale2, A. Sinisi4 
1Federico II University of Naples, Napoli, Italy; 2Diachem srl Molecular Biology 
Company, Naples, Italy; 3CNR, Napoli, Italy; 4Second University of Naples, Naples, 
Italy 
Background: Recent studies have shown that BRAF activation point mutations are 
present in about 45% (range 29-69%) of papillary thyroid cancers (PTC). Almost 
90% of the mutations are BRAF T1799A transversion in exon 15 which results in a 
(V600E) substitution. Fine needle aspiration biopsy (FNAB) is the primary tool to 
distinguish benign from malignant nodules .The aim of this study is to establish an 
accurate and sensitive molecular method to detect BRAF V600E mutation as a 
biomarker of early PTC. Methods: We analyzed the genomic DNA extracted from 
100 PTC patients, previously characterized by cytological examination. BRAF V600E 
mutation was evaluated by RFLP-PCR, using an artificial HpyCH4-IV restriction site 
in the PCR product, corresponding to V600E mutation. Our method detected 
heterozygous V600E BRAF mutation in 40% of PTC samples analyzed. Results: All 
samples analyzed in heterozygous showed a panel of three restriction fragments 
(147, 126 and 21 bp), whereas the wild-type samples showed a pattern of two 
restriction fragments (126 and 21 bp). The results of sequencing are overlapping up 
to a concentration of pathological cells of 35%, whereas our nested PCR-RFLP 
method was able to discriminate to a sensitivity of 1% pathological cells. 
Conclusions: The validation of the method of analysis performed on all samples by 
direct sequencing enhances the precision, accuracy, specificity and sensitivity of 
both the method and results. These data are indicative for an innovative and 
sensitive technique for the evaluation of the BRAF V600E mutation and can be a 
useful tool for screening BRAF V600E mutations. 
 
NEOPLASIA – TUMOR IMMUNITY 
 
NTIM1. Immunogenic Dendritic Cell Selection by Natural Killer Cells 
During Anti-Cancer Immune Response 
B. Morandi1, L. Mortara2, I. Bonaccorsi3, L. Chiossone4, R. Accolla2, M. Mingari1, L. 
Moretta1, G. Ferlazzo3 
1University of Genoa, Genoa, Italy; 2University of Insubria, Varese, Italy; 3University 
of Messina, Messina, Italy; 4Istituto G.Gaslini, Genoa, Italy 
Background: Previous studies have reported that activated natural killer (NK) cells 
can kill autologous immature dendritic cells (DCs) in vitro, whereas they spare fully 
activated DCs. This led to the proposal that activated NK cells might select a more 
immunogenic subset of DCs during a protective immune response. However, there is 
no demonstration that autologous DC killing by NK cells is an event occurring in vivo 
and, consequently, the functional relevance of this killing remains elusive. Methods: 
NK cells were activated in a mouse model by injecting MHC-devoid cells. Draining 
lymph nodes were collected and lymph node DC functions analyzed. Finally, in a 
model of anti-cancer vaccination, the functional relevance of DC editing by NK cells 
was investigated. Results: A significant decrease of CD11c+ DCs was observed in 
draining lymphnodes of mice inoculated with MHC-devoid cells. Residual lymph 
node DCs displayed an improved capability to induce T cell proliferation. In addition, 
during anti-cancer vaccination, the administration of MHC-devoid cells together with 
tumor cells increased the number of tumor-specific CTLs and resulted in a significant 
increase in survival of mice upon challenge with a lethal dose of tumor cells. 
Depletion of NK cells or the use of perforin knockout mice strongly decreased the 
tumor-specific CTL expansion and its protective role against tumor cell challenge. 
Conclusions: Our data support the hypothesis that NK cell-mediated DC killing 
takes place in vivo and is able to promote expansion of cancer-specific CTLs. Our 
results also indicate that cancer vaccines could be improved by strategies aimed at 
activating NK cells. 
 
NTIM2. Gene Regulation by microRNA Is Associated with CD8+ T Cells 
Immune Deviation in Renal Cell Carcinoma Patients: Role of JAK3 and MCL-1 
M. Gigante1, P. Pontrelli2, G. Maddalena1, W. Herr3, V. Mancini2, M. Battaglia2, W. 
Storkus4, L. Gesualdo2, E. Ranieri1 
1University of Foggia, Foggia, Italy; 2University of Bari, Bari, Italy; 3University of 
Mainz, Mainz, Germany; 4University of Pittsburgh, Pittsburgh, PA, United States of 
America 
Background: MicroRNAs (miRNAs) are important regulators of gene expression 
and numerous miRNAs are expressed aberrantly and correlate with tumorigenesis. 
In patients with renal cell carcinoma (RCC), T cell immune dysfunctions have been 
reported. The aim of our study was to assess gene expression profiles and their 
regulatory mechanisms by miRNAs on CD8+ T cells from RCC patients, at basal 
(day 0) and after stimulation against RCC line (day 35). Methods: We compared 
autologous and allogeneic CD8+ T-cell responses against RCC line generated from 
RCC patients and their HLA-matched healthy donors. We then analyzed the gene 
expression profiles of CD8+ T cells by microarray approach and then identified 
molecular mechanisms of gene regulation by miRNAs analysis. Results: 
Comparison of gene expression data in allogeneic CD8+ T cell vs autologous RCC-
reactive CD8+ T cells demonstrated differential expression of genes involved in 
apoptosis and regulation of cell proliferation. Among these genes, the down-
regulation of JAK3 and MCL-1 gene expression in patient CD8+ T cells versus their 
healthy counterparts was observed. We found evidence for defective suppressor 
activity of miR-29b and miR-198 in regulating gene expression of JAK3 and MCL-1 
in RCC CD8+ T cells. Transfection experiments on isolated PBMCs from RCC 
patients using anti-hsa-miR-29b and anti-hsa-miR-198 inhibitors revealed a 
significant up-regulation of both proteins and a significant improvement of cell 
survival in vitro. Conclusions: miR-29b and miR-198 play a key role in regulating 
immune-mediated mechanisms by interfering in CD8+ T cells gene expression of 
JAK3 and MCL-1 and may have important therapeutic implications.  
 
NTIM3. CD40 Cross-Linking Induces Migration of Renal Tumor Cell 
Through NFAT Activation and Integrin β1 Reorganization 
P. Pontrelli1, M. Gigante2, M. Sardarelli1, L. Balducci1, R. Cincione2, M. Gigante2, G. 
Grandaliano2, L. Gesualdo1, E. Ranieri2 
1University of Bari, Bari, Italy; 2University of Foggia, Foggia, Italy 
Background: CD40 crosslinking play an important role in regulating cell migration, 
adhesion and proliferation in renal cell carcinoma (RCC). CD40/CD40L interaction on 
RCC cells activates different intracellular pathways, however the molecular 
mechanisms leading to cell scattering are not clearly defined. Aim of our study was 
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to investigate the principal intracellular factors activated by CD40 ligation and their 
specific involvement in RCC cell migration. Methods: RCC cell lines were isolated 
from kidney tissue samples of patients affected by RCC and subsequently stimulated 
with CD40L. Results: We found that CD40-CD40L interaction induced cell 
proliferation through a cytoskeleton reorganization and integrin β1 distribution, 
whereas it did not affect apoptosis. Interestingly, CD40 ligation did not activate the 
pathway involving phosphatidylinositol 3-kinase (PI3K), Akt and p70 ribosomal S6 
kinase, but it increased the phosphorylation of extracellular signal-regulated kinase 
(ERK), c-Jun NH(2)-terminal kinase (JNK) and p38 MAPK. Furthermore, CD40 
crosslinking activated different transcriptional factors on RCC cell lines: AP-1, NF-κB 
and some members of the NFATs family. In particular, the specific inhibition of NFAT 
factors by cyclosporine A, completely blocked RCC cell motility induced by CD40 
ligation. Conclusions: These findings support the hypothesis that CD40 ligation 
induces cell scattering through cytoskeleton reorganization and activation of different 
intracellular signalling pathways, in particular the NFATs family. These factors could 
represent a potential therapeutic target in the setting of patients with metastatic 
RCC. 
 
NEOPLASIA – TUMOR PROGRESSION 
 
NTP1. Estrogen Induces Looping Between Tumor Suppressor RIZ Gene 
Promoter 2 with Exon 9a 
C. De Rosa1, E. Di Zazzo2, E. Todisco1, E. Griffo1, M. Spiniello1, M. Ombra3, B. 
Moncharmont2, N. Medici1, B. Perillo3, C. Abbondanza1 
1Seconda Università di Napoli, Naples, Italy; 2Università degli studi del Molise, 
Campobasso, Italy; 3C.N.R., Avellino, Italy 
Background: The dynamic intra- and inter-chromosomal links between specific loci 
contribute to the creation of cell type-specific gene expression profiles and to gene 
regulation during differentiation processes. Looping is implicated in bringing together 
far upstream or downstream regions with the gene promoter and body sites, and in 
establishing contacts between the 5' and 3' ends of genes, since 3' end-processing 
factors interact with components of the transcriptional machinery. The tumor 
suppressor PRDM2/RIZ gene plays a role in controlling cellular processes, such as 
cell cycle progression and regulation of development. The retinoblastoma protein-
ineracting zinc-finger gene (RIZ) is estrogen responsive and has two alternative 
promoters, the more downstream of which, promoter 2, is nearby to an ERE-
sequence and is involved in estrogen receptor transcriptional activation. Methods: 
With the innovative DNA-Picked Chromatin (DPC) assay after timecourse of 17-ß-
estradiol (E2) induction of MCF-7 breast cancer cells, we highlight preferential 
interaction between hormone-responsive RIZ promoter and the polyadenylation 
sites. Gene expression analysis of induced cell RNA was performed with qRT-PCR 
assay. Results: Within 60’ of E2 treatment of cells, we have observed increased 
exon segments, exons 9a and 10 (alternative polyA site), linked to isolated promoter 
2 and concomitant decrease of exon10 to RIZ promoter 1. The exon 9a shows a low 
association to RIZ promoter 1 without E2. qRT-PCR also demonstrated increased 
exon 9a-containing transcripts. Conclusions: The E2 remodels the chromatin 
architecture of PRDM2/RIZ gene locus to create a loop for the mRNA transcription 
with polyA-exon 9a, leading to the production of oncogenic variants. 
 
NTP2. Role of ER-α in the Modulatory Effect of Adiponectin on Breast 
Cancer Cell Growth 
M. Pellegrino1, L. Mauro1, F. De Amicis1, E. Ricchio1, S. Ando'1 
1University of Calabria, Arcavacata di Rende, Italy 
Background: Several studies suggest that adiponectin, a hormone mainly produced 
by adipose tissue, may influence cancer pathogenesis. Circulating adiponectin levels 
appear to be inversely associated with an increased risk of breast cancer. Methods: 
MTT assay, immunolocalizzation, RT-PCR, transient transfection, ChIP assay. 
Results: We demonstrated that adiponectin inhibited proliferation in ER-α-negative 
cells, whereas it stimulated growth in ER-α -positive cells. Adiponectin is able to 
reproduce the classic features of ER-α transactivation in MCF-7 cells: nuclear 
localization, down-regulation of its mRNA and protein levels, and up-regulation of the 
estrogen-dependent genes, catepsin D and pS2. In MCF-7 cells, adiponectin up-
regulated mRNA and protein levels of cyclin D1 (CD1), which, in contrast, appeared 
down-regulated in MDA-MB-231 cells. Similar opposite effects were elicited by 
adiponectin on CD1 promoter activity. Mutagenesis studies revealed that the 
modulation of CD1 promoter activity by adiponectin was mediated mainly by the Sp1 
motif. Moreover, adiponectin induced Sp1 nuclear localization and its 
phosphorylation. To provide insight into the molecular mechanism by which the Sp1 
motif modulates CD1 promoter activity, we performed ChIP experiments. In MCF-7 
cells adiponectin increased Sp1/ER-α complex, enhanced Pol-II and pCAF 
recruitment, addressing the involvement of an activator complex that mediated the 
adiponectin-induced transcriptional activation of CD1. In contrast, in MDA-MB-231 
cells adiponectin recruited Sp1, displaced Pol-II and recruited a corepressor complex 
containing SMRT, NCoR and HDAC1. Conclusions: Thus, on the basis of our 
findings we suggest that a proper use of novel therapeutic tools potentiating 
adiponectin signaling in breast cancer may target ER-α -negative tumor growth and 
progression. 
 
NTP3. Estrogen Receptor-β, through Sp1, Recruits a Corepressor 
Complex to the Estrogen Receptor-α Gene Promoter in Breast Cancer Cells 
D. Zito1, P. Rizza1, V. Bartella1, I. Barone1, F. Giordano1, C. Giordano1, L. Mauro1, S. 
Catalano1, D. Sisci1, M. Panno1, S. Fuqua2, S. Ando'1 
1Universita Della Calabria, Cosenza, Italy; 2Baylor College of Medicine, Houston, TX, 
United States of America 
Background: In the regulation of mammary gland growth and development human 
estrogen receptors (ERs) α and β play a crucial role. Normal breast tissues display a 
relative higher expression of ER-β than ER-α, which drastically changes during 
breast tumorogenesis. The different ratio of expression of the two proteins may be 
involved in breast carcinogenesis development. However, the molecular 
mechanisms underlying the potential opposing roles played by the two estrogen 
receptors on tumor cell growth remain to be elucidated. Methods: Transient 
transfection, Western Blotting, EMSA, ChIP, RT PCR, silencing. Results: In this 
study, we have showed that ER-β overexpression in breast cancer cells decreases 
cell proliferation and down-regulates ER-α mRNA and protein content, along with a 
concomitant repression of estrogen-regulated genes. Deletion analysis of the human 
ER-α promoter region, indicated that elevated levels of ER-β down-regulated basal 
ER-α promoter activity. Furthermore, site-directed mutagenesis revealed that the 
proximal GC-rich motifs at -223 and -214 are critical for the ER-β -induced ER-α 
down-regulation in breast cancer cells. The results indicate an enhancement 
recruitment of Sp1 and ER-β, together with the corepressor NCoR, to the ER-α 
promoter region concomitant with the hypoacetylation of histone H4 and 
displacement of RNA polymerase II. Silencing of NCoR gene expression by RNA 
interference reversed the down-regulatory effects of ER-β on ER-α gene expression 
and cell proliferation. Conclusions: Our data suggest a novel mechanism by which 
overexpression of ER-β through NCoR is able to down regulate ER-α gene 
expression, thus inhibiting the driving role of ER-α on breast cancer cell growth. 
 
NTP4. Role of Argonaute 2 in Estrogen Receptor-β-Mediated 
Transcriptional Gene Silencing in Breast Cancer Cells 
R. Tarallo1, G. Nassa1, M. Ravo1, G. Giurato1, F. Rizzo1, C. Cantarella1, C. Stellato1, 
A. Weisz1 
1Laboratory of Molecular Medicine and Genomics, University of Salerno, Baronissi, 
Italy 
Background: Estrogen receptor (ER) is the primary target for chemoprevention and 
endocrine therapy in breast cancer and provides prognostic and predictive 
information about tumor response to endocrine therapies. Expression of ER-β 
reduces cancer cell proliferation and tumor growth, suggesting an anti-proliferative 
and a positive prognostic value of this receptor subtype. Although ER-β seems to be 
a tumor suppressor, its role in human breast carcinogenesis remains to be 
elucidated. ER-α and ER-β could show the ability to interact with the same proteins 
resulting, however, in divergent transcriptional effects. Moreover, it has emerged that 
unliganded ER-β exhibits an active role in constitutive regulation of target genes 
transcription. Methods: Tandem affinity purification (TAP) and mass spectrometry 
(MS) were applied to identify unliganded ER-β nuclear interacting proteins. Among 
the over 300 partners identified we investigated the functional significance of ER-β-
AGO2, since this last protein has been directly implicated in transcriptional gene 
silencing (TGS) induced by microRNAs. Co-immunoprecipitation assays, confocal 
microscopy (Proximity Ligation Assay/PLA) ChIP-Seq, siRNA-mediated gene knock-
down (KD) and gene expression profiling were applied to this end. Results: Co-
immunoprecipitation and PLA confirmed ER-β/AGO2 association in MCF-7 cell 
clones expressing tagged ER-β. Co-immunoprecipitation was also observed for 
several known AGO2 interacting proteins, identified by TAP/MS as ER-β partners. 
ChIP-Seq allowed the identification of a large number of ER-β- and AGO-binding 
sites and the corresponding target genes, whereas AGO2 KD resulted in significant 
changes in gene expression profiles. Conclusions: Experimental evidences suggest 
that AGO2 is a partner of ER-β involved in gene regulation in hormone responsive 
breast cancer cells. Supported by AIRC; MIUR; Regione Campania; University of 
Salerno; Fondazion e con il Sud; EU COST Action BM1006 and ‘SeqAhead’ FEBS 
Short Term Fellowship to G.Nassa. 
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NTP5. Role of AKT-Regulated MicroRNAs in Non-Small Cell Lung 
Cancer  
I. Guerriero1, D. D'Angelo2, P. Pallante2, M. Santos1, M. Ravo3, A. Weisz3, A. Fusco2, 
G. Viglietto4 
1BioGem IRGS, Ariano Irpino (AV), Italy; 2Istituto di Endocrinologia ed Oncologia 
Sperimentale del CNR, Naples, Italy; 3Facoltà di Medicina e Chirurgia, Università 
degli Studi di Salerno, Baronissi (SA), Italy; 4Università degli Studi Magna Graecia di 
Catanzaro, Catanzaro, Italy 
Background: MicroRNAs (miRNAs) are small non-coding RNAs usually of 21-25 
nucleotides in length that regulate gene expression at post-transcriptional level. 
miRNA deregulation plays an important role in lung cancer development. The 
objective of this study is to discover the potential link between deregulation of the 
PI3K/AKT pathway and miRNA expression in lung cancer. Methods: By microarray 
hybridization we identified the miRNA expression profile in two cellular systems: (1) 
BEAS-2B, human immortalized, non tumorigenic, lung epithelial cells genetically 
modified for the activation of the PI3K/AKT pathway through expression of mutant 
AKT1 (E17K), PI3K (E545K) or silenced for PTEN; and (2) NCI-H460, non small cell 
lung cancer (NSCLC) cell line genetically modified for the knockdown of the 
PI3K/AKT pathway through the silencing of AKT1, AKT2 and PI3K. Results: 
Microarray data analysis identified several differentially expressed miRNAs in 
lentivirus-infected cells compared to the parental cell lines. In particular, miR-196a 
was significantly up-regulated in BEAS and down-regulated in H460. Subsequently, 
we observed that miR-196a is overexpressed in human primary lung cancer 
samples. miR-196a is predicted, using bioinformatic tools, to target genes, such as 
FoxO1, FoxO3 and p27, involved in the PI3K/AKT pathway. The generation of stable 
cellular clones which overexpress miR-196a, or silenced for this miRNA through the 
expression of an anti-miR-196a, is important to determine the role of miR-196a in the 
development of human lung cancer. By cell migration assays we demonstrated the 
involvement of miR-196a in the increased ability of cells to migrate. Conclusions: 
Further biological studies are necessary to characterize the role of miR-196a in 
NSCLC. 
 
NTP6. Abstract Withdrawn 
 
NTP7. Rosiglitazone and AS601245 Decrease Cell Adhesion and 
Migration Through Modulation of Specific Gene Expression in Human Colon 
Cancer Cells. 
R. Minelli1, A. Cerbone2, C. Toaldo3, E. Ciamporcero3, S. Pizzimenti3, P. Pettazzoni3, 
M. Dianzani3, C. Ferretti1, C. Dianzani1, G. Barrera3 
1Dipartimento di Scienza e Tecnologia del Farmaco, Turin, Italy; 2Merk-Serono Ivrea-
RBM Spa Istituto di Ricerche Biomediche A. Marxer, Colleretto Giacosa, Italy; 
3Dipartimento di Medicina e Oncologia Sperimentale, Turin, Italy 
Background: PPARs are nuclear receptors activated by ligands. Activation of 
PPARγ leads to a reduction of adhesion and motility in some cancer models. PPARγ 
transcriptional activity can be negatively regulated by JNK-mediated 
phosphorylation. We postulated that the use of agents able to inhibit JNK activity, 
could increase the effectiveness of PPARγ ligands. Methods: We analysed the 
effects of rosiglitazone (PPARγ ligand) and AS601245 (a selective JNK inhibitor) 
alone or in association, on adhesion and migration of CaCo-2, HT29, and SW480 
human colon cancer cells and investigated, through microarray analysis, the genes 
involved in these processes. Results: Cell adhesion and migration was strongly 
inhibited by rosiglitazone and AS601245. Combined treatment with the two 
compounds resulted in a greater reduction of the adhesion and migration capacity. 
Affymetrix analysis in CaCo-2 cells revealed that some genes were highly modulated 
by the combined treatment, could be involved in these biological responses. 
Rosiglitazone down-regulated the expression of fibrinogen chains (α, β, γ), which 
were further down-regulated by the combined treatment. Moreover, rosiglitazone, 
alone or in association with AS601245, caused a decrease in the fibrinogen release. 
ARHGEF7/β-PIX gene was highly down-regulated by combined treatment, and 
western blot analysis revealed that β-PIX protein is also down-modulated in CaCo-2, 
HT29 and SW480 cells. Transfection of CaCo-2 cells with β-PIX gene completely 
abrogated the inhibitory effect on cell migration, determined by rosiglitazone, 
AS601245 and combined treatment. Conclusions: Results demonstrated that β-PIX 
protein is involved in the inhibition of cell migration and sustain the positive 
interaction between PPARγ ligands and anti-inflammatory agents in humans. 
 
NTP8. The Outcomes of Notch3-Dependent T Cell Leukemia Are 
Modified by NF-κB Deletion 
A. Campese1, P. Grazioli1, G. Scafetta1, C. Noce1, S. Verkhovskaia1, C. Mari1, M. 
Felli1, A. Gulino1, I. Screpanti1 
1Sapienza, University of Rome, Rome, Italy 
Background: The Notch3 deregulation inside T-cell compartment of transgenic (N3-
tg) mice, induces an aggressive form of T-cell acute lymphoblastic leukemia (T-ALL), 
strongly sustained by an NF-κB constitutive activation, mainly represented by the 
p50/p65-dependent canonical pathway. To clarify the Notch/NF-κB relationships in 
the onset/progression of T-ALL, we decided to inhibit NF-κB canonical pathway in 
N3-tg mice. Methods: We generated N3-tg/p50-/- mice, deleted of the NF-κB/p50 
subunit in a Notch3 transgenic background. The follow-up of N3-tg/p50-/- versus N3-
tg mice was conducted and hematopoietic cell analysis was performed at different 
ages and in multiple tissues from the indicated animals by flow-cytometry 
techniques. Results: The p50 deletion inhibited the progression of T-ALL in N3-
tg/p50-/- mice, as defined primarily by the peripheral expansion of immature 
CD4+CD8+ T cells. Surprisingly, the double mutant mice succumb earlier than N3-tg 
counterparts. Moribund N3-tg/p50-/- mice display the trait of a myeloproliferative 
disease, with the dramatic expansion of Mac1+Gr1+ myeloid cells in both spleen and 
blood, as well as of granulocyte/monocyte progenitors in the bone marrow. 
Preliminary data indicate that these cells do not express Notch3, suggesting that in 
the absence of p50 expression, Notch3 is able to mainly influence the equilibrium of 
the myeloid compartment in trans. Conclusions: The results presented suggest that 
the ablation of NF-κB canonical pathway may strongly impact on the outcomes of a T 
cell specific deregulation of Notch signaling. Thus, providing a useful experimental 
model to extend our understanding of Notch/NF-κB interplay and to unravel novel 
strategies for the therapy of different hematological malignancies. 
 
NTP9. The Resveratrol-Analogue 4,4’-Dihydroxy-Trans-Stilbene 
Suppresses Transformation in Normal Mouse Fibroblast and Inhibits 
Proliferation and Invasion of Human Breast Cancer Cells 
C. Maccario1, M. Savio1, D. Ferraro1, L. Bianchi1, R. Pizzala1, L. Pretali1, L. Forti2, L. 
Stivala1 
1Università degli studi di Pavia, Pavia, Italy; 2Università di Modena e Reggio-Emilia, 
dip Chimica, Modena, Italy 
Background: 4,4’-dihydroxy-trans-stilbene (DHS) is a synthetic analogue of 
resveratrol (RSV). We previously demonstrated that DHS exerts a higher 
antiproliferative activity than RSV on normal human fibroblasts. Herein, our aim was 
to investigate the effect of DHS both on transformation of BALB/c 3T3 mouse 
fibroblasts and on proliferation and invasion of human breast cancer MCF-7 cells. 
Methods: Trypan blue staining was used for assessing cell death. Chemically 
induced (MNNG+TPA) transformation of BALB/c 3T3 mouse fibroblasts was 
performed with the CytoSelect 96-well cell transformation assay. MCF-7 cell 
proliferation was investigated by PI staining, BrdU incorporation, and Western 
blotting analysis. The Boyden chamber cell migration and invasion, gelatin 
zymography and wound healing assay were also performed. Results: DHS 
efficiently suppressed the two-stage chemically induced transformation in BALB/c 
3T3 cells. It also inhibited with high efficiency both anchorage-dependent and -
independent MCF-7 growth. In addition, a reduction in the S-phase cell population, 
associated with an increase in the p21 and p53 protein levels, and with a strong 
inhibition of the pRb protein phosphorylation, was evidenced in DHS-treated cells. 
Furthermore, DHS exerted a strong reduction of the matrix metalloproteinase-2 and -
9 activities, concomitantly with a marked reduction of cell-cell and cell-extracellular 
matrix interaction. Conclusions: These results demonstrate that the two 4,4’-
hydroxyl groups on the stilbenic backbone make DHS a more active molecule, 
compared to RSV, in inhibiting neoplastic transformation, cancer cell proliferation 
and invasion. Further in vivo studies to better characterize DHS absorption and 
metabolism, biosafety, and the mechanisms of its anticancer properties are in 
progress. 
 
NTP10. DDB2 Interacts with the Nucleotide Excision Repair Proteins at 
DNA Damaged Sites 
L. Stivala1, P. Perucca1, S. Sommatis1, R. Mocchi1, E. Prosperi2, O. Cazzalini1 
1Università di Pavia, Pavia, Italy; 2IGM-CNR, Pavia, Italy 
Background: DDB2 is a 48KDa protein originally identified as a component of the 
heterodimeric complex UV-DDB, together with DDB1. This complex has affinity for 
the major cytotoxic-mutagenic types of lesions introduced in DNA by UV irradiation, 
such as 6-4 photoproducts and cyclobutane pyrimidine dimers. These lesions lead to 
distortion of DNA, predisposing cells to accumulate mutations increasing 
susceptibility to cancer. Cells, as a protective mechanism against UV induced DNA 
damage, utilize nucleotide excision repair process. DDB2 plays an important role in 
the recognition step of UV-induced DNA damage in non-transcribed regions and it is 
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mutated in xeroderma pigmentosum (group E) patients. In this study, we analyse the 
possible interaction between DDB2 and other proteins involved in NER process. 
Methods: We have studied the localization of DDB2 in HeLa cells transiently 
transfected with pcDNA3.1-DDB2 construct and then irradiated with UV-C at 30 or 
100J/m2, respectively, for western blot and immunofluorescence analyses. 
Moreover, to study the direct interaction between DDB2 and other NER proteins, 
solubilised chromatin fractions were immunoprecipitated with DDB2 antibody. 
Results: Cellular localization of DDB2 was examined 5, 10, 30 min post-UV 
irradiation: the confocal analysis showed that DDB2 co-localized with DNA repair 
proteins recruited to DNA-damage sites after local UV-C irradiation. The results 
obtained by immunoprecipitation techniques demonstrated the interaction and 
physical association between DDB2 and cullin 4A, XPC, XPG, p21 and PCNA 
proteins after DNA damage. Conclusions: DDB2 protein is recruited at local DNA-
damaged sites where it directly interacts with NER proteins. 
 
NTP11. A Novel Role for DNA Polymerase Eta (Polη) in Regulating the 
Translesion Synthesis Pathway of DNA Damage Tolerance 
M. Durando1, C. Vaziri1 
1University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of 
America 
Background: Cellular DNA is constantly exposed to ubiquitous environmental 
genotoxins, such as UV irradiation in sunlight, that cause DNA damage and 
predispose to cancer and other diseases. Translesion synthesis (TLS) is a DNA 
damage-tolerance mechanism that uses specialized DNA polymerases to replicate 
genotoxin-damaged DNA when conventional polymerases stall. TLS polymerases 
replicate DNA with relatively low fidelity, and their activity must therefore be tightly 
regulated. Defects in the TLS pathway cause excessive mutagenesis, as evidenced 
by the xeroderma pigmentosum variant (XPV) syndrome, in which Poleta, the TLS 
polymerase DNA polymerase eta (Polη), is non-functional. Lack of Polη, which 
accurately replicates UV-damaged DNA, results in error-prone replication by 
inappropriate polymerases, UV-induced mutagenesis, and cancer. TLS polymerases 
are activated when the DNA replication factor PCNA is mono-ubiquitinated by the E3 
ubiquitin ligase Rad18. Although this mono-ubiquitination activates TLS, its 
regulation is poorly understood. Methods: We used in vitro and in vivo biochemical 
and imaging techniques to map functional interactions between effector proteins in 
the TLS pathway. Results: We have uncovered a previously unidentified function of 
Polη in the regulation of TLS. In addition to its polymerase activity, we show that 
Polη recruits Rad18 to damaged DNA to promote efficient PCNA ubiquitination and 
activate TLS. Conclusions: Whereas tumorigenesis in XPV patients has been 
thought to stem solely from defective Polη polymerase activity, our results reveal that 
Polη also has non-catalytic roles that regulate TLS. Our findings suggest that 
imbalanced Polη expression, regardless of exposure to UV light, could misregulate 
TLS to promote mutagenesis, thus perturbing genomic stability in previously 
uncharacterized ways. 
 
NTP12. Nottingham Prognostic Index and Triple-Negative Breast Cancer 
A. Londero1, S. Bertozzi2, L. Driul1, R. Petri2, S. Bernardi1 
1Clinic of Obstetrics and Gynecology, AOU “SSMM della Misericordia”, Udine, Italy; 
2Department of Surgery, AOU “SSMM della Misericordia”, Udine, Italy 
Background: The Notthingham Prognostic Index (NPI) classifies breast cancers into 
three prognostic categories: good prognosis for values <3.4 (85% 15-ys-OS) 
(group1), moderate prognosis for values 3.41-5.4 (42% 15-ys-OS) (group2), poor 
prognosis for values>5.4 (13% 15-ys-OS) (group3). Our study evaluates the NPI 
applicability in women affected by invasive triple-negative breast cancer (TNBC) 
compared to non-TNBC. Methods: A retrospective analysis was performed on 
patients operated in our Department for invasive breast cancer between January 
2002 and December 2007 (follow up ≥5years). Women were divided into three 
groups based on the three NPI prognostic categories, and TNBCs were compared 
with non-TNBCs in terms of overall survival. Results: During the considered period, 
917 women were operated for invasive breast cancer at a mean age of 61.4 years (± 
12.58). The histological type was in the majority of cases a ductal invasive cancer 
72% (661/917); the most frequent TNM stage was T1cN0M0 (stage I); TNBC 
prevalence was 8% (71/917). The 5- and 8-ys OS resulted respectively 99% (98-
100%) and 97% (95-98%) in group1, 88% (83-93%) and 83% (77-89%) in group2, 
69% (59-80%) and 55% (44-70%) in group3 (P < 0.05). The 5-ys OS in TNBC and 
non-TNBC stratified for the NPI categories resulted respectively 94% (87-100%) and 
99% (98-100%) in group1 (P < 0.05), 85% (71-100%) and 89% (84-94%) in group2 
(p0.834), 47% (26-85%) and 73% (63-85%) in group3 (P < 0.05). Conclusions: 
Despite its old origin and the limited factors considered, NPI represents a valuable 
prognostic tool also for TNBC. 
 
PERSONALIZED MEDICINE 
 
PM1. Establishment of a Colon Cancer Biobank and Database among 
Different Institutions 
R. Perego1, G. Cattoretti1, M. Totis2, B. Leone1, M. Beltramo3, G. Cesana1 
1University of Milano-Bicocca, Monza, Italy; 2S Gerardo Hospital, Monza, Italy; 
3Desio-Vimercate Hospital, Carate Brianza, Italy 
Background: In the post-genomic era there is still a gap between the available 
analytical tools and their impact on human diseases. On cancer pathology, that in 
the next years is expected to be the first cause of death, there is the major need to 
fill up this gap. In this context the establishment of biobanks in conjunction with 
databases containing all clinical/pathological/environmental risk data may help the 
achieving of this goal. We established a colon cancer biobank and relative database 
involving different hospitals and university departments. Methods: The biological 
material from colon cancer and normal colon has been collected in different 
institutions, the S Gerardo hospital and Desio-Vimercate hospital that hospitalize 
patients of a well-defined territory corresponding to Monza-Brianza province. An 
online questionnaire was produced to collect data on clinical, pathological, and 
environmental-risk information and the data were centralized in a single database. 
Models for patient informed consent and regulations to keep the data anonymous 
were establsihed. The guidelines of standardized operating procedures to collect and 
store the materials have been tested and made operative. Results: We are 
collecting 170 colon cancer cases/year in conjunction with clinical data. The biobank 
is favoring the standardization of clinical-diagnostic procedures in the involved 
hospitals. Conclusions: In three years the biobank will be able to provide material 
for oncological researches addressed to: i) discover biomarkers or therapeutic 
targets, ii) personalized medicine, iii) systems biomedicine. This experience will be 
also extended to other tumor pathologies. 
 
PM2. Identification of a Point Mutation in SMN1 Gene Causing Spinal 
Muscular Atrophy: Implications for Genetic Counseling and Prenatal Diagnosis 
G. Dubsky de Wittenau1, S. Radovic1, R. Pascolo1, F. Cesca1, M. Morgante1, F. 
Curcio1, R. Lonigro1 
1University of Udine, Udine, Italy 
Background: Spinal muscular atrophy (SMA) is one of the most common autosomal 
recessive genetic disorders characterized by progressive symmetric muscle 
weakness and paralysis. Carrier frequency of SMA is approximately 1/35 and 
therefore the incidence is 1 in 6000-8000 live births. Childhood disease is subdivided 
into three clinical forms with type I being the most severe. About 95% of SMA cases 
are caused by homozygous deletion of the SMN1 gene or its conversion to highly 
homologous SMN2. The remaining cases are heterozygous compound for a 
deletion/conversion of one SMN1 allele and a small intragenic mutation of the other 
allele. This work reports the case of a couple with two SMA type I affected deceased 
children and the research of mutation/s that determines SMA in this family. The final 
purpose is to perform prenatal diagnosis in a further pregnancy of the couple. 
Methods: SMN1 alleles copy number determination is performed by multiplex Real-
Time PCR method. Sequence analysis of exons and exon/intron junctions is 
performed by means of an automated Sanger sequencing. Results: The female of 
the couple is a SMN1 deletion carrier whereas the male that carries two SMN1 
copies harbours the rs104893922 point mutation (G>A), already described as 
associated to a severe SMA typeI phenotype. The same point-mutation has been 
identified in some of the healthy siblings. Conclusions: The point mutation 
identified, together with the more frequent SMN1 gene deletion, allows genetic 
counselling, carrier testing and prenatal diagnosis for the couple programming future 
pregnancy and for all relatives at reproductive risk in the family. 
 
PM3. Linked Data and Translational Medicine: The Role of ICD-11 
F. Gongolo1, L. Frattura1, V. Della Mea2, S. Brusaferro3 
1Friuli Venezia Giulia Region - Central Health Directorate - WHO-FIC CC, Udine, 
Italy; 2Dept. of Mathematics and Computer Science - University of Udine, Udine, 
Italy; 3Accreditation, Clinical Risk Management and Performance Evaluation AOU, 
Udine, Italy 
Background: Internet and digital information enable strong interactions within an 
information ecosystem of researchers, clinical practitioners and other resources and 
users of biomedical data. Currently the lack of standards for data representation is 
an obstacle in translational research, making difficult to extract all potential 
knowledge from data acquired through experiments and data analysis. However, the 
concept of linked data has recently gained relevance, indicating the practice of 
publishing structured data that can be interlinked and become more useful. The 
WHO International Classification of Diseases (ICD) is the world’s standard tool to 
capture health information. Methods: An exercise is set up using the content model 
of ICD-11, adopted for the11th revision of the classification, in which descriptive 
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characteristics of classification’s categories are linked to underpinning standardized 
terminologies to define information such as signs and symptoms, morphology, caUSl 
agents or treatment. Results: ICD-11 represents a good example of linked data 
exercise, leading the way to better data USge and therefore faster exploitation of 
information collected in translational research. Moreover the ICD-11 update and 
revision process, based on ontological tools, allows for collaborative web-based 
editing thus opening to all interested parties the possibility to rapidly update the 
classification and allowing fast transfer of biomedical discoveries into the 
classifications used in clinical practice. Conclusions: The content model of ICD-11 
represents a novel enhancing information transfer in translational medicine, but only 
a large web-based engagement of users in this domain will determine if the 
classification will become an effective tool for systematic bench-to-bedside 
knowledge exchange. 
 
REDOX REACTIONS IN HUMAN PATHOPHYSIOLOGY 
 
RR1. Membrane Oxidative Damage in Intestinal Caco-2 Cells: 
Protective Effect of a Wine Phenolic Extract 
M. Deiana1, D. Loru1, A. Incani1, A. Rosa1, A. Atzeri1, M. Melis1, B. Cabboi1, G. 
Serra1, M. Dessì1 
1University of Cagliari, Monserrato (CA), Italy 
Background: It has been suggested that the beneficial effects on the cardiovascular 
system ascribed to mild to moderate wine consumption may also arise from a local 
action in the gastrointestinal tract, where polyphenols and their metabolites 
concentrate. We investigated the ability of a red wine phenolic extract, obtained from 
the most typical and widespread grape variety grown in Sardinia, Cannonau, to exert 
a direct antioxidant action against the oxidative damage to intestinal mucosa. 
Methods: The protective action of the extract, obtained through liquid-liquid 
extraction with ethyl acetate, was evaluated as ability to counteract the loss of 
epithelial integrity, measured as transepithelial electrical resistance (TER) in 
differentiated human Caco-2 cell monolayers, following tert-butyl hydroperoxide 
(TBH) exposure, and through MDA, fatty acids hydroperoxides (HP) and 7-
ketocholesterol (7-keto) production (detected through HPLC analysis). Results: TBH 
treatment showed a significant decrease in Caco-2 TER from the lowest 
concentration tested (0.5 mM) already after 30 min of incubation. TBH 2.5 mM 
caused the complete loss of membrane integrity after 120 min of incubation. In 
Caco-2 cells exposed to TBH 2.5 mM for 120 min, a significantly high level of MDA 
compared to the non oxidized samples, paralleled by an increase of HP and 7-keto 
values, was detected, indicating an ongoing lipid peroxidation process. Pretreatment 
with the extract significantly slowed the decrease in TER and inhibited the increase 
of oxidation products. Conclusions: Our results point out for the first time a direct 
antioxidant action of the phenolic fraction from the wine Cannonau on enterocytes 
exposed to oxidizing species. 
 
RR2. Immune Responses Against Oxidative Stress-Derived Antigens 
Contributes to Hepatic Inflamamtion in Nonalcoholic Steatohepatitis (NASH). 
S. Sutti1, A. Jindal1, I. Locatelli1, M. Vacchiano1, C. Bozzola1, E. Albano1 
1University of East Piedmont, Novara, Italy 
Background: Nonalcoholic steatohepatitis (NASH) has become the most frequent 
chronic liver disease in relation to the worldwide increase of overweight and obesity. 
As NASH is often associated with the presence of circulating antibodies against 
proteins adducted by lipid peroxidation products, we have investigated the relevance 
of these immune response in the disease pathogenesis. Methods: NASH was 
induced by feeding C57BL/6 and Balb/c mice for 4 weeks with a methionine-choline 
deficient (MCD) diet. Results: Upon MCD feeding C57BL/6 mice showed more liver 
injury and increased hepatic expression of pro-inflammatory cyto/chemokines than 
Balb/c mice. In C57BL/6 mice NASH was also associated with increased prevalence 
of B- and T-lymphocyte infiltration and higher expression of lymphocyte chemokines 
CCL5 and CXCL10. Although liver oxidative damage was comparable in the two 
strains, we observed increased titres of IgG against malonyldialdehyde (MDA) and 4-
hydroxynonenal (4-HNE)-derived antigens only in MCD-fed C57BL/6 mice. 
Furthermore, only C57BL/6 mice had IgG deposits within the hepatic inflammatory 
infiltrates. To substantiate the role of immunity in the progression of NASH, Balb/c 
mice were immunized with MDA-adducted bovine serum albumin (MDA-BSA) and 
subsequently fed with the MCD diet. MDA-BSA immunization did not cause liver 
injury or inflammation in control mice. Following MCD diet, MDA-BSA-immunized 
mice showed higher ALT release, more diffuse lobular inflammation and a two-fold 
stimulation in TNF-α and IL-12 expression as compared to the naïve ones. 
Moreover, liver mRNAs for fibrosis markers pro-collagen 1α and TGF-β were 
significantly up-regulated by pre-immunization. Conclusions: These results indicate 
that oxidative stress-driven immunity contributes to hepatic inflammation in NASH. 
 
RR3. Oncostatin M Induces Epithelial-to-Mesenchymal Transition and 
Increased Invasiveness in Hepatic Cancer Cells Through Redox Mechanisms 
S. Cannito1, C. Paternostro1, C. Busletta1, D. Povero1, S. Colombatto1, E. Novo1, M. 
Parola2 
Dipartimento di Medicina e Oncologia Sperimentale, Turin, Italy; 2University of 
Torino, Faculty of Medicine, Turin, Italy 
Background: Oncostatin M (OSM) can orchestrate hypoxia-modulated liver 
processes (development, regeneration, angiogenesis) contributing to chronic liver 
disease progression and hepatocellular carcinoma (HCC) development. Accordingly, 
OSM and its related LIFRβ (leukemia inhibitory factor receptor β) subunit are 
overexpressed in cirrhotic liver. Since OSM can operate through hypoxia-inducible-
factors (HIFs) and hypoxia has been reported to induce epithelial-to-mesenchymal 
transition (EMT), this study has been designed to investigate whether OSM may act 
as a stimulus able to induce EMT in human hepatic cancer cells. Methods: EMT, 
invasiveness and signal transduction were analysed by morphological, molecular 
and cell biology techniques in HepG2, HuH7 and Madin-Darby canine kidney 
(MDCK) cells exposed to human recombinant OSM as well as by 
immunohistochemistry on liver specimens from HCV cirrhotic patients carrying G1 
and G2 HCC. Results: OSM induced EMT-related changes in all cells (nuclear 
translocation of SNAI1/2, E-cadherin down-regulation, overexpression of α-smooth 
muscle actin and expression of matrix metalloprotease-2) within 48-72 hrs and 
stimulated invasiveness in cancer cells. Data revealed a scenario involving early 
intracellular generation of reactive oxygen species (ROS), activation of PI-3K, 
ERK1/2, JNK1/2, p38MAPK and STAT3, and phosphorylation/inactivation of GSK-
3β. Cancer cell invasiveness was prevented by inhibiting ERK1/2, PI3K or JNK1/2 or 
by preventing ROS generation. Finally, OSM was expressed in HCC tumor cells in 
areas also positive for hypoxia-related antigens. Conclusions: OSM, expressed in 
human HCC and peritumoral cirrhotic tissue, can induce EMT in human hepatic 
cancer cells and stimulate invasiveness through redox-dependent activation of EMT-
related critical kinases and transcription factors. 
 
RR4. Xanthine Oxidase Directly and Irreversibly Modifies BH4 
Contributing to Endothelial Dysfunction in Ischemic Rat Hearts 
R. Biondi1, L. Bottiglieri2, N. Paolocci3, E. Capodicasa4, I. Tritto4, G. Ambrosio4, F. De 
Pascali5, J. Zweir5 
1Universita' di Perugia/Azienda Ospedaliera, Terni, Italy; 2Universita' di 
Perugia/Azienda Ospedaliera “Santa Maria” Terni, Terni, Italy; 3Johns Hopkins 
Medical institutions, Baltimore, MD, United States of America; 4Universita' di Perugia, 
Perugia, Italy; 5Ohio State University, Columbus, OH, United States of America 
Background: BH4 is a cofactor of nitricoxidesynthase activity. Changes in BH4 
bioavailability may affect vascular function. BH4 is also a potent hydroxyl radical 
scavenger. In cardiac diseases, xanthine oxidase (XO) activity is up-regulated. XO 
catalyzes the oxidation of xanthine to uric acid, generating superoxide. We 
hypothesized that enhanced XO activity may affect BH4 availability and function. 
Methods: To test whether BH4 and different pteridine derivatives have an impact on 
XO-mediated ROS-production, we evaluated inhibitory effects produced by 
incremental doses of BH4 and pteridines such as BH2, Bio, Pt and XPH2 on 
Xanthine/XO reaction, measuring the formation of urate as readout. Results: Urate 
formation from Xanthine/XO was inhibited by all pteridines tested, excepting for 
XPH2. Bio abolished the formation of urate at 20 μM. Higher concentrations of Pt 
(100 μM) were needed to achieve the same effect. BH4 and BH2 (200 μM) partially 
inhibited Xanthine/XO-driven production of urate (approximately 50%). We 
demonstrated that the production of superoxide anion does not occur when BH4 
reacts with XO. Therefore, we exposed increasing concentrations of BH4 to XO (0.1 
U / ml) in phosphate buffer at pH 7 for 15 min at 37 ° C and analyzed the products by 
HPLC. We found that BH4 was converted to XPH2, without BH2 as an intermediate 
product. The latter was proved by Fenton reaction-derived hydroxyl radical-driven 
BH4 transformation. Conclusions: Our data show that increased XO activity 
irreversibly transforms BH4 to XPH2. This alteration may contribute to the onset 
and/or progression of endothelial dysfunction during the course of acute or chronic 
cardiac diseases. 
 
RR5. NADH Accumulates During Early Ischemia in the Rat Heart as 
Detected by a Novel One-step Hplc Approach 
R. Biondi1, N. Paolocci2, E. Capodicasa3, M. Bettini4, I. Tritto3, G. Ambrosio3, L. 
Bottiglieri5 
1Universita' di Perugia/Azienda Ospedaliera, Terni, Italy; 2Johns Hopkins Medical 
Institutions, Baltimore, MD, United States of America; 3Universita di Perugia, 
Perugia, Italy; 4Dipartimento di Medicina Clinica e Sperimentale, Perugia, Italy; 
5Universita' di Perugia/azienda ospedaliera “Santa Maria” di Terni, Terni, Italy 
Background: Lack of oxygen due to myocardial ischemia alters the redox status of 
pyridine-dinucleotides. To directly test the latter possibility, we developed a method 
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to analyze NADH, NAD, NADPH, NADP levels in rat hearts subjected to ischemia-
reperfusion injury. Methods: A reaction of the oxidized-nucleotides with cyanide in 
basic solution leads to two stable fluorescent products, allowing us to separate all 
four nucleotides (NADH, NAD, NADP, and NADPH) and to quantify them on one 
single chromatogram. Langendorff-perfused rat hearts underwent global ischemia 
(15, 30 and 60 min) followed by 30-min reperfusion. The heart-chloroform extracts 
were analyzed by HPLC. Results: The analysis of HPLC chromatogram series of 
nicotinamide-adenine-dinucleotides over different ischemia time points revealed a 
sustained increase in the NADH level. This rise was already visible 15 min after 
ischemia (667.51 ± 51.07 nmol./gr to 15 min. ischemia vs 55.06 ± 7.46 nmol./gr 
control). When nicotinamide-adenine-dinucleotides phosphates are concerned, 
ischemia induced a significant NADPH decrease starting at 30 min of ischemia 
(69.55 ± 3.25 vs 79.48 ± 3.61 nmol/gr tissue in controls, P = 0.0098). These 
changes became even more evident after 60 min: NADPH levels dropped to 30.17 ± 
3.59 nmol/gr tissue (P = 0.00003). Conclusions: Our study shows that during early 
ischemia NADH accumulates in the heart tissue, likely due to an anoxia-induced 
blockade of the Krebs cycle. When the no-flow condition was longer than 15 min, the 
capacity of generating NADPH impaired during late ischemia. Altered bioavailability 
of pyridine-dinucleotides may have repercussions on cellular function and viability 
during the I/R injury. 
 
RR6. Polyphenol Compounds in Sardinian Wines Can Modulate Redox 
Cell Signalling Induced by a Dietary Mixture of Oxysterols in Human 
Enterocyte-like CaCo-2 Cells 
B. Cabboi1, M. Deiana1, M. Maina2, T. Guina2, G. Poli2, M. Dessì1, F. Biasi2 
1University of Cagliari, Cagliari, Italy; 2University of Turin, Turin, Italy 
Background: The beneficial role of polyphenols in human health, acting mainly as 
direct antioxidants has been widely documented. These compounds are distributed 
in all foods of plant origin, and exert many biological activities. Polyphenol food 
concentration is extremely variable due to different seasonal and geographic 
variations of vegetable growth. Sardinian wines (Cannonau and Vermentino) are 
particularly rich in flavonoids and phenolic acids, which have long residence time and 
accumulate in the mucosal intestinal layer where they can exert their beneficial 
effects. In this study we report the role of Sardinian wine extracts in modulating the 
main redox signaling pathways activated in differentiated CaCo-2 cells by a dietary 
mixture of the most representative oxysterols found in cholesterol-rich foodstuff. 
Methods: Differentiated CaCo-2 cells, whose phenotype is similar to normal mucosa 
of small intestine, were treated with a mixture of oxysterols (7-ketocholesterol, 5α,6α-
epoxycholesterol, 5β,6β-epoxycholesterol, 7α-hydroxycholesterol, and 7β-
hydroxycholesterol). Cells were pre-treated with Cannonau or Vermentino extracts. 
The activation of colonic NADPH oxidase (NOX1) and of the main transduction 
molecules (JNK, ERK and p38MAPK) were evaluated by Western Blotting. Reactive 
oxygen species (ROS) generation was detected using 2’,7’-dichlorofluorescein. 
Results: Pre-treatment with different wine extracts showed a decrease of ROS 
generation by decreasing NOX1 activity. Up-regulation of p38MAPK by dietary 
oxysterols was lowered by wine extracts. Conclusions: Our experimental model 
show that, besides their direct antioxidant action as free-radical scavengers, 
polyphenols present in Sardinian wines could exert their beneficial effects by 
interfering with red-ox cell signals, which involve NOX1 and p38MAPK down-
modulation. 
 
SIGNAL TRANSDUCTION 
 
ST1. Could Iron Overload Impair the Migratory Ability of Neurons? 
Evidence from a Cell-Based Model 
L. Steffani1, M. Ruscica1, F. Di Nitto1, S. Fargion1, P. Dongiovanni2, L. Valenti1, P. 
Magni1 
1Università degli Studi di Milano, Milan, Italy; 2Fondazione IRCCS Ca' Granda - 
Ospedale Maggiore Policlinico, Milan, Italy 
Background: Iron is essential for proper brain development in the fetal and early 
neonatal period. Iron represents a micronutrient for cellular metabolism and aerobic 
respiration, but cellular iron overload produces toxic build-up in many organs 
(including brain) via free radical formation. In thalassaemic patients with pubertal 
failure, iron overload is the most important factor afflicting the hypothalamic-pituitary 
axis, leading to hypogonadotrophic hypogonadism and growth failure. Methods: 
Mouse GN-11 cells (immature GnRH neurons with migratory ability) were used. 
Hepcidin, ferritin and transferrin receptor gene expression was evaluated by PCR. 
GN-11 chemotaxis was assessed by Boyden chamber assay. Activation of 
chemomigration-related cell signaling (extracellular signal-regulated kinase (ERK), 5' 
adenosine monophosphate-activated protein kinase (AMPK) and acetyl-CoA 
carboxylase (ACC)) was evaluated by Western blot analysis. Results: GN-11 cells 
express hepcidin, ferritin and transferrin receptor genes. 150 μM ferric ammonium 
citrate (FAC) treatment inhibited (-35%, P < 0.05) FBS-induced chemo-migration of 
GN-11 cells, which was rescued by pre-treatment with 100 μM deferoxamine, a 
specific iron chelator. Time-course experiments showed that 150 μM FAC was able 
to phosphorylate both ERK and AMPK after 10 min treatment. Specific ERK and 
AMPK inhibitors, U0126 and Compound C, respectively, abolished FAC-mediated 
signaling. Moreover, U0126 and Compound C (both 10 μM) counteracted FAC-
driven phosphorylation of ACC, an AMPK downstream protein. Conclusions: The 
present data show that iron negatively affects neuron migration via ERK and AMPK. 
Among the consequences of this event, iron overload may impair migration of GnRH 
neurons from the olfactory placode into forebrain and hypothalamus, where they 
promote reproductive competence. 
 
ST2. PRDM Gene Products in Testicular Germ Cell Tumors 
E. di Zazzo1, C. Porcile1, C. De Rosa2, A. Marino1, S. Bartollino1, C. Abbondanza2, B. 
Moncharmont1 
1Università degli Studi del Molise, Campobasso, Italy; 2Seconda Università degli 
studi di Napoli, Naples, Italy 
Background: Testicular germ cell tumors (TGCT) originate from primordial germ 
cells blocked at different stages during maturation, reflecting different histological 
tumor subtypes. A common genetic alteration in TGCT is a deletion of chromosome 
1 short arm, where the PRDM2 gene, a member of positive regulatory domain gene 
family, is located. Moreover recent studies demonstrated that members of PRDM 
gene family have an essential role in the early stages of testicular development. The 
aim of this study is to evaluate PRDM gene family members for a possible tumor-
suppressor function in TGCT. Methods: PRDM gene expression was assessed by 
mRNA RT-PCR. Cells were treated with 100 nM 17β-Estradiol (E2), 100 nM DHT or 
10 uM RA in serum free medium for 24h. RNA interference was performed using 
BLOCK-iT™ Pol II miR RNAi system. Proliferation assay was performed with 
propidium iodide staining and FACS analysis. Results: In GC1 mouse 
spermatogonial cells treatment with proliferation agents 5α-dihydrotestosterone 
(DHT) and E2 reduced PRDM2/RIZ1 expression levels whereas PRDM2 total forms 
showed no variation; the same treatment significantly increased PRDM4 and 
PRDM10 expression levels. Silencing PRDM2 gene expression by RNA interference 
increased PRDM10 expression levels and reduced the proliferation rate of 
spermatogonia. Conclusions: In spermatogonia as in MCF-7 cell line, E2 and DHT 
regulate PRDM2 gene expression suggesting that PRDM2 gene products could 
mediate the effect of these agents on cell cycle progression. PRDM4 and PRDM10 
are also responsive to steroid hormones and PRDM10 probably cooperates with 
PRDM2, as demonstrated by the increase of its expression levels after PRDM2 gene 
silencing. 
 
ST3. NHERF1 and CFTR Overexpression Restore Tight Junction 
Organisation and Function in Cystic Fibrosis Airway Epithelial Cells Via the 
Involvement of Ezrin and the RhoA/ROCK Pathway 
S. Castellani1, L. Guerra2, M. Favia2, S. Di Gioia1, V. Casavola2, M. Conese1 
1University of Foggia, Foggia, Italy; 2University of Bari, Bari, Italy 
Background: The pathophysiology of cystic fibrosis (CF) lung disease is 
characterised by abnormal ion and fluid transport across the epithelium with 
neutrophil-dominated inflammatory response. Tight junctions (TJs) restrict the transit 
of molecules through the paracellular route and act as a barrier to regulate access of 
inflammatory cells into the airway lumen. In CF cells, NHERF1 overexpression 
rescues CFTR-dependent chloride secretion by inducing the formation of the 
multiprotein complex NHERF1-RhoA-ezrin-actin. In this context, we studied whether 
NHERF1 and CFTR are involved in the organisation and function of TJs. Methods: 
TJ organisation was studied by confocal microscopy on ZO-1, occludin, claudin-1 
and JAM-1 in polarised wild-type (16HBE) and CF (CFBE) airway epithelial cells. 
Barrier function was studied by dextran permeability and neutrophil transmigration. 
Results: CFBE monolayers presented a disorganisation of TJ proteins as compared 
with 16HBE monolayers, paralleled by increased permeability to dextrans and 
neutrophil transmigration. Overexpression of NHERF1 or CFTR rescued TJ proteins 
to their proper location and restored the barrier function. Expression of a phospho-
dead ezrin mutant, T567A, increased permeability in 16HBE and in a CFBE clone 
stably overexpressing NHERF1 (CFBE/sNHERF1), whereas a constitutively active 
form of ezrin, T567D, achieved the opposite effect in CFBE. A dominant-negative 
form of RhoA (RhoA-N19) disrupted ZO-1 localisation at the TJs and increased 
permeability in CFBE/sNHERF1. The inhibitor Y27632 of Rho kinase (ROCK) 
increased permeability as well. Conclusions: These data suggest a role for the 
multiprotein complex CFTR-NHERF1-ezrin-actin in maintaining TJ organisation and 
barrier function, and suggest that the RhoA/ROCK pathway is involved. 
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ST4. The Akt1 Gain of Function Mutation, E17K, in Lung Epithelial 
Cells 
C. De Marco1, N. Rinaldo1, F. De Vita1, S. Lovisa2, L. Fabris2, G. Baldassarre2, D. 
Malanga3, G. Viglietto3 
1Biogem, Ariano Irpino (AV), Italy; 2Centro di Riferimento Oncologico, Aviano, Italy; 
3Università Magna Graecia, Catanzaro, Italy 
Background: Aberrant signalling from the phosphatidylinositol 3-kinase (PI3K)/Akt 
pathway is frequently observed in human cancer. Different studies have identified a 
gain-of-function mutation in the pleckstrin homology domain of Akt1 that results in a 
glutamic acid to lysine substitution at residue 17 (E17K) in multiple cancer types 
including lung carcinomas. So far the contribution of somatic Akt1 mutations to 
development of epithelial cancer has remained elusive. Methods: Herein, we 
examined the activity of the E17K mutant using immortalized human bronchial 
epithelial cells as model system (BEAS-2B cells). Results: Expression of Akt1-E17K 
mutant, but not of wild-type Akt1, in BEAS-2B cells induced multiple phenotypic 
alterations characteristic of tumour cells, including growth factor-independent DNA 
synthesis, anchorage-independent growth in soft agar, increased capability to 
migrate and invade, resistance to anoikis and tumorigenicity in nude mice. In 
addition, mutant Akt1 induced an expansion of a subset of putative tumor-initiating 
cells (TICs) as determined by an increase in the efficiency of sphere formation as 
well as by enhanced expression of stem cell markers, leading to the emergence of a 
cell population endowed with the capability to form aggressive, undifferentiated 
tumours at high efficiency (103-104 cells/injection). Knockdown of Oct-4 significantly 
inhibits the capability of BEAS-Akt1 cells to form sphere and to grow as xenograft in 
vivo. Conclusions: In summary, our data indicate that the Akt1-E17K mutant is 
oncogenic in lung epithelial cells and that the stem cell transcription factor Oct-4 is a 
key mediator of its oncogenic activity, thus contributing to the pathogenesis of lung 
cancer. 
 
ST5. Identification of Novel Estrogen Receptor-α (ERα) Protein 
Interactors Reveals Significant Differences Among Antiestrogen Compounds 
in Human Breast Cancer Cells 
F. Cirillo1, G. Nassa1, R. Tarallo1, C. Stellato1, M. De Filippo1, C. Ambrosino2, M. 
Baumann3, T. Nyman4, A. Weisz1 
1Laboratory of Molecular Medicine and Genomics, University of Salerno, Baronissi, 
Italy; 2Dept. of Biological and Environmental Sciences, University of Sannio, 
Benevento, Italy; 3Protein Chemistry Research Unit, Biomedicum Helsinki, Univ. of 
Helsinki, Helsinki, Finland; 4Protein Chemistry Gp. of the Inst. of Biotechnology, Univ. 
of Helsinki, Helsinki, Finland 
Background: ERα is a ligand-activated transcription-factor that promotes mammary 
epithelial cell growth and breast-carcinogenesis controlling key cellular pathways via 
protein-protein interactions within co-regulator complexes. ERα-ligands are classified 
as agonists (estrogens:17β-estradiol/E2), mixed agonists-antagonists 
(SERMs:Tamoxifen/Tam and Raloxifene/Ral) and pure-antagonists (ICI182,780-
Faslodex/ICI), according to response elicited in hormone-responsive cells. 
Crystallographic analyses on ERα bound to E2 or anti-estrogens Tam, Ral and ICI 
revealed ligand-dependent receptor conformations leading to generation of specific 
binding-sites at protein surface that represent potential docking-sites for different co-
regulators, still mainly unknown. Identifying ligand-specific ERα-interactors may lead 
to a better understanding of molecular mechanisms mediating anti-estrogen effects 
on breast cancer (BC). Methods: Tandem affinity purification (TAP) was applied to 
map nuclear ERα-interactomes induced by different ligands in hormone-responsive 
BC cells. For this purpose, MCF-7 cells stably expressing ERα fused to TAP-tag at 
the C-terminus were used to purify native receptor-containing nuclear multi-protein 
complexes from cells treated with either E2, SERMs or ICI. Isolated complexes were 
dissociated in vitro and analyzed by mass spectrometry (nanoLC-MS/MS). Results: 
This led to identification of a large number of novel ER partners and revealed 
significant differences among ligands tested. E2-promoted ERα-interactome (270 
proteins) is different and more complex that those elicited by TAM (71), Ral (48) or 
ICI (54) that, in turn, are significantly different from each other. Conclusions: In 
silico analysis of molecular functions represented by these interactomes indicates 
that E2 induces receptor association with epigenetic, transcriptional and actin-
polymerization factors. Moreover, although ICI-induced interactome is involved in 
negative regulation of biosynthetic processes, Tam- and Ral-dependent ones 
comprise regulators of macromolecular-complex synthesis and transcription-linked 
processes. Supported by AIRC; MUIR; Regione Campania; University of Salerno; 
Fondazione con il Sud; UICC-ICRETT fellowship to F. Cirillo; FEBS Short-Term 
Fellowships to G. Nassa.  
 
ST6. A Novel Morphogen-Dependent Control of IRES-Dependent 
Translation in Cancer and Development 
G. Canettieri1, L. Antonucci1, D. D'Amico1, S. Coni1, L. Di Magno1, E. De Smaele1, E. 
Ferretti1, L. Di Marcotullio1, B. Cardinali2, L. Ciapponi1, A. Gulino1 
1University La Sapienza, Rome, Italy; 2National Research Council, Rome, Italy 
Background: The Hedgehog morphogen is critical for development, stem/progenitor 
cell fate and is dysregulated in many cancers, such as medulloblastoma and basal 
cell carcinoma. Hedgehog signaling leads to the activation of Gli transcription factors 
and activation of gene expression, which is in part regulated by Suppressor of Fused 
(Sufu). To date it is not known whether Hedgehog also regulates protein translation. 
Methods: We have used biochemical, cell and stem cell culture techniques, as well 
as in vivo gene knockdown or overexpression studies in Drosophila melanogaster. 
Results: We show here that Hedgehog directly regulates IRES-dependent 
translation via a protein complex of Sufu and the RNA-binding protein CNBP. CNBP 
is up-regulated by Hedgehog and then, in a complex with Sufu, is recruited to 5’UTR 
sequences of target mRNAs where it promotes IRES-dependent protein translation. 
Sufu protects CNBP from ubiquitination and proteasomal degradation, thus 
promoting its activity. Consistent with the developmental and tumorigenic role of 
Hedgehog, CNBP is up-regulated in cerebellar stem cells, medulloblastomas and 
tumor stem cells, where it mediates self-renewal and cancer growth. Furthermore, 
this mechanism is also conserved in Drosophila, where CNBP directs wing 
development in synergy with Ci, the Drosophila Gli homolog. Conclusions: Taken 
together, we demonstrate that Hedgehog-dependent physiologic and tumorigenic 
processes require a conserved IRES-dependent translational control. We propose 
that the translational mediator CNBP and the IRES-dependent pathway can be 
considered promising novel targets for anti-cancer approaches. 
 
ST7. Itch-Dependent Nondegradative Ubiquitination of SuFu Controls 
Hedgehog Pathway 
L. Di Marcotullio1, P. Infante2, D. Mazzà2, M. Siler2, E. De Smaele2, E. Ferretti2, G. 
Canettieri2, A. Gulino2 
1University of Rome, Rome, Italy; 2University of Rome “La Sapienza”, Rome, Italy 
Background: Hedgehog (Hh) pathway regulates tissue patterning and cell 
proliferation through the activation of the transcription factors belonging to the Gli 
family. Gli proteins display a positive function, but can also be converted into a 
cleaved form with transcriptional repressor activity. This process is finely tuned by 
SuFu, which in the absence of signaling interacts and protects Gli3 full-length from 
degradation and promotes its conversion into a repressor form, Gli3R. The 
mechanistic aspects of this process are however poorly understood. Methods: 
Mouse fibroblasts (NIH3T3) and human epithelial kidney (HEK293) cells were used 
in this study. Protein-protein interaction was assessed by immunoprecipitation and 
GST-pulldown, ubiquitin modification by ubiquitination in vivo and in vitro assays. 
Depletion of Itch was obtained by siRNA. Results: We show here that the 
conversion of Gli3 into a repressor form is regulated by Itch, an HECT E3 ubiquitin 
ligase involved on major biological processes. Itch binds SuFu and promotes its 
ubiquitination both in vivo and in vitro. Of relevance, this Itch-mediated ubiquitination 
is insensitive to the proteasome activity and does not affect SuFu stability, 
suggesting that such a process drives a regulatory rather than a proteolytic 
response. Indeed, Sufu ubiquitination increases the binding of Gli3 to Sufu, thereby 
leading to Gli3R formation and inhibition of the Hh pathway. Of note, Hh agonists 
prevent Itch-triggered ubiquitination of SuFu, thus explaining how this process is 
regulated by the signaling pathway. Conclusions: Our findings suggest that Itch-
dependent SuFu ubiquitination, regulating dynamic protein-protein interaction, plays 
an important role in the control of Hh signaling. 
 
STEM CELLS IN TISSUE REGENERATION AND REGENERATIVE MEDICINE  
 
SC1. Human Amniotic Mesenchymal Stem Cells Modify the Function 
and Cytokine Production of F508del Airway Epithelial Cells Upon Coculture 
A. Carbone1, S. Castellani1, V. Paracchini2, M. Favia3, A. Diana4, S. Di Gioia1, M. 
Seia2, V. Casavola3, C. Colombo2, M. Conese1 
1University of Foggia, Foggia, Italy; 2Fondazione IRCCS Ospedale Maggiore 
Policlinico, Milan, Italy; 3University of Bari, Bari, Italy; 4A.O.U. Policlinico di Bari, Bari, 
Italy 
Background: In cystic fibrosis (CF), there is a lack/dysfunction of CF 
transmembrane conductance regulator (CFTR), a chloride channel, and epithelial 
sodium channel (ENaC) at the level of the respiratory epithelium. We evaluated 
human amniotic mesenchymal stem cells (hAMSCs) obtained from end-term 
placentae for their ability to modify defective function of CF respiratory epithelial 
cells. Methods: hAMSCs and CF bronchial epithelial cells (CFBE41o-) were 
cocultured on Transwell filters seeded at different ratios. Real-time PCR was used to 
study transcript levels of CFTR and ENaC. Expression of the CFTR protein was 
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investigated by flow cytometry and confocal microscopy. Chloride efflux was studied 
by fluorimetry. ENaC activity was assayed by apical fluid reabsorption. Cytokine 
secretion was studied in the apical and basolateral conditioned media. Results: 
hAMSCs expressed at low levels CFTR mRNA and gamma, but not alpha and beta, 
subunits of ENaC. Cocultures of hAMSCs with CFBE cells demonstrated that at least 
50-80% of hAMSCs acquired a detectable CFTR expression on the apical 
membrane above the background. Fluorimetric measure of ion chloride efflux 
allowed to detect an increased function of the CFTR channel in cocultures as 
compared with CFBE cells and hAMSCs alone. Amiloride-dependent fluid 
reabsorption decreased when CFBE cells were cocultured with hAMSCs compared 
to CFBE41o- cells alone. Unexpectedly, IL-1β, IL-6, IL-8 and TNF-α showed an 
increase depending on the hAMSC-CFBE ratio. Conclusions: Overall, these data 
show that hAMSCs are capable of resuming some pathological features of CF 
airway epithelial cells, although the cellular and molecular mechanisms have to be 
deciphered. 
 
SC2. Stem-Like Cells in Nephrospheres Present Multilineage 
Differentiative Abilities 
S. Bombelli1, M. Zipeto1, C. Bianchi1, B. Torsello1, V. Di Stefano1, G. Bovo2, P. 
Viganò3, G. Strada3, G. Cattoretti4, R. Perego1 
1Department Experimental Medicine- Milano-Bicocca University, Monza, Italy; 
2Pathology Department - S.Gerardo Hospital, Monza, Italy; 3Urology Department - 
Bassini Hospital, Cinisello Balsamo, Italy; 4Department of Surgical Sciences - 
Milano-Bicocca University, Monza, Italy 
Background: To isolate stem cells from adult kidney, we used the sphere forming 
assay approach coupled with the evaluation of self renewal and differentiative 
abilities. Methods: Nephrospheres were obtained culturing the cells from adult 
kidney in specific conditions. The sphere forming efficiency (SFE) was calculated. To 
identify and isolate the stem cell population within the nephrospheres the PKH dye, 
retained in quiescent cells, was used. The ability of nephrosphere forming cells and 
stem cells to differentiate into epithelial, podocytic and endothelial lineages was 
evaluated using specific media and 3D cultures performed with semisolid substrates. 
The regenerative abilities were evaluated transplanting the cells under the renal 
capsule of nude mice. Results: After 12 days in culture, we obtained nephrospheres 
propagable for at least eleven passages, with a SFE of 0.8%. The spheres are 
composed of a heterogeneous population of stem cells, a more PKH fluorescent 
(PKHhigh) population, and progenitors that are less fluorescent (PKHlow/neg). 
Nephrosphere forming cells and PKHhigh cells can differentiate into epithelial, 
podocytic and endothelial lineage; they can form tridimensional hollow structures 
miming the tubular in vivo behavior. Nephrosphere forming cells can generate 
tubular like structure in vivo, whereas PKHhigh cells inserted into the mice 
parenchyma maintain their undifferentiated status. Conclusions: Nephrospheres 
contain stem-like cells, as shown by the presence of quiescent cells able to self 
renew and by the ability to differentiate into renal multilineage phenotypes. This 
PKHhigh stem cells can be isolated and characterized and can represent a cellular 
material USble in regenerative medicine. 
 
SC3. Influence of Fibronectin and Collagen as Substrates for the 
Isolation and Expansion of Endothelial Progenitor Cells from Human 
Peripheral Blood 
F. Calcaterra1, E. Colombo2, M. Borsani3, M. Cappelletti2, D. Mavilio1, S. Della Bella3 
1IRCCS Istituto Clinico Humanitas, Lab Clinical Experimental Immunology, Rozzano, 
Italy; 2University of Milan, DiSTeB, Segrate, Italy; 3University of Milan, Rozzano, Italy 
Background: Endothelial progenitor cells (EPCs) have a crucial role in endothelial 
homeostasis. Among populations of endothelial cells that can be cultured from adult 
blood, endothelial colony-forming cells (ECFCs) are considered the true EPCs. 
Different methods can be used to isolate and expand ECFCs from peripheral blood, 
the main difference consisting in the substrate (fibronectin or collagen) used for cell 
seeding. The possible impact of the substrates on ECFC cultures has not been 
investigated, so far. In this study we compared ECFCs obtained using fibronectin or 
collagen during ECFC isolation and/or expansion. Methods: Healthy donor PBMCs 
were seeded on fibronectin or collagen and cultured in EGM-2. ECFC colonies were 
released from the original tissue-culture plates and replated onto tissue-culture flasks 
precoated with fibronectin or collagen, for further passages. All cultures were 
analyzed for isolation of ECFC colonies, cell yield after serial passaging, 
immunophenotype, cytokine production and in vitro angiogenesis. Results: 
Fibronectin sustained ECFC isolation more efficiently than collagen because, 
although similar numbers of colonies were obtained on the two substrates, ECFC 
colonies appeared earlier on fibronectin (P < 0.05). Collagen sustained ECFC 
expansion more efficiently, as ECFCs expanded on collagen showed longer survival 
(P < 0.02), lower rate of cultures undergoing senescence at early passages (P < 
0.02), and a higher cell yield. Preliminary results indicate that ECFCs expanded on 
fibronectin or collagen have similar immunophenotypes, cytokine profiles and ability 
for in vitro tubulogenesis. Conclusions: We suggest that isolation on fibronectin, 
followed by expansion on collagen, may represent the most efficient strategy to 
obtain ECFCs from peripheral blood samples. 
 
SC4. Mobilisation of Hematopoietic Stem/Progenitor Cells in Acute 
Lung Injury: Role of VLA-4 
S. Di Gioia1, T. Trotta1, S. Lepore1, C. Porro1, S. Castellani1, A. Maffione1, M. 
Conese1 
1University of Foggia, Foggia, Italy 
Background: The aim of this study was to determine whether there is a relationship 
between pulmonary inflammation, expression of VLA-4 (CD49d), LFA-1 (CD11a), 
and L-selectin (CD62L) and chemotaxis in resident hematopoietic stem/progenitor 
cells (HSPCs), as well as on their mobilisation in the blood. Methods: At 24, 48 and 
72 h following an intratracheal administration of a single LPS bolus in C57Bl/6 mice, 
pulmonary inflammation was studied in cytospins and bronchoalveolar lavage fluid 
(BALF) specimens. Expression of CD49d, CD11a and CD62L was analysed in Sca-
1+ HSPCs and subpopulations as well as in circulating Sca-1+ blood cells by flow 
cytometry. SDF-1-directed transmigration through an endothelial cell sheet was 
investigated. Results: In coincidence with a peak of neutrophils, cytokine (IL-1, TNF-
α, IL-6) and chemokine (KC, MIP-2, SDF-1) levels in BALF at 48 h, the number of 
marrow HSPCs expressing CD49d increased. The number of CD49d-positive 
HSPCs dropped at 72 h. The HSPC subset comprising bigger cells behaved the 
same. A significant decrease of circulating Sca-1+ cells in the mononuclear 
population, but not in the polymorphonuclear granulocytes, at 72 h following LPS 
administration was observed. Finally, SDF-1 directed chemotaxis of marrow HSPCs 
subset of bigger cells was higher in cells obtained from LPS-treated animals than 
those from controls at 72 h. Conclusions: Our data provide evidence for a temporal 
relationship between CD49d level fluctuation in HSPCs, their mobilization from the 
bone marrow and decrease in circulating HSPCs, likely for their influx in the inflamed 
lung, and show that the HSPC bigger subpopulation is affected by these changes. 
 
SC5. Erk1/2-Oct4A Interaction Mediates Oct4A Phosphorylation and 
Degradation 
F. Ferro1, R. Spelat1, F. Curcio1 
1Università di Udine, Udine, Italy 
Background: Embryonic stem (ES) cell self-renewal properties are attributed to 
critical Oct4A amounts. Although the Oct4A transcriptional targets have been deeply 
studied, little is known about its post-translational regulation.Sequence analysis 
revealed that Oct4A contains five putative ERK1/2 phosphorylation sites. Methods: 
We were able to show that Oct4A interacts with ERK1/2 in Ntera2 cell line, using 
both in vitro GST-pull down and in vivo co-immunoprecipitation assays.To explore 
the mechanism of ERK1/2-Oct4A interaction, we performed mass spectrometry 
analysis on HeLa cells transfected with Oct4A and MEk1CA.To investigate the 
possibility that ERK1/2 activation can enhance Oct4A degradation, we analyzed 
endogenous ubiquitination in HeLa cells transfected with Flag-Oct4A alone or with 
MEK1CA. Results: Consistent with the hypothesis that Oct4A is a putative ERK1/2 
substrate, we were able to show that Oct4A interacts with ERK1/2 in Ntera2 cell line, 
using both in vitro GST-pull down and in vivo co-immunoprecipitation assays. To 
explore the mechanism of ERK1/2-Oct4A interaction, we performed mass 
spectrometry analysis on HeLa cells transfected with Oct4A and MEk1CA and we 
identified phosphorylation of Ser 111, one of the previously evidenced 
phosphorylation sites. When we examined ubiquitination of Oct4A from the FLAG 
immunoprecipitation, we saw that the extent of Oct4 ubiquitination was clearly 
increased when MEk1CA was co-expressed and this increase was more evident 
after MG132 treatment, a proteosomal inhibitor. Conclusions: These results 
suggest an increase in Oct4A ubiquitination downstream of MEk1 
activation.Understanding and controlling this mechanism by which stem cells 
balance self-renewal would substantially advance our knowledge of stem cells and 
their clinical application. 
 
SC6. Proteomic Profile of CD24+ CD133+ Renal Multipotent 
Progenitors (RMP) 
G. Netti1, C. Prattichizzo1, M. Rocchetti2, L. Cormio3, G. Carrieri3, G. Stallone2, G. 
Grandaliano2, L. Gesualdo4, E. Ranieri1 
1Clinical Pathology Unit, Dept Biomedical Scieces, University of Foggia, Foggia, 
Italy; 2Nephrology Unit, Dept Biomedical Scieces, University of Foggia, Foggia, Italy; 
3Urology Unit, Dept Biomedical Scieces, University of Foggia, Foggia, Italy; 
4Nephrology Unit, DETO, University of Bari, Bari, Italy  
Background: RMP represent a population of undifferentiated pluripotent cells with 
both self-renewal and multilineage-differentiation characteristics. A population of 
CD24+CD133+RMP in adult human kidneys is able to repair injured renal tissue. 
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Proteomics provides a powerful approach for studying the characteristics of RMP 
and discovering molecular markers. Methods: RMP lines were isolated from normal 
kidneys of 30 patients undergoing nephrectomy for renal cell carcinoma. We have 
analyzed proteome profiles of two RMP lines using 2-DE analysis combined to nano-
HPLC-ESI-ion trap and MALDI-TOF-MS analysis.The identified proteins were 
studied by ingenuity pathway analysis (IPA) and validated by Immunoblot analysis. 
Results: An average of about 1080 spots were detected in the silver stained gels of 
total protein extract. The protein spots identified were involved in cellular 
cytoskeleton (28.6%), stress-response (23.8%), cellular metabolism (14.3%), cell-
proliferation and differentiation (9.5%). A large number of proteins were identified as 
chaperones, heat-shock-proteins, ubiquitin/proteasome,and oxidative-stress-
responsive-proteins. Functional clustering of differentially expressed proteins by IPA 
TM in comparison with the proximal tubular epithelial cell proteome from the same 
donors revealed that 17β-estradiol-pathway was overexpressed in RMP (IPA 
score=32).To confirm this observation we investigated the expression of three up-
regulated key-proteins of the pathway (17β-estradiol receptor, NME1, Zyxin) by 
immunoblot analysis and observed a significant increase of their expression in RMP 
cell lines compared to PTEC from the three donors. Conclusions: This study 
represents the first proteomic dataset for RMP and may provide a better insight into 
RMP-biology. Several studies explore the direct effects of sex-hormones on kidney 
and our data may suggest that RMP may represent a key-target for 17β-estradiol. 
Knowledge of RMP-biology may enable a better comprehension of the mechanisms 
of renal repair. 
 
SC7. Pharmacologic Attenuation of Cardiac Stem Cell Senescence 
E. Avolio, G. Aresu1, A. Caragnano1, R. Katare2, C. Vascotto1, P. Madeddu2, U. Livi1, 
C. Beltrami1, D. Cesselli1, A. Beltrami1 
1University of Udine, Udine, Italy; 2University of Bristol, Bristol, United Kingdom  
Background: We demonstrated that both age and pathology exert detrimental 
effects on human cardiac stem cells (CSC) and are associated with reduced 
telomerase activity and telomere length, telomere erosion, telomere induced 
dysfunction foci and CSC dysfunction in vitro. Our aims were to investigate whether 
CSC senescence is associated with their reduced reparative ability in vivo, to identify 
the molecular determinants possibly responsible for CSC senescence, to screen 
drugs (i.e. rapamycin, resveratrol, and DETA/NO) able to interfere with CSC 
senescence, and to verify if CSC drug treatment in vitro is effective in restoring the 
reparative potential of senescent CSC in vivo. Methods: CSCs were isolated both 
from normal (D) and failing (F) human hearts. The reparative capacity of CSC was 
evaluated in a SCID/beige mouse model of acute myocardial infarction (AMI). 
Echocardiography and cardiac catheterization were performed 2 weeks post-AMI. 
Fibrosis, angiogenesis, myocyte growth, myocyte apoptosis, and myocyte 
senescence were assessed. Western blot analysis of CSC was performed to identify 
pathways possibly associated with CSC senescence. Drug-screening assays were 
performed treating F-CSC for three days and analyzing them in terms of cell 
senescence, proliferation, and death. Results: Pathology attenuates the reparative 
ability of CSC in vivo. The short-term pharmacological treatment of CSC resulted in a 
significant reduction in p16+, p21+, and γH2A.X+Ki67- senescent cells, together with 
an increase in CSC proliferation. Last, in vitro treatment of F-CSC with 10nM 
rapamycin and 0.5µM resveratrol prior to their in vivo administration to infarcted mice 
restored their reparative ability in vivo, significantly improving global heart function. 
Conclusions: Pharmacological inhibition of CSC senescence enhances their 
regenerative capacities.
